from django.http import HttpResponse

from qbank.serializers import CourseSerializer, QuestionSerializer
from .models import *
from rest_framework.decorators import api_view
from rest_framework.response import Response

# Create your views here.
def index(request):
    data = [
        {
            "exhibits": None,
            "sequenceId": 1,
            "questionId": 3922,
            "questionIndex": 3922,
            "questionText": "<p>A group of investigators is studying the relationship between a particular 5-lipoxygenase genotype and atherosclerosis.&nbsp; A random sample of patients from a local university hospital is invited to participate in the study.&nbsp; Blood samples for leukocyte genotyping are obtained, and ultrasonography to assess carotid intima-media thickness (CIMT), a marker of atherosclerosis, is performed.&nbsp; Results show that the particular 5-lipoxygenase genotype is associated with abnormally increased CIMT, a predisposition to atherosclerosis.&nbsp; Which of the following best describes this study design?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"6804\" src=\"https://www.uworld.com/media/L13767.jpg\" ></p><p>A <strong>cross-sectional</strong> study is an <strong>observational</strong> study design that may be employed to estimate the <strong>prevalence</strong> of disease, or to examine <strong>associations</strong> between risk factors and disease as they exist in a well-defined population at <strong>one particular time</strong>.&nbsp; This type of design typically takes a <strong>snapshot</strong> and measures prevalence of risk factor and outcome simultaneously.</p><p>In this case, subjects are classified according to their risk factor (ie, presence or absence of the particular 5-lipoxygenase genotype) and disease status (ie, presence or absence of abnormally increased carotid intima-media thickness [CIMT]) <strong>at the same time</strong> (ie, snapshot).&nbsp; Then, the association between the presence of the risk factor and the disease is estimated.&nbsp; A major <strong>limitation</strong> of cross-sectional studies is that the temporal relationship between risk factor and disease is not always clear.&nbsp; In this example, however, demonstrating a temporal relationship is possible due to the nature of the risk factor (acquiring a particular genotype precedes atherosclerosis).</p><p><strong>(Choice A)</strong>&nbsp; A case-control study is designed by selecting both patients with a particular disease (cases) and patients without that disease (controls), and then determining their previous exposure status.&nbsp; In this case, the researchers selected a single sample from the target population and categorized subjects according to their presence or absence of the risk factor (ie, a particular 5-lipoxygenase genotype) and disease (ie, CIMT status) at a single point in time.</p><p><strong>(Choices C and E)</strong>&nbsp; In cohort studies, a group of exposed and unexposed subjects is followed over time for development of the outcome of interest.&nbsp; Contrary to the prospective cohort study, in the retrospective case, exposure and outcome have already occurred at the beginning of the study; therefore, exposure and outcome status are ascertained retrospectively.&nbsp; In both prospective and retrospective cohort studies, however, there is a follow-up of exposed and unexposed individuals across time.&nbsp; By contrast, in this example, a snapshot of the subjects was obtained at one particular time.</p><p><strong>(Choice D)</strong>&nbsp; A randomized clinical trial is an experimental study that directly compares &#8805;2 treatments or interventions.&nbsp; Typically, the subjects are randomly assigned to an intervention (eg, a medication) or placebo, and then followed for the development of the outcome of interest (eg, disease).</p><p><strong>Educational objective:</strong><br>In a cross-sectional study, risk factor and outcome are measured simultaneously at a particular point in time (snapshot study).&nbsp; In other study designs, a certain period separates the exposure from the outcome.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1012,
            "section": "Shelf Review",
            "subjectId": 240010,
            "subject": "Ambulatory Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": None,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 19502,
            "topic": "Study designs",
            "titleId": 19502,
            "title": "Study designs",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "2",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Case-control study",
                    "choiceNumber": 1,
                    "correctTaken": 387,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cross-sectional study",
                    "choiceNumber": 2,
                    "correctTaken": 3283,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prospective cohort study",
                    "choiceNumber": 3,
                    "correctTaken": 689,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Randomized clinical trial",
                    "choiceNumber": 4,
                    "correctTaken": 308,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Retrospective cohort study",
                    "choiceNumber": 5,
                    "correctTaken": 344,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": None,
            "isCorrect": False,
            "isIncorrect": False,
            "isMarked": False,
            "isOmitted": True,
            "isQuestionDirty": False,
            "isAnswerChoiceDisabled": False,
            "isQuestionDisabled": False,
            "questionMappingReferencesList": None,
            "questionMedia": None,
            "timeSpent": 0,
            "othersAvgTimeSpent": 64,
            "notes": None,
            "peopleTaken": 5011,
            "hotspotImageUrl": None,
            "lastUpdatedDate": "01/01/2022",
            "correctPercentile": 65,
            "isSubmitted": False,
            "isActive": True,
            "activeStatusId": 1,
            "hint": None,
            "allowCalculator": False,
            "difficultyLevelId": None,
            "additionalText": None,
            "mobileExcerpt": None,
            "passageExcerpt": None,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": None,
            "standards": None,
            "totalTimeSpentReview": 11,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": None,
            "examYear": 0,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": None,
            "copyrightId": None,
            "copyrightText": None,
            "frequentHighlights": None,
            "totalWeight": None,
            "weightScored": None,
            "maxAnswerSelection": 0,
            "scoreTypeId": None
        },
        {
            "exhibits": None,
            "sequenceId": 2,
            "questionId": 2732,
            "questionIndex": 2732,
            "questionText": "<p>A 54-year-old man who is homeless comes to the emergency department 24 hours after the onset of substernal chest pain and is diagnosed with an anterior wall myocardial infarction.&nbsp; The patient has no history of hypertension or diabetes mellitus and has had no previous chest pain, dyspnea, palpitations, syncope, or leg swelling.&nbsp; He has a 40-pack-year smoking history.&nbsp; Echocardiography shows normal left ventricular size and left ventricular anterior wall hypokinesis, as well as an ejection fraction of 40%.&nbsp; The patient declines pharmacologic therapy on discharge and is scheduled for an outpatient clinic visit but becomes lost to follow up.&nbsp; Two years later, the patient is found dead by one of his friends.&nbsp; Autopsy reveals a dilated left ventricle with a globular shape and thinned walls with a scar on the anterior wall.&nbsp; Which of the following would most likely have helped prevent this patient&#39;s pathologic findings?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"40495\" src=\"https://www.uworld.com/media/highresdefault/L66514.jpg\"  ></p><p>This patient&#39;s myocardial infarction (MI) 2 years ago resulted in left ventricular (LV) systolic dysfunction, and autopsy shows a dilated left ventricle with thinned walls and evidence of scarring.&nbsp; These findings are consistent with <a href=\"2795\">eccentric hypertrophy</a> due to <strong>ischemic heart disease</strong>.&nbsp; Both infarction and LV systolic dysfunction induce deleterious <strong>cardiac remodeling</strong> with pathologic cardiomyocyte hypertrophy and collagen deposition; these changes commonly progress to cause severe LV systolic dysfunction and create an increased risk for fatal cardiac arrhythmia (eg, ventricular tachycardia or fibrillation), which was the likely cause of death in this patient.</p><p>Cardiac remodeling is mostly driven by <strong>neurohormonal pathways</strong>, including the renin-angiotensin-aldosterone pathway; inhibition of this pathway with an <strong>ACE inhibitor</strong> (eg, enalapril, lisinopril) has been shown to <strong>reduce cardiac remodeling</strong> and <strong>improve survival</strong> in patients who have had MI, especially those with an LV ejection fraction of &#8804;40% and/or anterior wall MI.</p><p>Certain beta blockers (eg, metoprolol, carvedilol) have demonstrated similar benefit in all patients following MI, likely through inhibition of sympathetically driven cardiac remodeling pathways.&nbsp; Aldosterone antagonists (eg, spironolactone) have shown survival benefit in patients with MI and LV ejection fraction of &#8804;40%.</p><p><strong>(Choice A)</strong>&nbsp; Dihydropyridine calcium channel blockers (eg, amlodipine) are appropriate for treating hypertension and may reduce a component of cardiac remodeling that is stimulated by increased LV pressure load.&nbsp; However, these drugs have not shown the degree of survival benefit following MI that ACE inhibitors and other neurohormonal-inhibiting drugs have shown.</p><p><strong>(Choice B)</strong>&nbsp; Anticoagulation agents (eg, apixaban) are not routinely used following MI.&nbsp; These are appropriate to prevent systemic embolization (eg, stroke) in patients with LV aneurysm and mural thrombus, of which this patient has no evidence on autopsy.</p><p><strong>(Choice C)</strong>&nbsp; Low-dose aspirin is beneficial for secondary prevention of further cardiovascular events in patients who have had MI, but it is not known to benefit cardiac remodeling.</p><p><strong>(Choice E)</strong>&nbsp; Isosorbide dinitrate is useful in treating symptomatic angina, but it has not shown survival benefit following MI.</p><p><strong>(Choice F)</strong>&nbsp; P2Y<font size=\"2\"><sub>12</sub></font> inhibitors (eg, prasugrel, clopidogrel), in combination with aspirin, have been shown to reduce cardiovascular events within the first year after MI; however, these drugs do not reduce cardiac remodeling.</p><p><strong>Educational objective:</strong><br>Following myocardial infarction (MI), deleterious cardiac remodeling is mostly driven by neurohormonal mechanisms.&nbsp; ACE inhibitors (eg, enalapril, lisinopril), beta blockers (eg, metoprolol), and aldosterone antagonists (eg, spironolactone) improve survival following MI, likely due to inhibition of neurohormonal-mediated cardiac remodeling.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1012,
            "section": "Shelf Review",
            "subjectId": 240010,
            "subject": "Ambulatory Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": None,
            "systemId": 203,
            "system": "Cardiovascular System",
            "topicId": 2311,
            "topic": "Myocardial infarction",
            "titleId": 2311,
            "title": "Myocardial infarction",
            "topicAttributeId": 330578,
            "topicAttribute": "Coronary heart disease",
            "correctAnswer": "4",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Amlodipine",
                    "choiceNumber": 1,
                    "correctTaken": 324,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Apixaban",
                    "choiceNumber": 2,
                    "correctTaken": 185,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Aspirin",
                    "choiceNumber": 3,
                    "correctTaken": 495,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Enalapril",
                    "choiceNumber": 4,
                    "correctTaken": 3733,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Isosorbide dinitrate",
                    "choiceNumber": 5,
                    "correctTaken": 224,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prasugrel",
                    "choiceNumber": 6,
                    "correctTaken": 87,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": None,
            "isCorrect": False,
            "isIncorrect": False,
            "isMarked": False,
            "isOmitted": True,
            "isQuestionDirty": False,
            "isAnswerChoiceDisabled": False,
            "isQuestionDisabled": False,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "9049514",
                    "mediaDataId": 0,
                    "title": "Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure.  A report from the AIRE Study Investigators.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/9049514"
                }
            ],
            "questionMedia": None,
            "timeSpent": 0,
            "othersAvgTimeSpent": 75,
            "notes": None,
            "peopleTaken": 5048,
            "hotspotImageUrl": None,
            "lastUpdatedDate": "01/01/2022",
            "correctPercentile": 73,
            "isSubmitted": False,
            "isActive": True,
            "activeStatusId": 1,
            "hint": None,
            "allowCalculator": False,
            "difficultyLevelId": None,
            "additionalText": None,
            "mobileExcerpt": None,
            "passageExcerpt": None,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": None,
            "standards": None,
            "totalTimeSpentReview": 4,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": None,
            "examYear": 0,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": None,
            "copyrightId": None,
            "copyrightText": None,
            "frequentHighlights": None,
            "totalWeight": None,
            "weightScored": None,
            "maxAnswerSelection": 0,
            "scoreTypeId": None
        },
        {
            "exhibits": None,
            "sequenceId": 3,
            "questionId": 3961,
            "questionIndex": 3961,
            "questionText": "<p>A group of investigators plans to conduct a study to assess the relationship between colon cancer and elevated plasma C-reactive protein (CRP) levels.&nbsp; The study design involves determining the prevalence of elevated plasma CRP levels (based on prespecified cutoff values) and of colon cancer in a sample of individuals at a given point in time.&nbsp; The prevalence of elevated CRP levels is compared between patients with and without colon cancer.&nbsp; Which of the following is the best statement of the None hypothesis for this study?</p>",
            "questionHeader": "",
            "explanationText": "<p>To state the <strong>None hypothesis</strong> correctly, the study design must be considered.&nbsp; In this case, the study is <strong>cross-sectional</strong> as the investigators are taking a snapshot of a sample and measuring prevalence of elevated C-reactive protein (CRP) levels and of colon cancer at the same time.&nbsp; Therefore, the None hypothesis should state that there is no association between elevated plasma CRP levels (equivalent to exposure) and colon cancer (equivalent to outcome).&nbsp; In general, the None hypothesis represents a statement of <strong>no association</strong> between variables of interest.</p><p>As this is a cross-sectional study, the temporal relationship between the 2 variables (ie, whether the exposure preceded the outcome, or whether the outcome preceded the exposure) cannot be determined.&nbsp; It would not be suitable for the None hypothesis in this case to suggest a temporality or risk profile, whether having colon cancer is a risk factor impacting CRP levels <strong>(Choice B)</strong> or having elevated CRP levels is a risk factor for colon cancer <strong>(Choice C)</strong>.</p><p><strong>(Choice A)</strong>&nbsp; This would not be a suitable None hypothesis as it states that there is an association (&#x22;more prevalent&#x22;) between an exposure and outcome.</p><p><strong>(Choice D)</strong>&nbsp; This would have been a valid statement of the None hypothesis for a cohort study, in which individuals with and without elevated CRP levels are followed over time to determine the risk of colon cancer.</p><p><strong>Educational objective:</strong><br>The None hypothesis is the statement of no relationship between the exposure and the outcome.&nbsp; To state the None hypothesis correctly, the study design should be considered.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1012,
            "section": "Shelf Review",
            "subjectId": 240010,
            "subject": "Ambulatory Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": None,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 7245,
            "topic": "Hypothesis testing",
            "titleId": 7245,
            "title": "Hypothesis testing",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "5",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Colon cancer is more prevalent among subjects with elevated CRP levels",
                    "choiceNumber": 1,
                    "correctTaken": 203,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Having a diagnosis of colon cancer does not affect plasma CRP levels",
                    "choiceNumber": 2,
                    "correctTaken": 267,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Subjects with elevated plasma CRP levels are prone to colon cancer",
                    "choiceNumber": 3,
                    "correctTaken": 92,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The risk of colon cancer is the same for subjects with and without elevated plasma CRP levels",
                    "choiceNumber": 4,
                    "correctTaken": 769,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "There is no association between elevated plasma CRP level and colon cancer",
                    "choiceNumber": 5,
                    "correctTaken": 3695,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": None,
            "isCorrect": False,
            "isIncorrect": False,
            "isMarked": False,
            "isOmitted": True,
            "isQuestionDirty": False,
            "isAnswerChoiceDisabled": False,
            "isQuestionDisabled": False,
            "questionMappingReferencesList": None,
            "questionMedia": None,
            "timeSpent": 0,
            "othersAvgTimeSpent": 63,
            "notes": None,
            "peopleTaken": 5026,
            "hotspotImageUrl": None,
            "lastUpdatedDate": "01/01/2022",
            "correctPercentile": 73,
            "isSubmitted": False,
            "isActive": True,
            "activeStatusId": 1,
            "hint": None,
            "allowCalculator": False,
            "difficultyLevelId": None,
            "additionalText": None,
            "mobileExcerpt": None,
            "passageExcerpt": None,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": None,
            "standards": None,
            "totalTimeSpentReview": 11,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": None,
            "examYear": 0,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": None,
            "copyrightId": None,
            "copyrightText": None,
            "frequentHighlights": None,
            "totalWeight": None,
            "weightScored": None,
            "maxAnswerSelection": 0,
            "scoreTypeId": None
        },
        {
            "exhibits": None,
            "sequenceId": 4,
            "questionId": 4722,
            "questionIndex": 4722,
            "questionText": "<p>A 42-year-old woman is evaluated for depression and poor sleep.&nbsp; She also has mild headaches and muscle weakness.&nbsp; The review of hospital records indicates emergency department visits for anxiety and kidney stones.&nbsp; The patient is a lifetime nonsmoker and does not use illicit drugs.&nbsp; Blood pressure is 160/105 mm Hg and pulse is 85/min.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Sodium</td><td style=\"vertical-align:middle;\">139 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">Potassium</td><td style=\"vertical-align:middle;\">3.8 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">Chloride</td><td style=\"vertical-align:middle;\">102 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">Bicarbonate</td><td style=\"vertical-align:middle;\">24 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">Blood urea nitrogen</td><td style=\"vertical-align:middle;\">13 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Creatinine</td><td style=\"vertical-align:middle;\">0.9 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Glucose</td><td style=\"vertical-align:middle;\">98 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Calcium</td><td style=\"vertical-align:middle;\">11.7 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Albumin</td><td style=\"vertical-align:middle;\">3.7 g/dL</td></tr></tbody></table><p>Which of the following best explains this patient&#39;s hypertension?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t35223\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Secondary causes of hypertension</strong></p></td></tr><tr><td><p align=\"center\"><strong>Condition</strong></p></td><td><p align=\"center\"><strong>Clinical clues/features</strong></p></td></tr><tr><td><p align=\"center\"><strong>Renal parenchymal</strong></p><p align=\"center\"><strong>disease</strong></p></td><td><ul><li>Elevated serum creatinine</li><li>Abnormal urinalysis (proteinuria, red blood cell casts)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Renovascular</strong></p><p align=\"center\"><strong>disease</strong></p></td><td><ul><li>Severe hypertension with onset after age&nbsp;55</li><li>Recurrent flash pulmonary edema</li><li>Rise in serum creatinine</li><li>Abdominal bruit</li></ul></td></tr><tr><td><p align=\"center\"><strong>Primary</strong></p><p align=\"center\"><strong>aldosteronism</strong></p></td><td><ul><li>Spontaneous or easily provoked hypokalemia</li></ul></td></tr><tr><td><p align=\"center\"><strong>Pheochromocytoma</strong></p></td><td><ul><li>Paroxysmal hypertension with tachycardia</li><li>Pounding headaches, palpitations, diaphoresis</li></ul></td></tr><tr><td><p align=\"center\"><strong>Cushing syndrome</strong></p></td><td><ul><li>Cushingoid body habitus</li><li>Proximal muscle weakness</li><li>Hyperglycemia</li></ul></td></tr><tr><td><p align=\"center\"><strong>Thyroid disease</strong></p></td><td><ul><li>Hyperthyroidism: anxiety, heat intolerance, weight loss, tachycardia</li><li>Hypothyroidism: fatigue, cold intolerance, weight gain, bradycardia</li></ul></td></tr><tr><td><p align=\"center\"><strong>Primary<br />hyperparathyroidism</strong></p></td><td><ul><li>Hypercalcemia</li><li>Kidney stones</li><li>Neuropsychiatric symptoms</li></ul></td></tr><tr><td><p align=\"center\"><strong>Coarctation<br />of the aorta</strong></p></td><td><ul><li>Lateralizing hypertension</li><li>Brachial-femoral pulse delay</li></ul></td></tr></tbody></table></div><p>This patient with hypertension associated with hypercalcemia, muscle weakness, kidney stones, and neuropsychiatric symptoms (eg, depression, poor sleep)&nbsp;likely has <strong>primary hyperparathyroidism (PHPT)</strong>.</p><p>Excess parathyroid hormone causes <strong>hypercalcemia</strong> due to increased renal calcium reabsorption, gastrointestinal calcium absorption, and bone resorption.&nbsp; In addition to kidney stones, neuropsychiatric symptoms, and muscle weakness, other common manifestations include abdominal pain, constipation, and polyuria or polydipsia.&nbsp; The majority (~80%) of PHPT cases are due to parathyroid adenoma.</p><p>PHPT is commonly associated with <strong>hypertension</strong>; proposed mechanisms include increased renin secretion, sympathetic hyperresponsiveness, and peripheral artery vasoconstriction.&nbsp; Other cardiovascular manifestations of hyperparathyroidism include left ventricular hypertrophy, arrhythmias, and vascular and valvular calcification.&nbsp; Treatment of PHPT usually results in normalization of blood pressure.</p><p><strong>(Choice A)</strong>&nbsp; Amphetamine abuse can cause hypertension associated with additional signs and symptoms of sympathetic stimulation (eg, tachycardia, diaphoresis, hyperthermia) but would not cause hypercalcemia and kidney stones.</p><p><strong>(Choice B)</strong>&nbsp; Findings suggestive of Cushing syndrome include central obesity, muscle wasting, thin skin, and abdominal striae.&nbsp; Laboratory findings include hyperglycemia, leukocytosis, and hypokalemia.</p><p><strong>(Choice D)</strong>&nbsp; Hypertension can be induced by both hyperthyroidism (predominantly systolic hypertension) and hypothyroidism (predominantly diastolic hypertension).&nbsp; Although hyperthyroidism can cause hypercalcemia due to increased bone turnover, hypothyroidism does not have a significant effect on serum calcium concentration.</p><p><strong>(Choice E)</strong>&nbsp; Primary hyperaldosteronism (Conn syndrome) can cause hypertension and muscle weakness, but it is typically associated with hypokalemia (especially when patients are given diuretics) rather than hypercalcemia.</p><p><strong>(Choice F)</strong>&nbsp; Although renal artery stenosis can occur in young women with fibromuscular dysplasia, it is much more common in older men with atherosclerosis.&nbsp; Suggestive findings include resistant hypertension, abdominal bruit, recurrent flash pulmonary edema, and acute kidney injury following initiation of an ACE inhibitor.</p><p><strong>(Choice G)</strong>&nbsp; Renal parenchymal disease can cause secondary hypertension but usually presents with elevated serum creatinine and abnormal urinalysis.&nbsp; In addition, patients are usually hypocalcemic rather than hypercalcemic.</p><p><strong>Educational objective:</strong><br>Hyperparathyroidism is a cause of secondary hypertension and should be suspected in patients who have hypertension associated with hypercalcemia, renal stones, abdominal pain, or neuropsychiatric symptoms.&nbsp; Other cardiovascular manifestations of hyperparathyroidism include left ventricular hypertrophy, arrhythmias, and vascular and valvular calcification.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1012,
            "section": "Shelf Review",
            "subjectId": 240010,
            "subject": "Ambulatory Medicine",
            "secondarySubjectId": 250002,
            "secondarySubject": "Medicine",
            "systemId": 203,
            "system": "Cardiovascular System",
            "topicId": 15573,
            "topic": "Secondary hypertension",
            "titleId": 15573,
            "title": "Secondary hypertension",
            "topicAttributeId": 330611,
            "topicAttribute": "Hypertension",
            "correctAnswer": "3",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Amphetamine abuse",
                    "choiceNumber": 1,
                    "correctTaken": 129,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cushing syndrome",
                    "choiceNumber": 2,
                    "correctTaken": 167,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hyperparathyroidism",
                    "choiceNumber": 3,
                    "correctTaken": 3947,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypothyroidism",
                    "choiceNumber": 4,
                    "correctTaken": 153,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Primary hyperaldosteronism",
                    "choiceNumber": 5,
                    "correctTaken": 162,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Renal artery stenosis",
                    "choiceNumber": 6,
                    "correctTaken": 303,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Renal parenchymal disease",
                    "choiceNumber": 7,
                    "correctTaken": 205,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": None,
            "isCorrect": False,
            "isIncorrect": False,
            "isMarked": False,
            "isOmitted": True,
            "isQuestionDirty": False,
            "isAnswerChoiceDisabled": False,
            "isQuestionDisabled": False,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27847154",
                    "mediaDataId": 0,
                    "title": "Primary hyperparathyroidism predicts hypertension: results from the National Inpatient Sample.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27847154"
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27864805",
                    "mediaDataId": 0,
                    "title": "Endocrine hypertension: a practical approach.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27864805"
                }
            ],
            "questionMedia": None,
            "timeSpent": 0,
            "othersAvgTimeSpent": 110,
            "notes": None,
            "peopleTaken": 5066,
            "hotspotImageUrl": None,
            "lastUpdatedDate": "01/01/2022",
            "correctPercentile": 77,
            "isSubmitted": False,
            "isActive": True,
            "activeStatusId": 1,
            "hint": None,
            "allowCalculator": False,
            "difficultyLevelId": None,
            "additionalText": None,
            "mobileExcerpt": None,
            "passageExcerpt": None,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": None,
            "standards": None,
            "totalTimeSpentReview": 14,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": None,
            "examYear": 0,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": None,
            "copyrightId": None,
            "copyrightText": None,
            "frequentHighlights": None,
            "totalWeight": None,
            "weightScored": None,
            "maxAnswerSelection": 0,
            "scoreTypeId": None
        },
        {
            "exhibits": None,
            "sequenceId": 5,
            "questionId": 15655,
            "questionIndex": 17090,
            "questionText": "<p>A 76-year-old man with coronary artery disease comes to the office for follow-up 6 months after an uncomplicated coronary artery bypass surgery.&nbsp; The exertional chest pain that was bothering the patient before the surgery has completely resolved.&nbsp; He reports no palpitations, shortness of breath, light-headedness, or syncope.&nbsp; The patient has a history of hypertension, diet-controlled type 2 diabetes mellitus, and gout.&nbsp; Medications include low-dose aspirin, metoprolol, and rosuvastatin.&nbsp; He has a 30-pack-year smoking history but quit 5 years ago.&nbsp; The patient does not use alcohol or illicit drugs.&nbsp; Physical examination shows an irregular pulse.&nbsp; The chest surgical incision is well healed.&nbsp; There are no heart murmurs, and the lungs are clear on auscultation.&nbsp; There is no peripheral edema.&nbsp; ECG obtained in the office is shown in the <a href=\"27867\">exhibit</a>.&nbsp; Which of the following is the best management for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient&#39;s ECG demonstrates <strong>saw-toothed</strong>&nbsp;<a href=\"27868\">flutter waves</a> consistent with <strong>atrial flutter</strong>.&nbsp; The atrial rate is typically approximately 300/min, and the ventricular response can be constant or variable.&nbsp; This patient has a variable ventricular response rate that creates an <strong>irregular rhythm</strong>, whereas a constant ventricular response rate (eg, a constant 3:1 ventricular response at a rate of 100/min) can create a regular-appearing rhythm.</p><p>Atrial flutter usually results from a large <a href=\"21372\">reentrant circuit</a> involving the cavotricuspid isthmus of the right atrium.&nbsp; Risk factors are similar to those for atrial fibrillation and include age, hypertension, and heart failure.&nbsp; The arrhythmia is also frequently seen following cardiac surgery.&nbsp; Atrial flutter carries a similar <strong>risk of arterial thromboembolism</strong> to atrial fibrillation; therefore, this patient with multiple <a href=\"54472\">CHA<font size=\"2\"><sub>2</sub></font>DS<font size=\"2\"><sub>2</sub></font>-VASc</a> risk factors should be started on <strong>chronic anticoagulation</strong> (eg, rivaroxaban, apixaban) therapy.</p><p>Although not needed in this patient (whose pulse is ~60-70/min), management also involves rate control, which can sometimes be difficult to accomplish with medications alone (eg, metoprolol, verapamil).&nbsp; Definitive management often requires radiofrequency ablation to disrupt the reentrant circuit, or electric cardioversion is also sometimes an option.&nbsp; These interventions increase the risk of a thromboembolic event and should be preceded by several weeks of anticoagulation therapy.</p><p><strong>(Choice A)</strong>&nbsp; Atrioventricular (AV) nodal slow pathway ablation is used to treat AV nodal reentrant tachycardia, a type of paroxysmal supraventricular tachycardia.&nbsp; <a href=\"50634\">ECG</a> usually shows a regular rhythm with rapid rate and no visible P waves.&nbsp; The reentrant circuit in atrial flutter does not involve the AV node.</p><p><strong>(Choice B)</strong>&nbsp; Exercise stress testing is used to evaluate for coronary artery disease in patients with suggestive symptoms (eg, chest pain on exertion), but it is not indicated in this patient.</p><p><strong>(Choice C)</strong>&nbsp; Flecainide is a class IC antiarrhythmic that is sometimes used to treat atrial fibrillation.&nbsp; Such rhythm-control agents are less preferable for atrial flutter because of poor efficacy and the risk of precipitating rapid ventricular response.</p><p><strong>(Choice E)</strong>&nbsp; Routine follow-up in 6 months is not appropriate because atrial flutter significantly increases the risk of thromboembolic stroke in this patient with multiple CHA<font size=\"2\"><sub>2</sub></font>DS<font size=\"2\"><sub>2</sub></font>-VASc risk factors.</p><p><strong>Educational objective:</strong><br>Atrial flutter is recognized by saw-toothed flutter waves on ECG; the rhythm can be regular or irregular depending on the variability of the ventricular response rate.&nbsp; Atrial flutter carries a similar risk of arterial thromboembolization to atrial fibrillation and should be similarly managed with chronic anticoagulation.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1012,
            "section": "Shelf Review",
            "subjectId": 240010,
            "subject": "Ambulatory Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": None,
            "systemId": 203,
            "system": "Cardiovascular System",
            "topicId": 5595,
            "topic": "Atrial flutter",
            "titleId": 5595,
            "title": "Atrial flutter",
            "topicAttributeId": 331282,
            "topicAttribute": "Cardiac arrhythmias and syncope",
            "correctAnswer": "4",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Atrioventricular nodal slow pathway ablation",
                    "choiceNumber": 1,
                    "correctTaken": 745,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Exercise stress testing",
                    "choiceNumber": 2,
                    "correctTaken": 21,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Flecainide initiation",
                    "choiceNumber": 3,
                    "correctTaken": 993,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Oral anticoagulant therapy",
                    "choiceNumber": 4,
                    "correctTaken": 2987,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Routine follow-up in 6 months",
                    "choiceNumber": 5,
                    "correctTaken": 281,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": None,
            "isCorrect": False,
            "isIncorrect": False,
            "isMarked": False,
            "isOmitted": True,
            "isQuestionDirty": False,
            "isAnswerChoiceDisabled": False,
            "isQuestionDisabled": False,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "15694889",
                    "mediaDataId": 0,
                    "title": "Atrial flutter and the risk of thromboembolism: a systemic review and meta-analysis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/15694889"
                }
            ],
            "questionMedia": None,
            "timeSpent": 0,
            "othersAvgTimeSpent": 88,
            "notes": None,
            "peopleTaken": 5025,
            "hotspotImageUrl": None,
            "lastUpdatedDate": "01/01/2022",
            "correctPercentile": 59,
            "isSubmitted": False,
            "isActive": True,
            "activeStatusId": 1,
            "hint": None,
            "allowCalculator": False,
            "difficultyLevelId": None,
            "additionalText": None,
            "mobileExcerpt": None,
            "passageExcerpt": None,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": None,
            "standards": None,
            "totalTimeSpentReview": 41,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": None,
            "examYear": 0,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": None,
            "copyrightId": None,
            "copyrightText": None,
            "frequentHighlights": None,
            "totalWeight": None,
            "weightScored": None,
            "maxAnswerSelection": 0,
            "scoreTypeId": None
        },
        {
            "exhibits": None,
            "sequenceId": 6,
            "questionId": 11348,
            "questionIndex": 12501,
            "questionText": "<p>A 21-year-old woman is evaluated for syncope.&nbsp; She has had recurrent episodes of syncope since her mid-teens.&nbsp; The first episode happened when she was having blood drawn for a test.&nbsp; She has also passed out several times while standing in a crowded church.&nbsp; The syncope is typically preceded by a feeling of warmth, lightheadedness, diaphoresis, and nausea.&nbsp; During one episode, the patient had a minor head injury and facial laceration.&nbsp; Her medical history is otherwise insignificant.&nbsp; She takes no medications and uses no illicit drugs.&nbsp; Blood pressure is 122/76 mm Hg supine and 125/80 mm Hg after 2 minutes of standing.&nbsp; Pulse is 72/min and regular.&nbsp; Physical examination is unremarkable.&nbsp; ECG shows normal sinus rhythm with no significant abnormalities.&nbsp; Long-term ECG monitoring is most likely to show which of the following immediately preceding and during the syncopal episode?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t31410\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Vasovagal &amp; situational syncope</strong></p></td></tr><tr><td><p align=\"center\"><strong>Triggers</strong></p></td><td><ul><li>Pain,* anxiety,* emotional stress, heat, prolonged standing</li><li>Situational: cough,* micturition,* defecation, eating, hair-combing*</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br />presentation</strong></p></td><td><ul><li>Prodrome (eg, warmth, pallor, nausea, diaphoresis)</li><li>Rapid recovery of consciousness (eg,&nbsp;&lt;1-2&nbsp;min)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><ul><li>Mainly based on clinical history of event</li><li>Upright tilt table testing sometimes indicated in uncertain cases</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Reassurance &amp; avoidance of triggers</li><li>Counterpressure techniques for recurrent episodes</li></ul></td></tr><tr><td colspan=\"2\"><p>*Particularly common triggers in the pediatric population.</p></td></tr></tbody></table></div><p>Syncope is a quick-resolving loss of consciousness that results from transient cerebral hypoperfusion leading to loss of postural tone (eg, collapse).&nbsp; This patient is most likely experiencing <strong>vasovagal syncope</strong> (neurocardiogenic syncope), which occurs due to an alteration in autonomic drive.&nbsp; Most commonly, abrupt <strong>parasympathetic activation</strong> leads to a <strong>cardioinhibitory</strong> response that manifests as <strong>bradycardia with sinus arrest</strong>.&nbsp; Less commonly, <strong>decreased sympathetic drive</strong> leads to a <strong>vasodepressor</strong> response, resulting in peripheral vasodilation and abrupt hypotension.&nbsp; In both scenarios, cerebral perfusion suddenly decreases and syncope occurs.&nbsp; The episode resolves quickly (typically &lt;1 minute) as cerebral perfusion is rapidly restored.</p><p>Vasovagal syncope most commonly affects young patients and is often triggered by <strong>emotional stress</strong> (eg, fear of venipuncture) or prolonged standing.&nbsp; The diagnosis is usually clinical.&nbsp; A <strong>prodrome</strong> (eg, nausea, diaphoresis, pallor, lightheadedness) typically precedes vasovagal syncope and helps differentiate it from serious causes of syncope (eg, cardiogenic syncope).&nbsp; In addition, measurement of normal orthostatic blood pressure helps rule out orthostatic syncope.</p><p>Isolated episodes of vasovagal syncope require no treatment other than reassurance.&nbsp; Recurrent episodes may warrant counseling to avoid common triggers as well as training in counterpressure techniques (eg, leg-crossing, hand grip) to try to avert a syncope episode once prodromal symptoms occur.</p><p><strong>(Choices A and E)</strong>&nbsp; Atrial arrhythmias (eg, atrial fibrillation, atrial flutter) with a rapid ventricular rate (eg, &gt;150/min) and ventricular arrhythmias (eg, ventricular tachycardia) can cause cardiogenic syncope due to inadequate ventricular filling and loss of cardiac output.&nbsp; The syncope is typically sudden; patients may experience palpitations prior to the episode, but a prodrome of nausea and diaphoresis is not typical.</p><p><strong>(Choice C)</strong>&nbsp; Sinus tachycardia does not cause syncope.&nbsp; Patients often have sinus tachycardia as a reflex response after a syncope episode.</p><p><strong>(Choice D)</strong>&nbsp; Third-degree atrioventricular block can cause cardiogenic syncope but typically in patients with a history of heart disease (eg, myocardial infarction, systemic amyloidosis, Lyme carditis).&nbsp; It would be unusual in this young woman with no significant medical history.&nbsp; Varying degrees of atrioventricular block can occur as a cardioinhibitory response in vasovagal syncope; however, sinus bradycardia with sinus arrest is the typical finding on cardiac monitoring.</p><p><strong>Educational objective:</strong><br>Vasovagal syncope is typically preceded by a prodrome (eg, nausea, diaphoresis, pallor, lightheadedness) and usually occurs due to a cardioinhibitory response from increased parasympathetic activity.&nbsp; Cardiac monitoring immediately preceding the syncope typically shows sinus bradycardia and asystole due to sinus arrest.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1012,
            "section": "Shelf Review",
            "subjectId": 240010,
            "subject": "Ambulatory Medicine",
            "secondarySubjectId": 250002,
            "secondarySubject": "Medicine",
            "systemId": 203,
            "system": "Cardiovascular System",
            "topicId": 19621,
            "topic": "Syncope",
            "titleId": 19621,
            "title": "Syncope",
            "topicAttributeId": 331282,
            "topicAttribute": "Cardiac arrhythmias and syncope",
            "correctAnswer": "2",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Atrial fibrillation",
                    "choiceNumber": 1,
                    "correctTaken": 158,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bradycardia and sinus arrest",
                    "choiceNumber": 2,
                    "correctTaken": 3045,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Sinus tachycardia",
                    "choiceNumber": 3,
                    "correctTaken": 1538,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Third-degree atrioventricular block",
                    "choiceNumber": 4,
                    "correctTaken": 143,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ventricular tachycardia",
                    "choiceNumber": 5,
                    "correctTaken": 177,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": None,
            "isCorrect": False,
            "isIncorrect": False,
            "isMarked": False,
            "isOmitted": True,
            "isQuestionDirty": False,
            "isAnswerChoiceDisabled": False,
            "isQuestionDisabled": False,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "19713422",
                    "mediaDataId": 0,
                    "title": "Guidelines for the diagnosis and management of syncope (version 2009).",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/19713422"
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "11551877",
                    "mediaDataId": 0,
                    "title": "Mechanism of syncope in patients with isolated syncope and in patients with tilt-positive syncope.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/11551877"
                }
            ],
            "questionMedia": None,
            "timeSpent": 0,
            "othersAvgTimeSpent": 75,
            "notes": None,
            "peopleTaken": 5062,
            "hotspotImageUrl": None,
            "lastUpdatedDate": "01/01/2022",
            "correctPercentile": 60,
            "isSubmitted": False,
            "isActive": True,
            "activeStatusId": 1,
            "hint": None,
            "allowCalculator": False,
            "difficultyLevelId": None,
            "additionalText": None,
            "mobileExcerpt": None,
            "passageExcerpt": None,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": None,
            "standards": None,
            "totalTimeSpentReview": 5,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": None,
            "examYear": 0,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": None,
            "copyrightId": None,
            "copyrightText": None,
            "frequentHighlights": None,
            "totalWeight": None,
            "weightScored": None,
            "maxAnswerSelection": 0,
            "scoreTypeId": None
        },
        {
            "exhibits": None,
            "sequenceId": 7,
            "questionId": 3931,
            "questionIndex": 3931,
            "questionText": "<p>A study was conducted to assess the association between L-tryptophan use and the development of Eosinophilia-Myalgia Syndrome (EMS).&nbsp; Patients with EMS were asked about the use of products containing L-tryptophan during the last 6 months.&nbsp; At the same time, people without EMS were randomly selected from the same population where the patients came from, and asked about their experience with L-tryptophan containing products within the last 6 months.&nbsp; The study showed that the use of L-tryptophan is significantly associated with EMS.&nbsp; Which of the following measures of association are the investigators most likely to report?</p>",
            "questionHeader": "",
            "explanationText": "<p>The above case describes a typical case-control study design.&nbsp; Patients with the disease of interest (cases) and people without the disease (controls) are asked about previous exposure to the variable being studied (L-tryptophan use).&nbsp; The main measure of association is the exposure odds ratio, in which the exposure of people with the disease (cases) is compared to the exposure of those without the disease (controls).</p><p><strong>(Choices A and D)</strong>&nbsp; Incidence measures (e.g., relative risk or relative rate) cannot be directly measured in case-control studies because the people being studied are those who have already developed the disease.&nbsp; Relative risk and relative rate are calculated in cohort studies, where people are followed over time for the occurrence of the disease.</p><p><strong>(Choice B)</strong>&nbsp; Median survival is calculated in cohort studies or clinical trials, and is usually used to compare the median survival times in two or more groups of patients (e.g., receiving a new treatment or placebo).</p><p><strong>(Choice E)</strong>&nbsp; Prevalence odds ratio is calculated in cross-sectional studies to compare the prevalence of a disease between different populations.</p><p><strong>Educational Objective:</strong><br>A case-control study is used to compare the exposure of people with the disease (cases) to the exposure of the people without the disease (controls).&nbsp; The main measure of association is the exposure odds ratio.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1012,
            "section": "Shelf Review",
            "subjectId": 240010,
            "subject": "Ambulatory Medicine",
            "secondarySubjectId": 250002,
            "secondarySubject": "Medicine",
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 10611,
            "topic": "Odds ratio",
            "titleId": 10611,
            "title": "Odds ratio",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "3",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Relative risk",
                    "choiceNumber": 1,
                    "correctTaken": 75033,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Median survival",
                    "choiceNumber": 2,
                    "correctTaken": 2737,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Exposure odds ratio",
                    "choiceNumber": 3,
                    "correctTaken": 187534,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Relative rate",
                    "choiceNumber": 4,
                    "correctTaken": 8304,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prevalence odds ratio",
                    "choiceNumber": 5,
                    "correctTaken": 14351,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": None,
            "isCorrect": False,
            "isIncorrect": False,
            "isMarked": False,
            "isOmitted": True,
            "isQuestionDirty": False,
            "isAnswerChoiceDisabled": False,
            "isQuestionDisabled": False,
            "questionMappingReferencesList": None,
            "questionMedia": None,
            "timeSpent": 0,
            "othersAvgTimeSpent": 55,
            "notes": None,
            "peopleTaken": 287959,
            "hotspotImageUrl": None,
            "lastUpdatedDate": "01/01/2022",
            "correctPercentile": 65,
            "isSubmitted": False,
            "isActive": True,
            "activeStatusId": 1,
            "hint": None,
            "allowCalculator": False,
            "difficultyLevelId": None,
            "additionalText": None,
            "mobileExcerpt": None,
            "passageExcerpt": None,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": None,
            "standards": None,
            "totalTimeSpentReview": 4,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": None,
            "examYear": 0,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": None,
            "copyrightId": None,
            "copyrightText": None,
            "frequentHighlights": None,
            "totalWeight": None,
            "weightScored": None,
            "maxAnswerSelection": 0,
            "scoreTypeId": None
        },
        {
            "exhibits": None,
            "sequenceId": 8,
            "questionId": 17714,
            "questionIndex": 19174,
            "questionText": "<p>A 23-year-old man comes to the clinic for a physical examination prior to joining a professional soccer team.&nbsp; The patient goes on a 10-mile run 3 or 4 times per week, during which he experiences no chest pain, lightheadedness, or shortness of breath.&nbsp; Medical history is unremarkable.&nbsp; He does not smoke or drink alcohol.&nbsp; The patient lives in Texas and has not traveled recently.&nbsp; Family history includes myocardial infarction in his father at age 56.&nbsp; Blood pressure is 114/62 mm Hg and pulse is 54/min.&nbsp; Cardiac examination reveals normal heart sounds with no murmurs.&nbsp; The lungs are clear to auscultation.&nbsp; ECG shows sinus bradycardia with occasional dropped QRS complexes preceded by progressive lengthening of the PR interval.&nbsp; No ST-segment abnormalities are present, and the QTc interval is normal.&nbsp; Which of the following is the most appropriate next step in the management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T67725\"><table class=\"table-default-style table-header-footer-style\" style=\"width:100%\"><tbody><tr><td colspan=\"4\"><p align=\"center\"><strong>Atrioventricular block</strong></p></td></tr><tr><td></td><td><p align=\"center\"><strong>Clinical presentation</strong></p></td><td><p align=\"center\"><strong>ECG features</strong></p></td><td><p align=\"center\"><strong>Management</strong></p></td></tr><tr><td><p align=\"center\"><strong>First degree</strong></p></td><td><p align=\"center\">Asymptomatic</p></td><td><p align=\"center\">PR interval prolongation</p></td><td><p align=\"center\">Observation</p></td></tr><tr><td><p align=\"center\"><strong>Mobitz type I second degree</strong></p></td><td><p align=\"center\">Usually asymptomatic</p></td><td><p align=\"center\">Progressive PR interval lengthening followed by dropped QRS complex</p></td><td><p align=\"center\">Observation</p><p align=\"center\">(rarely PPM placement)</p></td></tr><tr><td><p align=\"center\"><strong>Mobitz type II second degree</strong></p></td><td><p align=\"center\">Fatigue, lightheadedness, syncope</p></td><td><p align=\"center\">Constant PR interval with randomly dropped QRS complexes</p></td><td><p align=\"center\">PPM placement</p></td></tr><tr><td><p align=\"center\"><strong>Third degree (complete)</strong></p></td><td><p align=\"center\">Fatigue, lightheadedness, syncope</p></td><td><p align=\"center\">Complete dissociation of P waves &amp; QRS complexes</p></td><td><p align=\"center\">PPM placement</p></td></tr><tr><td colspan=\"4\"><p><strong>PPM</strong> = permanent pacemaker.</p></td></tr></tbody></table></div><p>This patient&#39;s ECG shows progressive lengthening of the PR interval followed by a dropped QRS complex, consistent with <strong>Mobitz type I second-degree atrioventricular (AV) block</strong>.&nbsp; Highly trained <strong>endurance athletes</strong> typically have very <strong>high resting vagal tone</strong>, making sinus bradycardia and low-grade AV block (ie, first degree and Mobitz type I second degree) common findings on resting ECG.&nbsp; These are <strong>benign</strong> findings and <strong>require no intervention</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Exercise stress testing is used to evaluate for obstructive atherosclerotic coronary artery disease (CAD).&nbsp; AV nodal ischemia can lead to AV block, but there is no suspicion for significant CAD in this young patient who experiences no symptoms (eg, chest pain, shortness of breath) at high levels of exertion.</p><p><strong>(Choice B)</strong>&nbsp; Varying degrees of AV block can occur in a small percentage of patients with Lyme disease who do not receive antibiotic treatment.&nbsp; However, transmission of Lyme disease is uncommon in Texas (it is usually transmitted in the northeastern and upper Midwestern parts of the <a href=\"514\">United States</a>), and low-grade AV block is an expected finding in this highly trained endurance athlete.</p><p><strong>(Choice C)</strong>&nbsp; Permanent pacemaker placement is indicated for advanced AV block, including Mobitz type II second-degree AV block (ie, randomly dropped QRS complexes) and third-degree AV block (ie, complete dissociation of P waves and QRS complexes).</p><p><strong>(Choice E)</strong>&nbsp; The presence of a systolic ejection murmur can suggest aortic stenosis or hypertrophic cardiomyopathy, which would warrant transthoracic echocardiography for further investigation.&nbsp; However, echocardiography is not indicated in this asymptomatic patient with no cardiac murmurs.</p><p><strong>Educational objective:</strong><br>Low-grade atrioventricular block, including first degree and Mobitz type I second degree, are common findings on resting ECG in highly trained endurance athletes because of their high levels of resting vagal tone.&nbsp; These findings are benign and require no intervention.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1012,
            "section": "Shelf Review",
            "subjectId": 240010,
            "subject": "Ambulatory Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": None,
            "systemId": 203,
            "system": "Cardiovascular System",
            "topicId": 23476,
            "topic": "Heart block",
            "titleId": 23476,
            "title": "Heart block",
            "topicAttributeId": 331282,
            "topicAttribute": "Cardiac arrhythmias and syncope",
            "correctAnswer": "4",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Exercise stress testing",
                    "choiceNumber": 1,
                    "correctTaken": 322,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lyme serology",
                    "choiceNumber": 2,
                    "correctTaken": 378,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pacemaker placement",
                    "choiceNumber": 3,
                    "correctTaken": 641,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reassurance with no further intervention",
                    "choiceNumber": 4,
                    "correctTaken": 3127,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Transthoracic echocardiography",
                    "choiceNumber": 5,
                    "correctTaken": 543,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": None,
            "isCorrect": False,
            "isIncorrect": False,
            "isMarked": False,
            "isOmitted": True,
            "isQuestionDirty": False,
            "isAnswerChoiceDisabled": False,
            "isQuestionDisabled": False,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "2191578",
                    "mediaDataId": 0,
                    "title": "ECG variants and cardiac arrhythmias in athletes: clinical relevance and prognostic importance.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/2191578"
                }
            ],
            "questionMedia": None,
            "timeSpent": 0,
            "othersAvgTimeSpent": 75,
            "notes": None,
            "peopleTaken": 5011,
            "hotspotImageUrl": None,
            "lastUpdatedDate": "01/01/2022",
            "correctPercentile": 62,
            "isSubmitted": False,
            "isActive": True,
            "activeStatusId": 1,
            "hint": None,
            "allowCalculator": False,
            "difficultyLevelId": None,
            "additionalText": None,
            "mobileExcerpt": None,
            "passageExcerpt": None,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": None,
            "standards": None,
            "totalTimeSpentReview": 10,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": None,
            "examYear": 0,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": None,
            "copyrightId": None,
            "copyrightText": None,
            "frequentHighlights": None,
            "totalWeight": None,
            "weightScored": None,
            "maxAnswerSelection": 0,
            "scoreTypeId": None
        },
        {
            "exhibits": None,
            "sequenceId": 9,
            "questionId": 13362,
            "questionIndex": 21471,
            "questionText": "<p>A 76-year-old woman comes to the office due to intermittent palpitations for the last 6 months.&nbsp; The patient describes episodes of her heart beating fast.&nbsp; These happen on average once a week, last up to an hour, and resolve spontaneously.&nbsp; She cannot identify any provoking factors but thinks they occur typically when she is tired.&nbsp; The patient has had no chest pain, dyspnea, syncope, or lower extremity swelling.&nbsp; She has a history of hypertension.&nbsp; The patient is a lifetime nonsmoker.&nbsp; Blood pressure is 145/85 mm Hg, and pulse is 75/min and regular.&nbsp; There are no heart murmurs.&nbsp; The lungs are clear on auscultation.&nbsp; Peripheral pulses are full and symmetric.&nbsp; ECG shows normal sinus rhythm.&nbsp; Echocardiogram shows moderate left atrial enlargement, left ventricular hypertrophy, ejection fraction of 65%, and no valvular abnormalities.&nbsp; Further workup is most likely to identify which of the following in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t39455\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Atrial fibrillation</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathogenesis</strong></p></td><td><ul><li>Atrial remodeling due to:<ul style=\"list-style-type:circle;\"><li>Age-related myocardial changes</li><li>Atrial enlargement from heart disease (eg, HTN, MS)</li></ul></li><li>Foci of rapid electrical activity:<ul style=\"list-style-type:circle;\"><li>Commonly originate in pulmonary veins</li><li>Alcohol intake &amp; &uarr; sympathetic drive may contribute</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br />presentation </strong></p></td><td><ul><li>Asymptomatic or palpitations &plusmn; dyspnea, fatigue</li><li>Irregularly irregular pulse</li><li>May present with thromboembolic event (eg, stroke)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis </strong></p></td><td><ul><li>ECG shows variable R-R intervals &amp; no P waves</li><li>Continuous ECG often needed for paroxysmal disease</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>HTN</strong> = hypertension; <strong>MS</strong> = mitral stenosis.</p></td></tr></tbody></table></div><p><strong>Atrial fibrillation</strong> (AF) is the most common sustained cardiac arrhythmia, with a prevalence that increases dramatically with <strong>age</strong>; approximately 70% of those affected are age &#8805;65.&nbsp; Patients often have episodes of <strong>paroxysmal</strong> (intermittent) AF in the initial stages and progress to persistent or permanent AF over time.</p><p><strong>Atrial enlargement</strong> and subsequent atrial remodeling likely play an important role in the development of AF, and patients usually have some form of <strong>underlying heart disease</strong> that contributes to this pathophysiologic mechanism.&nbsp; Hypertension (which can lead to left ventricular hypertrophy) and coronary artery disease (which can lead to ischemic reductions in left ventricular function) can both cause secondary atrial enlargement and are the most commonly associated comorbidities.</p><p>This elderly patient with hypertension and left ventricular hypertrophy has intermittent palpitations with left atrial enlargement on echocardiogram, suggestive of AF.&nbsp; AF is recognized on <a href=\"8818\">ECG</a> by an irregularly irregular rhythm with varying R-R intervals and the absence of P waves.&nbsp; However, due to the <strong>intermittent</strong> nature of paroxysmal AF, patients can often have a regular pulse with a normal sinus rhythm; therefore, ECG will often fail to make the diagnosis and continuous ambulatory ECG monitoring (eg, for 24 hours) may be needed.</p><p><strong>(Choice B)</strong>&nbsp; Atrioventricular nodal reentrant tachycardia (AVNRT) and atrioventricular reentrant tachycardia (AVRT) are types of paroxysmal supraventricular tachycardia.&nbsp; These arrhythmias typically present with episodes of palpitations, dyspnea, or presyncope/syncope.&nbsp; They are less common than AF overall and, unlike AF, have a regular rhythm and typically occur in adolescents and young adults.</p><p><strong>(Choices C and D)</strong>&nbsp; Like AF, both <a href=\"14682\">second-degree atrioventricular block</a> (with dropped beats) and sinus node dysfunction (sick sinus syndrome, with periods of bradycardia sometimes alternating with tachycardia) increase in prevalence with age.&nbsp; However, these bradyarrhythmias are less likely than AF in this patient with intermittent palpitations, left ventricular hypertrophy, and left atrial enlargement.&nbsp; When symptomatic, they are more likely to cause dyspnea, fatigue, or symptoms of cerebral hypoperfusion (eg, dizziness, lightheadedness, syncope).</p><p><strong>(Choice E)</strong>&nbsp; Ventricular tachycardia can present with intermittent palpitations, dizziness, chest discomfort, and presyncope or syncope.&nbsp; It is usually seen in patients with underlying structural heart disease (eg, dilated cardiomyopathy) or previous myocardial infarction.</p><p><strong>Educational objective:</strong><br>Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, and affected patients usually have underlying heart disease (eg, hypertension, coronary artery disease) and left atrial enlargement.&nbsp; The prevalence of AF increases dramatically with age; approximately 70% of those affected are age &#8805;65.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1012,
            "section": "Shelf Review",
            "subjectId": 240010,
            "subject": "Ambulatory Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": None,
            "systemId": 203,
            "system": "Cardiovascular System",
            "topicId": 2014,
            "topic": "Atrial fibrillation",
            "titleId": 2014,
            "title": "Atrial fibrillation",
            "topicAttributeId": 331282,
            "topicAttribute": "Cardiac arrhythmias and syncope",
            "correctAnswer": "1",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Atrial fibrillation",
                    "choiceNumber": 1,
                    "correctTaken": 3156,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Atrioventricular nodal reentrant tachycardia",
                    "choiceNumber": 2,
                    "correctTaken": 1054,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intermittent second-degree atrioventricular block",
                    "choiceNumber": 3,
                    "correctTaken": 210,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Sinus node dysfunction",
                    "choiceNumber": 4,
                    "correctTaken": 494,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ventricular tachycardia",
                    "choiceNumber": 5,
                    "correctTaken": 180,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": None,
            "isCorrect": False,
            "isIncorrect": False,
            "isMarked": False,
            "isOmitted": True,
            "isQuestionDirty": False,
            "isAnswerChoiceDisabled": False,
            "isQuestionDisabled": False,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "11343485",
                    "mediaDataId": 0,
                    "title": "Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention:  the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/11343485"
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "16527828",
                    "mediaDataId": 0,
                    "title": "Prevalence, incidence and lifetime risk of atrial fibrillation:  the Rotterdam study.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/16527828"
                }
            ],
            "questionMedia": None,
            "timeSpent": 0,
            "othersAvgTimeSpent": 94,
            "notes": None,
            "peopleTaken": 5094,
            "hotspotImageUrl": None,
            "lastUpdatedDate": "01/01/2022",
            "correctPercentile": 61,
            "isSubmitted": False,
            "isActive": True,
            "activeStatusId": 1,
            "hint": None,
            "allowCalculator": False,
            "difficultyLevelId": None,
            "additionalText": None,
            "mobileExcerpt": None,
            "passageExcerpt": None,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": None,
            "standards": None,
            "totalTimeSpentReview": 9,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": None,
            "examYear": 0,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": None,
            "copyrightId": None,
            "copyrightText": None,
            "frequentHighlights": None,
            "totalWeight": None,
            "weightScored": None,
            "maxAnswerSelection": 0,
            "scoreTypeId": None
        },
        {
            "exhibits": None,
            "sequenceId": 10,
            "questionId": 3629,
            "questionIndex": 3629,
            "questionText": "<P>A study was done to evaluate a new serologic screening test for human immunodeficiency virus (HIV) infection.&nbsp; A total of 1000 people were randomly selected from the population, screened using the new test, and screened again using the gold standard (i.e., Western blot analysis) to determine true infection state.&nbsp; The findings are as follows:</P><BLOCKQUOTE><TABLE border=1 cellSpacing=0 cellPadding=5 width=500><TBODY><TR><TD><P align=center><B>Test Results</B></P></TD><TD><P align=center><B>True HIV Infection</B></P></TD><TD><P align=center><B>No HIV Infection</B></P></TD><TD><P align=center><B>Total</B></P></TD></TR><TR><TD><P align=center><B>Positive</B></P></TD><TD><P align=center>140</P></TD><TD><P align=center>60</P></TD><TD><P align=center>200</P></TD></TR><TR><TD><P align=center><B>Negative</B></P></TD><TD><P align=center>40</P></TD><TD><P align=center>760</P></TD><TD><P align=center>800</P></TD></TR><TR><TD><P align=center><B>Total</B></P></TD><TD><P align=center>180</P></TD><TD><P align=center>820</P></TD><TD><P align=center>1000</P></TD></TR></TBODY></TABLE></BLOCKQUOTE><P>What is the sensitivity of this new serologic screening test?</P>",
            "questionHeader": "",
            "explanationText": "<P>Sensitivity and specificity are used to measure a test's validity.&nbsp; Sensitivity is defined as the proportion of positive test results among the subjects with the disease.&nbsp; Specificity is defined as the proportion of negative test results among the subjects without the disease.</P><BLOCKQUOTE><TABLE border=1 cellSpacing=0 cellPadding=5 width=550><TBODY><TR><TD><P align=center><B>Test Results</B></P></TD><TD><P align=center><B>Disease Present</B></P></TD><TD><P align=center><B>Disease Absent</B></P></TD><TD><P align=center><B>Total</B></P></TD></TR><TR><TD><P align=center><B>Positive</B></P></TD><TD><P align=center>A<BR>True positive (TP)</P></TD><TD><P align=center>B<BR>False positive (FP)</P></TD><TD><P align=center>A + B</P></TD></TR><TR><TD><P align=center><B>Negative</B></P></TD><TD><P align=center>C<BR>False negative (FN)</P></TD><TD><P align=center>D<BR>True negative (TN)</P></TD><TD><P align=center>C + D</P></TD></TR><TR><TD><P align=center><B>Total</B></P></TD><TD><P align=center>A + C</P></TD><TD><P align=center>B + D</P></TD><TD><P align=center>A + B + C + D</P></TD></TR></TBODY></TABLE></BLOCKQUOTE><P>Sensitivity = TP / (TP + FN) = A / (A + C)</P><P>Sensitivity determines how well the test identifies the people with the disease.&nbsp; It is usually the first test used, similar to the use of a screening test when there is a public health threat.&nbsp; The true-positive rate describes the sensitivity of the test.</P><P>Specificity = TN / (TN + FP) = D / (B + D)</P><P>Specificity determines how well the test identifies the people without the disease.&nbsp; The true-negative rate describes the specificity of the test.</P><P>A perfectly valid diagnostic test should have sensitivity and specificity equal to 1, but this is seldom possible.&nbsp; The more sensitive the test, the less specific it is (and vice versa).</P><P>In this example, the sensitivity is 140/180.</P><P><B>Educational objective:</B><BR>Know how to calculate the sensitivity and specificity of a test.</P>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1012,
            "section": "Shelf Review",
            "subjectId": 240010,
            "subject": "Ambulatory Medicine",
            "secondarySubjectId": 250002,
            "secondarySubject": "Medicine",
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 24431,
            "topic": "Sensitivity and specificity",
            "titleId": 24431,
            "title": "Sensitivity and specificity",
            "topicAttributeId": 330659,
            "topicAttribute": "Probability and principles of testing",
            "correctAnswer": "1",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "140/180",
                    "choiceNumber": 1,
                    "correctTaken": 148747,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "140/200",
                    "choiceNumber": 2,
                    "correctTaken": 17187,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "60/820",
                    "choiceNumber": 3,
                    "correctTaken": 3073,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "60/200",
                    "choiceNumber": 4,
                    "correctTaken": 780,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "180/1000",
                    "choiceNumber": 5,
                    "correctTaken": 1042,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": None,
            "isCorrect": False,
            "isIncorrect": False,
            "isMarked": False,
            "isOmitted": True,
            "isQuestionDirty": False,
            "isAnswerChoiceDisabled": False,
            "isQuestionDisabled": False,
            "questionMappingReferencesList": None,
            "questionMedia": None,
            "timeSpent": 0,
            "othersAvgTimeSpent": 40,
            "notes": None,
            "peopleTaken": 170829,
            "hotspotImageUrl": None,
            "lastUpdatedDate": "01/01/2022",
            "correctPercentile": 87,
            "isSubmitted": False,
            "isActive": True,
            "activeStatusId": 1,
            "hint": None,
            "allowCalculator": False,
            "difficultyLevelId": None,
            "additionalText": None,
            "mobileExcerpt": None,
            "passageExcerpt": None,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": None,
            "standards": None,
            "totalTimeSpentReview": 6,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": None,
            "examYear": 0,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": None,
            "copyrightId": None,
            "copyrightText": None,
            "frequentHighlights": None,
            "totalWeight": None,
            "weightScored": None,
            "maxAnswerSelection": 0,
            "scoreTypeId": None
        },
        {
            "exhibits": None,
            "sequenceId": 11,
            "questionId": 4532,
            "questionIndex": 4532,
            "questionText": "<p>A 72-year-old man comes to the office for a health maintenance examination.&nbsp; The patient feels well and does not report any symptoms, aside from occasional pain in his knees.&nbsp; Medical history is significant for hypertension and osteoarthritis, for which he takes hydrochlorothiazide, lisinopril, and as-needed acetaminophen.&nbsp; The patient has a 30-pack-year smoking history but quit 15 years ago.&nbsp; He does not use alcohol.&nbsp; He is a retired plumber and lives with his wife in a retirement community.&nbsp; During the visit, the patient reveals that a friend recently had an abdominal aortic aneurysm repair and inquires whether he should be screened for the same disorder.&nbsp; Which of the following is the most appropriate next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t36221\"><table class=\"table-default-style\" style=\"width:432px\"><tbody><tr><td colspan=\"2\" style=\"width:65.0%\"><p align=\"center\"><strong>Screening: abdominal aortic aneurysm</strong></p></td></tr><tr><td style=\"width:35.0%\"><p align=\"center\"><strong>Patient<br />population</strong></p></td><td style=\"width:65.0%\"><ul><li><strong>Men</strong></li><li>Age <strong>65-75</strong></li></ul></td></tr><tr><td style=\"width:35.0%\"><p align=\"center\"><strong>Risk factor<br />indication</strong></p></td><td style=\"width:65.0%\"><ul><li>Any <strong>smoking</strong> history</li></ul></td></tr><tr><td style=\"width:35.0%\"><p align=\"center\"><strong>Test</strong></p></td><td style=\"width:65.0%\"><ul><li>One-time abdominal duplex ultrasonography</li></ul></td></tr></tbody></table></div><p><strong>Abdominal aortic aneurysm</strong> (AAA) is a common disorder with a long asymptomatic phase.&nbsp; The mortality rate for patients with ruptured AAA is very high (75%-90%), but the risk is mitigated if the aneurysm is repaired prior to rupture, making it an appropriate subject for screening in patients at risk.&nbsp; The primary risk factors for AAA include male gender, smoking history, and age &gt;65.</p><p>The US Preventive Services Task Force recommends screening for AAA with a <strong>one-time abdominal ultrasound</strong> in <strong>men age 65-75</strong> who have <strong>ever smoked</strong> (ie, any lifetime exposure &gt;100 cigarettes).&nbsp; Screening and surgical repair of large AAAs (&gt;5.5 cm) have been found to decrease AAA-specific mortality in this population.&nbsp; Ultrasonography is the recommended screening modality because of its high sensitivity (&gt;95%), low cost, noninvasive nature, and lack of ionizing radiation.</p><p>Screening for AAA may also be beneficial for men age 65-75 who have not smoked but have other significant risk factors (eg, first-degree family history of AAA rupture).&nbsp; Screening in younger men and in women appears to have little, if any, benefit and is not recommended.</p><p><strong>(Choices B and E)</strong>&nbsp; CT and MRI both have high sensitivity for AAA, and AAA is often detected incidentally on abdominal imaging performed for other purposes.&nbsp; However, these tests are more expensive and less validated than ultrasound for screening.&nbsp; In addition, CT exposes patients to ionizing radiation.</p><p><strong>(Choice D)</strong>&nbsp; Transesophageal and, to a lesser degree, transthoracic echocardiogram can detect dilation of the proximal ascending aorta, but they do not play a role in screening for AAA.</p><p><strong>Educational objective:</strong><br>The primary risk factors for abdominal aortic aneurysm include male gender, smoking history, and age &gt;65.&nbsp; The US Preventive Services Task Force recommends screening for this condition with a one-time abdominal ultrasound in men age 65-75 who ever smoked.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1012,
            "section": "Shelf Review",
            "subjectId": 240010,
            "subject": "Ambulatory Medicine",
            "secondarySubjectId": 250008,
            "secondarySubject": "Family Medicine",
            "systemId": 203,
            "system": "Cardiovascular System",
            "topicId": 1958,
            "topic": "Aortic aneurysm",
            "titleId": 1958,
            "title": "Aortic aneurysm",
            "topicAttributeId": 330556,
            "topicAttribute": "Aortic and peripheral artery diseases",
            "correctAnswer": "3",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "No further testing required",
                    "choiceNumber": 1,
                    "correctTaken": 907,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain a CT scan of the abdomen",
                    "choiceNumber": 2,
                    "correctTaken": 449,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain an abdominal ultrasound",
                    "choiceNumber": 3,
                    "correctTaken": 3749,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain an echocardiogram",
                    "choiceNumber": 4,
                    "correctTaken": 20,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain an MRI of the abdomen",
                    "choiceNumber": 5,
                    "correctTaken": 10,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": None,
            "isCorrect": False,
            "isIncorrect": False,
            "isMarked": False,
            "isOmitted": True,
            "isQuestionDirty": False,
            "isAnswerChoiceDisabled": False,
            "isQuestionDisabled": False,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24473919",
                    "mediaDataId": 0,
                    "title": "Ultrasonography screening for abdominal aortic aneurysms: a systematic evidence review for the U.S. Preventive Services Task Force.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24473919"
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24957320",
                    "mediaDataId": 0,
                    "title": "Screening for abdominal aortic aneurysm: U.S. Preventive Services Task Force recommendation statement",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24957320"
                }
            ],
            "questionMedia": None,
            "timeSpent": 0,
            "othersAvgTimeSpent": 58,
            "notes": None,
            "peopleTaken": 5135,
            "hotspotImageUrl": None,
            "lastUpdatedDate": "01/01/2022",
            "correctPercentile": 73,
            "isSubmitted": False,
            "isActive": True,
            "activeStatusId": 1,
            "hint": None,
            "allowCalculator": False,
            "difficultyLevelId": None,
            "additionalText": None,
            "mobileExcerpt": None,
            "passageExcerpt": None,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": None,
            "standards": None,
            "totalTimeSpentReview": 10,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": None,
            "examYear": 0,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": None,
            "copyrightId": None,
            "copyrightText": None,
            "frequentHighlights": None,
            "totalWeight": None,
            "weightScored": None,
            "maxAnswerSelection": 0,
            "scoreTypeId": None
        },
        {
            "exhibits": None,
            "sequenceId": 12,
            "questionId": 4738,
            "questionIndex": 4738,
            "questionText": "<p>An imaging study detects an incidental 3.5-cm infrarenal abdominal aortic aneurysm in a 70-year-old man.&nbsp; He has no associated symptoms.&nbsp; Medical history is significant for hypertension, type 2 diabetes, and hypercholesterolemia.&nbsp; The patient is maintained on anticoagulation due to paroxysmal atrial fibrillation.&nbsp; He has smoked 1-2 packs of cigarettes a day for the past 40 years, and he drinks 1 or 2 glasses of wine daily.&nbsp; The patient is physically active, bikes regularly, and enjoys hiking.&nbsp; On physical examination, blood pressure is 150/78 mm Hg and pulse is 80/min.&nbsp; Heart sounds are normal, and the lungs are clear.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Serum creatinine</td><td style=\"vertical-align:middle;\">1.7 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Low-density lipoprotein (LDL)</td><td style=\"vertical-align:middle;\">150 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Hemoglobin A1c</td><td style=\"vertical-align:middle;\">7.8%</td></tr></tbody></table><p>Which of the following is most strongly associated with aneurysm progression in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t48452\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Abdominal aortic aneurysm</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Advanced age (eg, &gt;60)</li><li>Smoking, male sex, hypertension</li><li>History of atherosclerosis or CTD</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical presentation</strong></p></td><td><ul><li>Mostly asymptomatic</li><li>Rapid expansion<ul style=\"list-style-type:circle;\"><li>Dull abdominal/back pain</li><li>Distal embolization</li></ul></li><li>Rupture<ul style=\"list-style-type:circle;\"><li>Sudden, severe abdominal/back pain &plusmn; shock</li><li>Umbilical/flank hematoma</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Smoking cessation</li><li>Elective repair for size &gt;5.5 cm (asymptomatic)</li><li>Urgent repair for symptomatic &amp; HD stable patients</li><li>Emergency repair for symptomatic &amp; HD unstable patients</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>CTD</strong> = connective tissue disease; <strong>HD</strong> = hemodynamically.</p></td></tr></tbody></table></div><p><strong>Abdominal aortic aneurysm</strong> (AAA) is generally defined as an enlargement of the abdominal aorta to a diameter &#8805;3 cm.&nbsp; It is often incidentally detected on imaging, as many patients have no symptoms unless and until rupture occurs.&nbsp; Rupture is more likely with large aneurysmal size (&gt;5.5 cm) or rapid rate of expansion (eg, &gt;1 cm/year), and preemptive surgical repair is the definitive treatment.&nbsp; However, surgery carries a relatively high risk of complication, with the risk of repair typically greater than the risk of rupture until the aneurysm reaches a large size.&nbsp; Therefore, <strong>management</strong> of <strong>small to moderately sized AAA</strong> involves surveillance with serial abdominal ultrasound and <strong>lifestyle modification</strong> to limit AAA progression.</p><p><strong>Risk factors</strong> for AAA include advanced age (eg, &gt;60), smoking, male sex, family history, hypertension, and a history of atherosclerosis or underlying connective tissue disease.&nbsp; Of these, active smoking is the strongest modifiable influence for AAA development and progression.&nbsp; Smoking is believed to disrupt the arterial wall elastin matrix via stimulation of enhanced protease activity, chronic inflammation, and smooth muscle dysfunction, and <strong>smoking cessation</strong> is considered the best intervention to <strong>minimize AAA progression</strong>.</p><p>Because of the relationship between smoking and AAA, a one-time abdominal ultrasound is recommended to screen for AAA in men ages 65 to 75 with any smoking history.</p><p><strong>(Choice B)</strong>&nbsp; Anticoagulation has not been shown to either slow or accelerate AAA progression.&nbsp; Patients with AAA who have an appropriate indication for anticoagulation (eg, atrial fibrillation) should remain on it.</p><p><strong>(Choices C and D)</strong>&nbsp; AAA is considered a coronary artery disease equivalent; therefore, moderate exercise and enhanced lipid control are associated with overall improved cardiovascular outcomes in such patients.&nbsp; However, exercise and lipid control do not limit AAA progression to the same extent as smoking cessation.</p><p><strong>(Choice E)</strong>&nbsp; AAA is more common in individuals with hypertension, indicating that hypertension may play a role in initial AAA development.&nbsp; However, hypertension, especially isolated systolic hypertension, has not been reliably correlated with AAA progression.</p><p><strong>(Choice F)</strong>&nbsp; Diabetes is a strong risk factor for atherosclerosis and cardiovascular disease.&nbsp; However, the risk of AAA development and progression is lower in patients with diabetes compared to those without, for reasons that are unclear.</p><p><strong>Educational objective:</strong><br>The management of small to moderately sized (ie, 3 cm to 5.5 cm) abdominal aortic aneurysms (AAAs) involves lifestyle modification, with smoking cessation as the best intervention to minimize AAA progression.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1012,
            "section": "Shelf Review",
            "subjectId": 240006,
            "subject": "Surgery",
            "secondarySubjectId": 250010,
            "secondarySubject": "Ambulatory Medicine",
            "systemId": 203,
            "system": "Cardiovascular System",
            "topicId": 1958,
            "topic": "Aortic aneurysm",
            "titleId": 1958,
            "title": "Aortic aneurysm",
            "topicAttributeId": 330556,
            "topicAttribute": "Aortic and peripheral artery diseases",
            "correctAnswer": "1",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Active smoking",
                    "choiceNumber": 1,
                    "correctTaken": 3358,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Anticoagulation",
                    "choiceNumber": 2,
                    "correctTaken": 13,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Exercise activities",
                    "choiceNumber": 3,
                    "correctTaken": 15,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "LDL &gt;130 mg/dL",
                    "choiceNumber": 4,
                    "correctTaken": 81,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Systolic hypertension",
                    "choiceNumber": 5,
                    "correctTaken": 1539,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Uncontrolled diabetes mellitus",
                    "choiceNumber": 6,
                    "correctTaken": 31,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": None,
            "isCorrect": False,
            "isIncorrect": False,
            "isMarked": False,
            "isOmitted": True,
            "isQuestionDirty": False,
            "isAnswerChoiceDisabled": False,
            "isQuestionDisabled": False,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "15210603",
                    "mediaDataId": 0,
                    "title": "Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/15210603"
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "10587395",
                    "mediaDataId": 0,
                    "title": "The association between cigarette smoking and abdominal aortic aneurysms.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/10587395"
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27521823",
                    "mediaDataId": 0,
                    "title": "Association of hypertension with abdominal aortic aneurysm expansion.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27521823"
                }
            ],
            "questionMedia": None,
            "timeSpent": 0,
            "othersAvgTimeSpent": 55,
            "notes": None,
            "peopleTaken": 5037,
            "hotspotImageUrl": None,
            "lastUpdatedDate": "01/01/2022",
            "correctPercentile": 66,
            "isSubmitted": False,
            "isActive": True,
            "activeStatusId": 1,
            "hint": None,
            "allowCalculator": False,
            "difficultyLevelId": None,
            "additionalText": None,
            "mobileExcerpt": None,
            "passageExcerpt": None,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": None,
            "standards": None,
            "totalTimeSpentReview": 6,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": None,
            "examYear": 0,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": None,
            "copyrightId": None,
            "copyrightText": None,
            "frequentHighlights": None,
            "totalWeight": None,
            "weightScored": None,
            "maxAnswerSelection": 0,
            "scoreTypeId": None
        },
        {
            "exhibits": None,
            "sequenceId": 13,
            "questionId": 19984,
            "questionIndex": 21474,
            "questionText": "<p>A 72-year-old man comes to the office due to palpitations for the past 1 week.&nbsp; The patient has had no fever, cough, chest pain, or dizziness.&nbsp; Medical history is significant for mild chronic obstructive pulmonary disease, long-standing hypertension, hyperlipidemia, and chronic stable angina.&nbsp; He uses an albuterol/ipratropium inhaler as needed.&nbsp; The patient is a former smoker; he does not use alcohol but drinks 2 or 3 cups of coffee daily.&nbsp; Temperature is 37.1 C (98.8 F), blood pressure is 136/78 mm Hg, pulse is 116/min, respirations are 16/min.&nbsp; Oxygen saturation is 97% on room air.&nbsp; On physical examination, the patient appears comfortable with normal work of breathing.&nbsp; Lung auscultation reveals mildly prolonged expiration with no wheezing or crackles.&nbsp; Cardiac examination shows irregular tachycardia.&nbsp; The remainder of the physical examination is unremarkable.&nbsp; ECG rhythm strip is shown in the <a href=\"46409\">exhibit</a>.&nbsp; Which of the following most likely increased the risk of development of this patient&#39;s arrhythmia?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t72704\"><table class=\"table-default-style table-footer-only-style\"><tbody><tr><td colspan=\"2\" style=\"width:65.0%\"><p align=\"center\"><strong>Comorbidities that encourage atrial fibrillation</strong></p></td></tr><tr><td style=\"width:35.0%\"><p align=\"center\"><strong>Precipitants of atrial dilation &amp;/or conduction remodeling</strong></p></td><td style=\"width:65.0%\"><ul><li>Advanced age</li><li>Systemic hypertension</li><li>Mitral valve dysfunction</li><li>Left ventricular failure</li><li>Coronary artery disease &amp; related factors (eg, DM, smoking)</li><li>Obesity &amp; obstructive sleep apnea</li></ul><ul><li>Chronic hypoxic lung disease (eg, COPD)</li></ul></td></tr><tr><td style=\"width:35.0%\"><p align=\"center\"><strong>Triggers of increased automaticity</strong></p></td><td style=\"width:65.0%\"><ul><li>Hyperthyroidism</li><li>Excessive alcohol use</li><li>Increased sympathetic tone<ul style=\"list-style-type:circle;\"><li>Acute illness (eg, sepsis, PE, MI)</li><li>Cardiac surgery</li></ul></li></ul><ul><li>Sympathomimetic drugs (eg, cocaine)</li></ul></td></tr><tr><td colspan=\"2\" style=\"width:65.0%\"><p><strong>COPD</strong> = chronic obstructive pulmonary disease; <strong>DM</strong> = diabetes mellitus; <strong>MI</strong> = myocardial infarction;<br /><strong>PE</strong> = pulmonary embolism.</p></td></tr></tbody></table></div><p>This patient&#39;s <a href=\"46411\">ECG</a> rhythm strip shows a rapid rhythm with irregularly irregular R-R intervals and an absence of organized P waves, consistent with <strong>atrial fibrillation</strong> with rapid ventricular response (ie, rate &gt;100/min).&nbsp; The pathogenesis of atrial fibrillation involves an underlying substrate created by <strong>atrial remodeling</strong>, or changes in the atrial structure and conduction system that result from <strong>aging</strong> and <strong>comorbidities</strong>.&nbsp; Chronic <strong>hypertension</strong> is the <strong>most common</strong> comorbidity associated with atrial fibrillation and is likely one of the strongest contributors to atrial remodeling.</p><p>Most of the contribution of chronic hypertension to atrial remodeling is likely via <strong>left atrial dilation</strong>.&nbsp; With the left ventricle pumping against chronically increased pressure load, compensatory concentric left ventricular (LV) hypertrophy develops, which decreases LV diastolic filling.&nbsp; Given the thin left atrial walls, even subtle pressure increases transmitted back to the left atrium can have a significant effect on left atrial stretching and dilation.&nbsp; The left atrial stretching likely also contributes to <strong>atrial fibrosis</strong> and some degree of <strong>atrial conduction remodeling</strong>.</p><p>Chronic obstructive pulmonary disease (COPD) can also contribute to atrial fibrillation in several ways.&nbsp; Severe COPD associated with significant hypoxemia can cause right atrial dilation due to hypoxic pulmonary vasoconstriction and resulting pulmonary hypertension.&nbsp; In addition, COPD exacerbation can increase sympathetic tone and act as a trigger for atrial fibrillation.&nbsp; Beta-2 agonists (eg, albuterol, salmeterol) used for the treatment of COPD may also be occasional triggers of atrial fibrillation.&nbsp; However, the underlying substrate (created by chronic hypertension in this patient) is a more important factor <strong>(Choice B)</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Acquired long QT syndrome typically results from <a href=\"21241\">medications</a> that prolong the QT interval.&nbsp; It increases the risk of polymorphic ventricular tachycardia (ie, torsade de pointes), but it is not a contributor to atrial fibrillation.</p><p><strong>(Choice C)</strong>&nbsp; Despite the common belief that caffeine consumption is considered a trigger for atrial fibrillation and other arrhythmias (due to increased sympathetic tone), studies have not shown any significant association.</p><p><strong>(Choice E)</strong>&nbsp; Coronary artery disease (CAD) and its associated risk factors (eg, diabetes mellitus, smoking) likely somewhat contribute to atrial remodeling but less so than chronic hypertension.&nbsp; In patients with atrial fibrillation, the association of CAD with the arrhythmia is primarily seen among those who develop acute myocardial infarction or ischemic heart failure.</p><p><strong>Educational objective:</strong><br>Chronic hypertension is the most common comorbidity associated with atrial fibrillation and is likely one of the strongest contributors to the predisposing atrial remodeling.&nbsp; Aging is also a strong contributor.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1012,
            "section": "Shelf Review",
            "subjectId": 240010,
            "subject": "Ambulatory Medicine",
            "secondarySubjectId": 250008,
            "secondarySubject": "Family Medicine",
            "systemId": 203,
            "system": "Cardiovascular System",
            "topicId": 2014,
            "topic": "Atrial fibrillation",
            "titleId": 2014,
            "title": "Atrial fibrillation",
            "topicAttributeId": 331282,
            "topicAttribute": "Cardiac arrhythmias and syncope",
            "correctAnswer": "4",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acquired long QT syndrome",
                    "choiceNumber": 1,
                    "correctTaken": 307,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Beta-2 agonist use",
                    "choiceNumber": 2,
                    "correctTaken": 653,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Caffeine consumption",
                    "choiceNumber": 3,
                    "correctTaken": 902,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Chronic hypertension",
                    "choiceNumber": 4,
                    "correctTaken": 2064,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Coronary artery disease",
                    "choiceNumber": 5,
                    "correctTaken": 1114,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": None,
            "isCorrect": False,
            "isIncorrect": False,
            "isMarked": False,
            "isOmitted": True,
            "isQuestionDirty": False,
            "isAnswerChoiceDisabled": False,
            "isQuestionDisabled": False,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "7733127",
                    "mediaDataId": 0,
                    "title": "The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba follow-up study.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/7733127"
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "12574085",
                    "mediaDataId": 0,
                    "title": "Atrial fibrillation in hypertension: predictors and outcome.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/12574085"
                }
            ],
            "questionMedia": None,
            "timeSpent": 0,
            "othersAvgTimeSpent": 111,
            "notes": None,
            "peopleTaken": 5040,
            "hotspotImageUrl": None,
            "lastUpdatedDate": "01/01/2022",
            "correctPercentile": 40,
            "isSubmitted": False,
            "isActive": True,
            "activeStatusId": 1,
            "hint": None,
            "allowCalculator": False,
            "difficultyLevelId": None,
            "additionalText": None,
            "mobileExcerpt": None,
            "passageExcerpt": None,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": None,
            "standards": None,
            "totalTimeSpentReview": 10,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": None,
            "examYear": 0,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": None,
            "copyrightId": None,
            "copyrightText": None,
            "frequentHighlights": None,
            "totalWeight": None,
            "weightScored": None,
            "maxAnswerSelection": 0,
            "scoreTypeId": None
        },
        {
            "exhibits": None,
            "sequenceId": 14,
            "questionId": 19505,
            "questionIndex": 20991,
            "questionText": "<p>A 38-year-old man comes to the office for follow-up after his blood pressure was found to be elevated at a health fair.&nbsp; The patient has had no headache, blurry vision, or chest pain.&nbsp; He does not use tobacco, alcohol, or illicit drugs.&nbsp; Temperature is 36.7 C (98.1 F), blood pressure is 148/96 mm Hg in the right arm and 146/94 mm Hg in the left, pulse is 74/min, and respirations are 14/min.&nbsp; BMI is 36 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Examination shows a regular heart rate and rhythm with no heart murmurs or carotid and abdominal bruits.&nbsp; Peripheral pulses are 2+ without radiofemoral delay.&nbsp; Breath sounds are normal.&nbsp; ECG is normal, and a 48-hour ambulatory blood pressure monitor shows an average pressure of 138/88 mm Hg.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T38622\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Laboratory evaluation of hypertension</strong></p></td></tr><tr><td><p align=\"center\"><strong>Renal function tests</strong></p></td><td><ul><li>Serum electrolytes (Na, K, Ca)</li><li>Serum creatinine</li><li>Urinalysis</li><li>Urine albumin/creatinine ratio (optional)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Endocrine tests</strong></p></td><td><ul><li>Fasting glucose or hemoglobin A1c</li><li>Lipid profile</li><li>TSH</li></ul></td></tr><tr><td><p align=\"center\"><strong>Cardiac tests</strong></p></td><td><ul><li>ECG</li><li>Echocardiography (optional)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Other tests</strong></p></td><td><ul><li>Complete blood count</li><li>Uric acid (optional)</li></ul></td></tr></tbody></table></div><p>This patient has a <a href=\"43399\">new diagnosis of hypertension</a> confirmed with office and ambulatory blood pressure measurements.&nbsp; Diagnostic criteria for hypertension vary according to different guidelines, but a blood pressure persistently at <strong>&#8805;130 mm Hg systolic and/or &#8805;80 mm Hg diastolic</strong> is generally considered hypertensive.</p><p>The initial evaluation of hypertension is directed to rule out common secondary causes, end-organ complications, and additional risk factors that may influence management.&nbsp; Hypertension is a major risk factor for <strong>chronic kidney disease</strong>, and conversely, kidney disease can cause secondary hypertension.&nbsp; Therefore, patients&#39; renal function, including <strong>serum creatinine, electrolytes, and urinalysis</strong>, should be assessed at the time of diagnosis.</p><p>Because the risk of cardiovascular complications is greater in patients with comorbid hyperlipidemia or diabetes mellitus, a blood glucose (or hemoglobin A1c) and lipid panel are indicated.&nbsp; Also, many experts recommend a serum TSH for all patients with hypertension because thyroid disorders are common and often present with asymptomatic hypertension.</p><p><strong>(Choices A and B)</strong>&nbsp; Screening for infrequent secondary causes is needed only for patients with an atypical presentation (eg, onset at age &lt;30), resistant hypertension (ie, uncontrolled despite an appropriate 3-drug regimen), or specific signs of a secondary hypertensive disorder.&nbsp; Examples of signs of a secondary hypertension include hypokalemia, suggesting hyperaldosteronism and confirmed with a plasma renin/aldosterone ratio, or atypical body fat distribution, suggesting Cushing syndrome and confirmed with 24-hour urinary free cortisol.</p><p><strong>(Choice D)</strong>&nbsp; ECG is recommended in the initial evaluation of hypertension to rule out common cardiovascular complications (eg, left ventricular hypertrophy, myocardial infarction).&nbsp; However, in the absence of abnormal examination (eg, murmur) or ECG findings, more advanced testing (eg, echocardiography) is not generally necessary.</p><p><strong>Educational objective:</strong><br>Hypertension is a major risk factor for chronic kidney disease and conversely, kidney disease can cause secondary hypertension.&nbsp; Therefore, patients with hypertension should have their renal function (including serum creatinine, electrolytes, and urinalysis) assessed at the time of diagnosis.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1012,
            "section": "Shelf Review",
            "subjectId": 240008,
            "subject": "Family Medicine",
            "secondarySubjectId": 250010,
            "secondarySubject": "Ambulatory Medicine",
            "systemId": 203,
            "system": "Cardiovascular System",
            "topicId": 6690,
            "topic": "Primary hypertension",
            "titleId": 6690,
            "title": "Primary hypertension",
            "topicAttributeId": 330611,
            "topicAttribute": "Hypertension",
            "correctAnswer": "3",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Order 24-hour urinary free cortisol",
                    "choiceNumber": 1,
                    "correctTaken": 296,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Order plasma renin and aldosterone",
                    "choiceNumber": 2,
                    "correctTaken": 1382,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Order serum creatinine",
                    "choiceNumber": 3,
                    "correctTaken": 3203,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Order transthoracic echocardiography",
                    "choiceNumber": 4,
                    "correctTaken": 198,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": None,
            "isCorrect": False,
            "isIncorrect": False,
            "isMarked": False,
            "isOmitted": True,
            "isQuestionDirty": False,
            "isAnswerChoiceDisabled": False,
            "isQuestionDisabled": False,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29146533",
                    "mediaDataId": 0,
                    "title": "2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29146533"
                }
            ],
            "questionMedia": None,
            "timeSpent": 0,
            "othersAvgTimeSpent": 83,
            "notes": None,
            "peopleTaken": 5079,
            "hotspotImageUrl": None,
            "lastUpdatedDate": "01/01/2022",
            "correctPercentile": 63,
            "isSubmitted": False,
            "isActive": True,
            "activeStatusId": 1,
            "hint": None,
            "allowCalculator": False,
            "difficultyLevelId": None,
            "additionalText": None,
            "mobileExcerpt": None,
            "passageExcerpt": None,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": None,
            "standards": None,
            "totalTimeSpentReview": 9,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": None,
            "examYear": 0,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": None,
            "copyrightId": None,
            "copyrightText": None,
            "frequentHighlights": None,
            "totalWeight": None,
            "weightScored": None,
            "maxAnswerSelection": 0,
            "scoreTypeId": None
        },
        {
            "exhibits": None,
            "sequenceId": 15,
            "questionId": 4127,
            "questionIndex": 4127,
            "questionText": "<p>A 75-year-old man comes to the clinic due to a 6-month history of periodic substernal chest pressure, which he experiences when walking uphill or climbing 2 flights of stairs.&nbsp; His medical history is significant for hyperlipidemia, for which he takes atorvastatin.&nbsp; The patient smokes a pack of cigarettes daily and occasionally consumes alcohol.&nbsp; Blood pressure is 120/78 mm Hg and pulse is 75/min.&nbsp; Physical examination shows no abnormalities.&nbsp; Resting ECG is normal.&nbsp; A treadmill stress test shows a horizontal ST-segment depression in leads V1-V4 at 73% of predicted maximal heart rate.&nbsp; Echocardiography demonstrates normal resting left ventricular systolic function.&nbsp; The patient prefers medical management.&nbsp; He is prescribed sublingual nitroglycerin to take as needed when anginal pain occurs and he is also prescribed a daily medication to help prevent anginal episodes.&nbsp; The daily medication most likely functions through which of the following mechanisms?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T31989\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Treatment of chronic stable angina</strong></p></td></tr><tr><td><p align=\"center\"><strong>Beta blockers</strong></p></td><td><ul><li>First-line therapy</li><li>&#8595; Myocardial contractility &amp; heart rate</li></ul></td></tr><tr><td><p align=\"center\"><strong>Nondihydropyridine CCBs</strong></p></td><td><ul><li>Alternative to beta blocker</li><li>&#8595; Myocardial contractility &amp; heart rate</li></ul></td></tr><tr><td><p align=\"center\"><strong>Dihydropyridine CCBs</strong></p></td><td><ul><li>Added to beta blocker when needed</li><li>Coronary artery vasodilation</li></ul><ul><li>&#8595; Afterload by systemic vasodilation</li></ul></td></tr><tr><td><p align=\"center\"><strong>Nitrates</strong></p></td><td><ul><li>Long-acting added for persistent angina</li><li>&#8595; Preload by dilation of capacitance veins</li></ul></td></tr><tr><td><p align=\"center\"><strong>Ranolazine</strong></p></td><td><ul><li>Alternative therapy for refractory angina</li><li>&#8595; Myocardial calcium influx</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>CCBs</strong> = calcium channel blockers.</p></td></tr></tbody></table></div><p>This patient has <strong>coronary artery disease</strong> with symptoms and clinical findings consistent with <strong>stable angina</strong>.&nbsp; Stable angina is defined as chest discomfort that predictably occurs with exertion and is relieved with rest; it results from a <strong>mismatch of myocardial oxygen</strong> supply and demand.&nbsp; In patients for whom coronary revascularization is not possible or desired, stable angina is treated medically.&nbsp; The 3 main medication classes for the prevention of stable angina symptoms are beta blockers, calcium channel blockers, and long-acting nitrates.</p><p><strong>Beta blockers</strong> (eg, metoprolol, atenolol) are recommended as <strong>first-line</strong> therapy for controlling anginal symptoms and improving exercise tolerance in patients with stable angina.&nbsp; These drugs primarily function by <strong>reducing myocardial oxygen demand</strong> through a <strong>decrease in heart rate</strong> and <strong>myocardial contractility</strong> and are highly effective in minimizing or eliminating exertional angina.&nbsp; Nondihydropyridine calcium channel blockers (eg, verapamil, diltiazem) treat angina primarily through the same mechanisms and are an alternative first-line therapy in patients with a beta blocker contraindication.</p><p><strong>(Choice A)</strong>&nbsp; Ranolazine exerts its antianginal effect by inhibiting the late phase of sodium influx into ischemic cardiac myocytes.&nbsp; This causes reduced calcium influx through the sodium-calcium exchanger, leading to a reduction in ventricular wall stress and myocardial oxygen demand.&nbsp; Ranolazine is often reserved for patients with stable angina that is refractory to other medical therapies.</p><p><strong>(Choices B and C)</strong>&nbsp; The dihydropyridine calcium channel blockers (eg, amlodipine, felodipine) treat angina in 2 ways: They increase myocardial oxygen supply through coronary artery vasodilation and reduce myocardial oxygen demand through systemic arterial vasodilation and a reduction in cardiac afterload (beta blockers only mildly reduce afterload).&nbsp; The dihydropyridines are typically used in combination with beta blockers because monotherapy can result in reflex tachycardia and worsening anginal symptoms.</p><p><strong>(Choice D)</strong>&nbsp; Nitrates treat angina primarily through the dilation of venous capacitance vessels and a reduction in cardiac preload.&nbsp; The result is a reduction in left ventricular wall stress and reduced myocardial oxygen demand.&nbsp; Long-acting nitrates (eg, isosorbide mononitrate) are often added to beta blockers in patients with persistent, stable angina.&nbsp; As-needed, short-acting nitrates (eg, sublingual nitroglycerin) can provide brief anginal relief but are not used for long-term anginal prevention.</p><p><strong>Educational objective:</strong><br>Beta blockers are first-line therapy for preventing symptoms and improving exercise tolerance in patients with stable angina.&nbsp; They help prevent angina by decreasing exertional heart rate and myocardial contractility, leading to a reduction in myocardial oxygen demand.&nbsp; Calcium channel blockers and long-acting nitrates are also used.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1012,
            "section": "Shelf Review",
            "subjectId": 240010,
            "subject": "Ambulatory Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": None,
            "systemId": 203,
            "system": "Cardiovascular System",
            "topicId": 2149,
            "topic": "Coronary artery disease",
            "titleId": 2149,
            "title": "Coronary artery disease",
            "topicAttributeId": 330578,
            "topicAttribute": "Coronary heart disease",
            "correctAnswer": "5",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Altered myocardial calcium level",
                    "choiceNumber": 1,
                    "correctTaken": 502,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Coronary artery vasodilation",
                    "choiceNumber": 2,
                    "correctTaken": 667,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Decreased cardiac afterload",
                    "choiceNumber": 3,
                    "correctTaken": 608,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Decreased cardiac preload",
                    "choiceNumber": 4,
                    "correctTaken": 1076,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Decreased myocardial contractility",
                    "choiceNumber": 5,
                    "correctTaken": 2252,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": None,
            "isCorrect": False,
            "isIncorrect": False,
            "isMarked": False,
            "isOmitted": True,
            "isQuestionDirty": False,
            "isAnswerChoiceDisabled": False,
            "isQuestionDisabled": False,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20861717",
                    "mediaDataId": 0,
                    "title": "Treatment of stable angina pectoris.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20861717"
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23166210",
                    "mediaDataId": 0,
                    "title": "2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23166210"
                }
            ],
            "questionMedia": None,
            "timeSpent": 0,
            "othersAvgTimeSpent": 88,
            "notes": None,
            "peopleTaken": 5105,
            "hotspotImageUrl": None,
            "lastUpdatedDate": "01/01/2022",
            "correctPercentile": 44,
            "isSubmitted": False,
            "isActive": True,
            "activeStatusId": 1,
            "hint": None,
            "allowCalculator": False,
            "difficultyLevelId": None,
            "additionalText": None,
            "mobileExcerpt": None,
            "passageExcerpt": None,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": None,
            "standards": None,
            "totalTimeSpentReview": 7,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": None,
            "examYear": 0,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": None,
            "copyrightId": None,
            "copyrightText": None,
            "frequentHighlights": None,
            "totalWeight": None,
            "weightScored": None,
            "maxAnswerSelection": 0,
            "scoreTypeId": None
        },
        {
            "exhibits": None,
            "sequenceId": 16,
            "questionId": 4291,
            "questionIndex": 4291,
            "questionText": "<p>A 50-year-old man comes to the office for a follow-up visit.&nbsp; He has essential hypertension that was diagnosed a year ago.&nbsp; Laboratory results at that time for complete blood cell count, chemistry panel, and urinalysis were normal.&nbsp; At his last office visit 4 weeks ago, the patient&#39;s blood pressure was 144/92 mm Hg.&nbsp; He exercises regularly and has been compliant with a low-salt diet.&nbsp; Current medications include a thiazide diuretic and an ACE inhibitor.&nbsp; He quit smoking 2 years ago after a 25-pack-year history.&nbsp; The patient drinks 3 or 4 glasses of wine every day and 6-8 beers on weekend nights with his friends.&nbsp; He does not use illicit drugs.&nbsp; His father died following a stroke at age 60.&nbsp; Today, the patient&#39;s blood pressure is 143/88 mm Hg, and pulse is 76/min.&nbsp; The rest of his physical examination is normal.&nbsp; Which of the following is the most appropriate next step in management of this patient&#39;s hypertension?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient with <strong>hypertension</strong> has a <strong>persistently elevated blood pressure</strong> (BP) despite taking appropriate antihypertensive medication.&nbsp; Common causes of such persistent BP elevations include medication nonadherence, dietary indiscretion (eg, excessive sodium intake), and concurrent medications (eg, nonsteroidal anti-inflammatory drugs, decongestants, glucocorticoids) that raise BP.</p><p>In addition, <strong>excessive alcohol intake</strong> (ie, &gt;2 drinks/day) and binge drinking (ie, &#8805;5 drinks in a single sitting) are associated with increased incidence of hypertension, higher BP, and <strong>failure to respond to appropriate antihypertensive therapy</strong>.&nbsp; In contrast, moderate alcohol intake (eg, &#8804;2 drinks/day for men, &#8804;1 drink/day for women) is associated with lower BP, decreased incidence of coronary artery disease, and lower cardiovascular mortality.&nbsp; Although adding other agents to control this patient&#39;s BP may eventually be necessary, the first step should be counseling regarding his drinking.</p><p><strong>(Choices B and E)</strong>&nbsp; Addition or titration of antihypertensive medication may be considered for this patient later if moderation of alcohol intake is unsuccessful.&nbsp; If a third medication is needed, a calcium channel blocker (eg, amlodipine) is preferred over a beta blocker in the absence of additional specific indications (eg, heart failure, hyperthyroidism).&nbsp; Thiazide diuretics have a nonlinear dose-response curve; the BP-lowering effect is proportionately greater at lower doses, and up-titration often induces greater adverse effects than benefits.</p><p><strong>(Choices C and D)</strong>&nbsp; Screening tests (eg, plasma aldosterone/renin ratio, renal vascular ultrasonography) for secondary causes of hypertension are recommended for patients with treatment-resistant hypertension (ie, BP elevated despite &#8805;3 appropriate antihypertensive medications).&nbsp; They also are indicated for unusual presentations (eg, young or very old age of onset, sudden onset) and when standard initial tests suggest a secondary cause (eg, hypokalemia).&nbsp; Most patients have primary hypertension; in the absence of specific indications, routine testing for secondary causes is not cost effective and may result in false-positive results.</p><p><strong>Educational objective:</strong><br>Excessive alcohol intake (ie, &gt;2 drinks/day) and binge drinking (ie, &#8805;5 drinks in a single sitting) are associated with increased incidence of hypertension, higher blood pressure, and failure to respond to appropriate antihypertensive therapy.&nbsp; In contrast, moderate alcohol intake is associated with lower blood pressure.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1012,
            "section": "Shelf Review",
            "subjectId": 240010,
            "subject": "Ambulatory Medicine",
            "secondarySubjectId": 250008,
            "secondarySubject": "Family Medicine",
            "systemId": 203,
            "system": "Cardiovascular System",
            "topicId": 6690,
            "topic": "Primary hypertension",
            "titleId": 6690,
            "title": "Primary hypertension",
            "topicAttributeId": 330611,
            "topicAttribute": "Hypertension",
            "correctAnswer": "1",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Counsel for reduction in alcohol intake",
                    "choiceNumber": 1,
                    "correctTaken": 3933,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increase the dose of thiazide diuretic",
                    "choiceNumber": 2,
                    "correctTaken": 199,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain a plasma aldosterone/renin ratio",
                    "choiceNumber": 3,
                    "correctTaken": 327,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain a renal vascular sonogram",
                    "choiceNumber": 4,
                    "correctTaken": 318,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Start a beta blocker",
                    "choiceNumber": 5,
                    "correctTaken": 244,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": None,
            "isCorrect": False,
            "isIncorrect": False,
            "isMarked": False,
            "isOmitted": True,
            "isQuestionDirty": False,
            "isAnswerChoiceDisabled": False,
            "isQuestionDisabled": False,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29565029",
                    "mediaDataId": 0,
                    "title": "Hypertension.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29565029"
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24891935",
                    "mediaDataId": 0,
                    "title": "Alcohol-induced hypertension: mechanism and prevention.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24891935"
                }
            ],
            "questionMedia": None,
            "timeSpent": 0,
            "othersAvgTimeSpent": 81,
            "notes": None,
            "peopleTaken": 5020,
            "hotspotImageUrl": None,
            "lastUpdatedDate": "01/01/2022",
            "correctPercentile": 78,
            "isSubmitted": False,
            "isActive": True,
            "activeStatusId": 1,
            "hint": None,
            "allowCalculator": False,
            "difficultyLevelId": None,
            "additionalText": None,
            "mobileExcerpt": None,
            "passageExcerpt": None,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": None,
            "standards": None,
            "totalTimeSpentReview": 10,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": None,
            "examYear": 0,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": None,
            "copyrightId": None,
            "copyrightText": None,
            "frequentHighlights": None,
            "totalWeight": None,
            "weightScored": None,
            "maxAnswerSelection": 0,
            "scoreTypeId": None
        },
        {
            "exhibits": None,
            "sequenceId": 17,
            "questionId": 2692,
            "questionIndex": 2692,
            "questionText": "<p>A 56-year-old man comes to the office due to 3 months of dyspnea that was initially exertional but has progressively worsened to the point that the patient is now breathless even at rest.&nbsp; He has not had any chest pain, palpitations, syncope, or ankle swelling.&nbsp; The patient has no significant past medical history, and he takes no medications.&nbsp; He has been smoking a pack of cigarettes daily for the last 30 years and has been drinking alcohol heavily for the past 5 years.&nbsp; His mother died of breast cancer at age 57.&nbsp; The patient&#39;s temperature is 37.1 C (98.8 F), blood pressure is 113/76 mm Hg, and pulse is 86/min.&nbsp; A third heart sound is heard on cardiac auscultation; there are no murmurs.&nbsp; Chest auscultation indicates bibasilar crackles.&nbsp; His abdomen is soft and with no evidence of ascites.&nbsp; Laboratory results are as follows:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"375\"><tbody><tr><td colspan=\"2\">Complete blood count</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Hematocrit</td><td>32%</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Mean corpuscular volume</td><td>101 &micro;m<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td>60,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td>6000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" height=\"15\"></td></tr><tr><td colspan=\"2\">Liver function studies</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Alkaline phosphatase</td><td>44 U/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Aspartate aminotransferase</td><td>180 U/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Alanine aminotransferase</td><td>66 U/L</td></tr></tbody></table></blockquote><p>Chest x-ray reveals cardiac silhouette enlargement and signs of pulmonary venous congestion.&nbsp; Echocardiography shows a dilated left ventricle with an estimated left ventricular ejection fraction of 25%.&nbsp; Coronary angiography reveals no evidence of obstructive coronary artery disease.&nbsp; Which of the following measures is most likely to reverse this patient&#39;s heart function?</p>",
            "questionHeader": "",
            "explanationText": "<p>This clinical presentation - dyspnea, third heart sound, bibasilar crackles, and low ejection fraction on echocardiogram - is consistent with decompensated congestive heart failure due to left ventricular (LV) systolic dysfunction.&nbsp; In this patient with no evidence of coronary artery disease on angiography, the most likely etiology is dilated cardiomyopathy due to heavy alcohol consumption (macrocytic anemia [mean corpuscular volume &gt;100 &micro;m<font size=\"2\"><sup>3</sup></font>], thrombocytopenia, &gt;2:1 ratio of aspartate aminotransferase to alanine aminotransferase).</p><p><strong>Alcoholic cardiomyopathy</strong> is a diagnosis of exclusion in patients with <strong>dilated</strong> cardiomyopathy and history of alcohol abuse in whom no other potential causes of cardiomyopathy (eg, coronary artery disease, valvular heart disease) are suspected or identified.&nbsp; The degree of LV dysfunction in alcoholic cardiomyopathy is directly related to the daily amount and overall duration of alcohol intake.&nbsp; The primary therapy for such patients is complete <strong>abstinence</strong> from alcohol use; this intervention is associated with improvement or <strong>normalization</strong> of LV function over time.</p><p><strong>(Choice B)</strong>&nbsp; Cigarette smoking is a strong risk factor for coronary heart disease, and smoking cessation should be encouraged in all patients, regardless of the presence or absence of coronary artery disease.&nbsp; However, tobacco cessation does not reverse the progression of alcoholic cardiomyopathy.</p><p><strong>(Choices C, D, and G)</strong>&nbsp; Patients with alcoholic cardiomyopathy should be managed in the same way as patients with other forms of dilated cardiomyopathy:&nbsp; salt and water restriction, diuretics as needed, ACE inhibitors or angiotensin II receptor blockers, beta blockers, mineralocorticoid receptor antagonists, and (if indicated) digoxin.&nbsp; However, strict abstinence from alcohol use remains the mainstay of therapy to reverse or halt further progression of cardiomyopathy.</p><p><strong>(Choice E)</strong>&nbsp; Niacin deficiency can occur with alcoholism, but supplementation has no role in management of patients with alcoholic cardiomyopathy.</p><p><strong>(Choice F)</strong>&nbsp; Glucocorticoid therapy (prednisolone) is occasionally used for patients with alcoholic hepatitis who have a high discriminant function, but it has no role in management of alcoholic cardiomyopathy.</p><p><strong>Educational objective:</strong><br>Complete cessation of alcohol consumption is the mainstay of therapy in patients with alcoholic cardiomyopathy and is associated with improvement or normalization of left ventricular function over time.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1012,
            "section": "Shelf Review",
            "subjectId": 240002,
            "subject": "Medicine",
            "secondarySubjectId": 250010,
            "secondarySubject": "Ambulatory Medicine",
            "systemId": 203,
            "system": "Cardiovascular System",
            "topicId": 2175,
            "topic": "Dilated cardiomyopathy",
            "titleId": 2175,
            "title": "Dilated cardiomyopathy",
            "topicAttributeId": 330628,
            "topicAttribute": "Myopericardial diseases",
            "correctAnswer": "1",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Abstinence from alcohol",
                    "choiceNumber": 1,
                    "correctTaken": 3409,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cessation of cigarette smoking",
                    "choiceNumber": 2,
                    "correctTaken": 293,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Initiation of ACE inhibitor therapy",
                    "choiceNumber": 3,
                    "correctTaken": 1160,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Initiation of digoxin therapy",
                    "choiceNumber": 4,
                    "correctTaken": 405,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Niacin supplementation",
                    "choiceNumber": 5,
                    "correctTaken": 77,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prednisolone therapy",
                    "choiceNumber": 6,
                    "correctTaken": 33,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reduction of salt intake",
                    "choiceNumber": 7,
                    "correctTaken": 54,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": None,
            "isCorrect": False,
            "isIncorrect": False,
            "isMarked": False,
            "isOmitted": True,
            "isQuestionDirty": False,
            "isAnswerChoiceDisabled": False,
            "isQuestionDisabled": False,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21962423",
                    "mediaDataId": 0,
                    "title": "Alcoholic cardiomyopathy: a review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21962423"
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25458176",
                    "mediaDataId": 0,
                    "title": "Natural history and prognostic factors in alcoholic cardiomyopathy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25458176"
                }
            ],
            "questionMedia": None,
            "timeSpent": 0,
            "othersAvgTimeSpent": 104,
            "notes": None,
            "peopleTaken": 5431,
            "hotspotImageUrl": None,
            "lastUpdatedDate": "01/01/2022",
            "correctPercentile": 62,
            "isSubmitted": False,
            "isActive": True,
            "activeStatusId": 1,
            "hint": None,
            "allowCalculator": False,
            "difficultyLevelId": None,
            "additionalText": None,
            "mobileExcerpt": None,
            "passageExcerpt": None,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": None,
            "standards": None,
            "totalTimeSpentReview": 11,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": None,
            "examYear": 0,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": None,
            "copyrightId": None,
            "copyrightText": None,
            "frequentHighlights": None,
            "totalWeight": None,
            "weightScored": None,
            "maxAnswerSelection": 0,
            "scoreTypeId": None
        },
        {
            "exhibits": None,
            "sequenceId": 18,
            "questionId": 3880,
            "questionIndex": 3880,
            "questionText": "A new screening test was devised to detect pancreatic cancer at early stages using a serum marker (CA19-9) of the disease.&nbsp; A study of this new test showed that its use prolongs the survival of patients with pancreatic cancer by several months.&nbsp; The researchers concluded that use of the test improves the prognosis of patients with pancreatic cancer.&nbsp; Which of the following is a potential problem with this conclusion?",
            "questionHeader": "",
            "explanationText": "<p>Lead-time bias should always be considered while evaluating any screening test.&nbsp; This bias occurs when there is an incorrect assumption or conclusion of prolonged apparent survival and better prognosis due to a screening test.&nbsp; What actually happens is that detection of the disease was made at an earlier point in time, but the disease course itself or the prognosis did not change, so the screened patients appeared to live longer from the time of diagnosis to the time of death.&nbsp; (USMLE tip: think of lead-time bias when you see &#x22;a new screening test&#x22; for poor prognosis diseases like lung or pancreatic cancer.)</p><p><strong>(Choices A, B and E)</strong>&nbsp; Observer&#39;s bias, measurement bias and ascertainment bias refer to misclassification of an outcome and/or exposure (e.g., labeling diseased subjects as non-diseased and vice versa) and are related to the design of the study.&nbsp; The scenario described does not mention how the study was designed.</p><p><strong>(Choice D)</strong>&nbsp; Although the results of the study could be potentially confounded, there is no information on how potential confounders were treated during the design or analysis stage of this study.</p><p><strong>Educational Objective:</strong><br>Understand the concept of lead-time bias in screening tests.&nbsp; The typical example of lead-time bias is prolongation of apparent survival in patients to whom a test is applied, without changing the prognosis of the disease.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1012,
            "section": "Shelf Review",
            "subjectId": 240010,
            "subject": "Ambulatory Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": None,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 24175,
            "topic": "Bias",
            "titleId": 24175,
            "title": "Bias",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "3",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Observer&#39;s bias",
                    "choiceNumber": 1,
                    "correctTaken": 8870,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Measurement bias",
                    "choiceNumber": 2,
                    "correctTaken": 10050,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lead-time bias",
                    "choiceNumber": 3,
                    "correctTaken": 245321,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Confounding",
                    "choiceNumber": 4,
                    "correctTaken": 12211,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ascertainment bias",
                    "choiceNumber": 5,
                    "correctTaken": 10850,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": None,
            "isCorrect": False,
            "isIncorrect": False,
            "isMarked": False,
            "isOmitted": True,
            "isQuestionDirty": False,
            "isAnswerChoiceDisabled": False,
            "isQuestionDisabled": False,
            "questionMappingReferencesList": None,
            "questionMedia": None,
            "timeSpent": 0,
            "othersAvgTimeSpent": 26,
            "notes": None,
            "peopleTaken": 287302,
            "hotspotImageUrl": None,
            "lastUpdatedDate": "01/01/2022",
            "correctPercentile": 85,
            "isSubmitted": False,
            "isActive": True,
            "activeStatusId": 1,
            "hint": None,
            "allowCalculator": False,
            "difficultyLevelId": None,
            "additionalText": None,
            "mobileExcerpt": None,
            "passageExcerpt": None,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": None,
            "standards": None,
            "totalTimeSpentReview": 4,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": None,
            "examYear": 0,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": None,
            "copyrightId": None,
            "copyrightText": None,
            "frequentHighlights": None,
            "totalWeight": None,
            "weightScored": None,
            "maxAnswerSelection": 0,
            "scoreTypeId": None
        },
        {
            "exhibits": None,
            "sequenceId": 19,
            "questionId": 20678,
            "questionIndex": 22180,
            "questionText": "<p>A 26-year-old woman comes to the office due to an intensely pruritic rash on her back that has been present for the past 24 hours.&nbsp; The rash developed shortly after the patient awoke from a nap and has been spreading.&nbsp; Other than the rash, she has no symptoms.&nbsp; The patient reports no changes in cosmetic products or detergents.&nbsp; She has not been ill recently and has never had a similar rash.&nbsp; The patient has no known chronic medical conditions and takes no medications or supplements.&nbsp; She is not sexually active, and her last menstrual period was 2 weeks ago.&nbsp; Vital signs are normal.&nbsp; Appearance of the skin on examination is shown in the <a href=\"47118\">exhibit</a>.&nbsp; Oropharyngeal and cardiopulmonary examinations reveal no abnormalities.&nbsp; Heart and lung sounds are normal.&nbsp; Which of the following is the most appropriate next step in management?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t73618\"><table class=\"table-default-style\" style=\"width:576px\"><tbody><tr><td colspan=\"2\" style=\"width:75.0%;\"><p align=\"center\"><strong>Acute urticaria</strong></p></td></tr><tr><td style=\"width:25.0%;\"><p align=\"center\"><strong>Etiologies</strong></p></td><td style=\"width:75.0%;\"><ul><li>Medications, insect stings</li><li>Infections, rheumatologic diseases</li><li>Many cases are idiopathic</li></ul></td></tr><tr><td style=\"width:25.0%;\"><p align=\"center\"><strong>Pathophysiology</strong></p></td><td style=\"width:75.0%;\"><ul><li>Mast cells release histamine &rarr; dermal edema</li></ul></td></tr><tr><td style=\"width:25.0%;\"><p align=\"center\"><strong>Clinical features</strong></p></td><td style=\"width:75.0%;\"><ul><li>Pruritic, erythematous plaques (ie, wheals)</li><li>Each wheal lasts &lt;24 hr, urticaria duration &lt;6 weeks</li><li>Diffuse or localized</li></ul></td></tr><tr><td style=\"width:25.0%;\"><p align=\"center\"><strong>Evaluation</strong></p></td><td style=\"width:75.0%;\"><ul><li>No workup for 1st episode</li><li>Allergy testing if specific trigger (eg, food) is suspected</li><li>Laboratory testing/biopsy if systemic symptoms are present</li></ul></td></tr><tr><td style=\"width:25.0%;\"><p align=\"center\"><strong>Treatment &amp; prognosis</strong></p></td><td style=\"width:75.0%;\"><ul><li>2nd-generation H<sub>1</sub> antihistamines</li><li>Add H<sub>2</sub> antihistamines or systemic corticosteroids if severe</li><li>Two-thirds of cases self-resolve</li></ul></td></tr></tbody></table></div><p>This patient has <strong>acute urticaria</strong>, intensely pruritic, well-circumscribed erythematous plaques (ie, wheals) caused by <strong>mast cell</strong> activation in the superficial dermis.&nbsp; Acute urticaria usually represents an IgE-mediated allergic reaction (eg, medication, insect bite, food); additional etiologies include infection (eg, bacterial, viral) and systemic illness (eg, rheumatologic disorder, mastocytosis).&nbsp; However, many cases are idiopathic.</p><p>Initial management includes a <strong>second-generation H</strong><font size=\"2\"><sub><strong>1</strong></sub></font>&nbsp;<strong>blocker</strong> (eg, cetirizine).&nbsp; A <strong>single episode</strong>, such as this patient&#39;s presentation, typically requires <strong>no additional evaluation</strong>.&nbsp; Laboratory evaluation and biopsy are recommended when urticaria is unresponsive to therapy, exhibits atypical features (eg, purpura), or is accompanied by systemic symptoms (eg, arthritis, weight loss) <strong>(Choice C)</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Intramuscular epinephrine is indicated for treatment of anaphylaxis, a severe, multisystem hypersensitivity reaction.&nbsp; Although patients with anaphylaxis may have urticaria, they typically have abnormal vital signs (eg, hypotension) and extradermal (eg, respiratory, gastrointestinal) manifestations.&nbsp; Treatment for isolated urticaria does not require epinephrine.</p><p><strong>(Choice B)</strong>&nbsp; Serum IgE level is typically elevated in atopic dermatitis, which presents acutely with <a href=\"44948\">erythematous papules</a> and vesicles, not wheals.&nbsp; Although acute urticaria is IgE mediated, the serum IgE level is not typically elevated.</p><p><strong>(Choice D)</strong>&nbsp; High-potency topical corticosteroids are used to treat plaque psoriasis, which presents with pruritic, <a href=\"44939\">erythematous plaques</a> with silvery scales, which are absent in this patient.&nbsp; Lesions typically develop over time on the extensor extremities rather than abruptly throughout the back.</p><p><strong>Educational objective:</strong><br>Initial management of acute urticaria includes a second-generation H<font size=\"2\"><sub>1</sub></font> blocker (eg, cetirizine).&nbsp; No additional evaluation is needed for a single episode of urticaria, although laboratory evaluation and biopsy are recommended for episodes that are unresponsive to therapy, that exhibit atypical features, or that are accompanied by systemic symptoms.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1012,
            "section": "Shelf Review",
            "subjectId": 240008,
            "subject": "Family Medicine",
            "secondarySubjectId": 250010,
            "secondarySubject": "Ambulatory Medicine",
            "systemId": 201,
            "system": "Allergy & Immunology",
            "topicId": 19915,
            "topic": "Urticaria",
            "titleId": 19915,
            "title": "Urticaria",
            "topicAttributeId": 330569,
            "topicAttribute": "Anaphylaxis and allergic reactions",
            "correctAnswer": "5",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Administer epinephrine",
                    "choiceNumber": 1,
                    "correctTaken": 238,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain serum IgE level",
                    "choiceNumber": 2,
                    "correctTaken": 244,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain skin biopsy",
                    "choiceNumber": 3,
                    "correctTaken": 88,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prescribe a high-potency topical corticosteroid",
                    "choiceNumber": 4,
                    "correctTaken": 863,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prescribe an H<font size=\"2\"><sub>1</sub></font>-receptor antagonist",
                    "choiceNumber": 5,
                    "correctTaken": 3578,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": None,
            "isCorrect": False,
            "isIncorrect": False,
            "isMarked": False,
            "isOmitted": True,
            "isQuestionDirty": False,
            "isAnswerChoiceDisabled": False,
            "isQuestionDisabled": False,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28671445",
                    "mediaDataId": 0,
                    "title": "Acute and chronic urticaria: evaluation and treatment.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28671445"
                }
            ],
            "questionMedia": None,
            "timeSpent": 0,
            "othersAvgTimeSpent": 73,
            "notes": None,
            "peopleTaken": 5010,
            "hotspotImageUrl": None,
            "lastUpdatedDate": "01/01/2022",
            "correctPercentile": 71,
            "isSubmitted": False,
            "isActive": True,
            "activeStatusId": 1,
            "hint": None,
            "allowCalculator": False,
            "difficultyLevelId": None,
            "additionalText": None,
            "mobileExcerpt": None,
            "passageExcerpt": None,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": None,
            "standards": None,
            "totalTimeSpentReview": 8,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": None,
            "examYear": 0,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": None,
            "copyrightId": None,
            "copyrightText": None,
            "frequentHighlights": None,
            "totalWeight": None,
            "weightScored": None,
            "maxAnswerSelection": 0,
            "scoreTypeId": None
        },
        {
            "exhibits": None,
            "sequenceId": 20,
            "questionId": 19414,
            "questionIndex": 20899,
            "questionText": "<p>A 42-year-old woman comes for follow-up after a recent urinary tract infection treated with a short course of antibiotics.&nbsp; During her emergency department visit, the patient was told that her blood pressure was &#x22;mildly elevated.&#x22;&nbsp; She currently has no symptoms.&nbsp; Medical history is otherwise insignificant, and the patient does not regularly see a physician.&nbsp; Family history is unremarkable.&nbsp; The patient jogs twice a week and eats a healthy diet.&nbsp; She takes no medications.&nbsp; Blood pressure is 142/91 mm Hg.&nbsp; BMI is 28 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Physical examination is unremarkable.&nbsp; ECG and laboratory tests, including a basic metabolic panel, are unremarkable.&nbsp; Which of the following is the best next step in managing this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient has had 2 separate episodes of mildly <strong>elevated blood pressure</strong> (BP) while she was in a medical setting (in the office and the emergency department), which suggest hypertension.&nbsp; However, office-based BP measurements are a poor predictor of high BP outside of the office because of the relatively common occurrence of white coat hypertension (eg, BP 5-10 mm Hg higher in the office than at home).&nbsp; Therefore, in the absence of end-organ damage, the diagnosis of hypertension <strong>must be confirmed</strong> by one of the following:</p><ul><li><p><strong>Ambulatory BP readings</strong>, as measured by an automatic device worn continuously by the patient for 24-48 hours.&nbsp; The device monitors BP at regular intervals (eg, 15-60 min).</p></li><li><p>If continuous ambulatory BP monitoring is not available, an acceptable alternative is <strong>home BP monitoring</strong> done twice a day (morning and evening) for a week.</p></li><li><p>If home BP monitoring is not possible, 3 office readings (preferably by an automated machine while the patient is alone) at least a week apart are needed.</p></li></ul><p>In contrast, if end-organ damage (eg, left ventricular hypertrophy, retinopathy, nephropathy) is present or if the patient has a systolic BP &#8805;180 mm Hg or diastolic BP &#8805;120 mm Hg, then the diagnosis of hypertension can be established in the office without additional confirmation, and therapy should be started quickly.&nbsp; This patient has neither end-organ damage nor confirmed hypertension, so antihypertensive therapy does not need to be started yet <strong>(Choices D and E)</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Weight loss is unlikely to improve BP significantly in this nonobese patient who is already exercising and following a good diet.&nbsp; In addition, waiting 12 months for an evaluation is too long and risks the patient being lost to follow-up or developing end-organ damage; a shorter interval is advised.</p><p><strong>(Choice C)</strong>&nbsp; Polysomnography is used to diagnose obstructive sleep apnea (OSA), which is associated with hypertension and obesity.&nbsp; This patient does not have confirmed hypertension, and although she is overweight, she is not at high <a href=\"9497\">risk for OSA</a>.&nbsp; In general, OSA screening is typically considered in patients with excessive daytime somnolence who have 2 other clinical manifestations (eg, hypertension, loud snoring, choking while asleep).</p><p><strong>Educational objective:</strong><br>Patients with severe hypertension or evidence of end-organ damage should be prescribed antihypertensive therapy immediately.&nbsp; For those with only mild blood pressure elevations, the diagnosis should first be confirmed outside of a health care setting with ambulatory blood pressure monitoring or home measurement.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1012,
            "section": "Shelf Review",
            "subjectId": 240010,
            "subject": "Ambulatory Medicine",
            "secondarySubjectId": 250008,
            "secondarySubject": "Family Medicine",
            "systemId": 203,
            "system": "Cardiovascular System",
            "topicId": 6690,
            "topic": "Primary hypertension",
            "titleId": 6690,
            "title": "Primary hypertension",
            "topicAttributeId": 330611,
            "topicAttribute": "Hypertension",
            "correctAnswer": "2",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Advise weight loss and follow-up in 12 months",
                    "choiceNumber": 1,
                    "correctTaken": 449,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain multiple home blood pressure readings",
                    "choiceNumber": 2,
                    "correctTaken": 3520,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain polysomnography",
                    "choiceNumber": 3,
                    "correctTaken": 34,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Start double antihypertensive therapy",
                    "choiceNumber": 4,
                    "correctTaken": 133,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Start single antihypertensive agent",
                    "choiceNumber": 5,
                    "correctTaken": 932,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": None,
            "isCorrect": False,
            "isIncorrect": False,
            "isMarked": False,
            "isOmitted": True,
            "isQuestionDirty": False,
            "isAnswerChoiceDisabled": False,
            "isQuestionDisabled": False,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30189994",
                    "mediaDataId": 0,
                    "title": "2017 ACC/AHA Blood Pressure Guideline Treatment Recommendations and Risk For Cardiovascular Events And All-Cause Mortality.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30189994"
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26456709",
                    "mediaDataId": 0,
                    "title": "What is the evidence base for diagnosing hypertension and for subsequent BP treatment targets in the prevention of cardiovascular disease?",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26456709"
                }
            ],
            "questionMedia": None,
            "timeSpent": 0,
            "othersAvgTimeSpent": 66,
            "notes": None,
            "peopleTaken": 5068,
            "hotspotImageUrl": None,
            "lastUpdatedDate": "01/01/2022",
            "correctPercentile": 69,
            "isSubmitted": False,
            "isActive": True,
            "activeStatusId": 1,
            "hint": None,
            "allowCalculator": False,
            "difficultyLevelId": None,
            "additionalText": None,
            "mobileExcerpt": None,
            "passageExcerpt": None,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": None,
            "standards": None,
            "totalTimeSpentReview": 3,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": None,
            "examYear": 0,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": None,
            "copyrightId": None,
            "copyrightText": None,
            "frequentHighlights": None,
            "totalWeight": None,
            "weightScored": None,
            "maxAnswerSelection": 0,
            "scoreTypeId": None
        },
        {
            "exhibits": None,
            "sequenceId": 21,
            "questionId": 3934,
            "questionIndex": 3934,
            "questionText": "<p>A group of investigators conducted a randomized placebo-controlled clinical trial to assess the effect of a new aldosterone receptor antagonist on the progression of chronic heart failure.&nbsp; The primary outcome was all-cause mortality.&nbsp; A decrease in all-cause mortality in the treatment group was reported, with a relative risk of 0.71 (p = 0.001).&nbsp; Which of the following statements is the best interpretation of the reported association?</p>",
            "questionHeader": "",
            "explanationText": "<p>Relative risk (RR) is a point estimate of association, but it does not account for random error.&nbsp; It is always possible that the calculated RR occurred by chance.&nbsp; The p-value is used to strengthen the results of the study and represents the probability of observing a given (or more extreme) result by chance alone, assuming the None hypothesis is true.&nbsp; In this scenario, assuming there were no difference in all-cause mortality between the treatment and placebo groups (None hypothesis), the probability of obtaining a RR of 0.71 or a more extreme value due to chance alone is 0.1% (ie, p = 0.001 because 0.1/100 = 0.001).&nbsp; The commonly accepted upper limit (cut-off point) of the p-value for a result to be considered statistically significant is 0.05 (ie, p &lt;5% is statistically significant).</p><p><strong>(Choices A and E)</strong>&nbsp; Both the p-value and the confidence interval are measures of statistical significance.&nbsp; A 95% confidence interval that contains 1.0 (None value for RR) would mean that the results are not statistically significant.&nbsp; This is not consistent with the obtained p-value of 0.001, which is statistically significant.</p><p><strong>(Choice C)</strong>&nbsp; A RR = 0.71 shows that the drug decreased the risk of mortality by 29% (as 1.0 - 0.71 = 0.29 or 29%).</p><p><strong>(Choice D)</strong>&nbsp; The p-value reflects random variability, not bias (which is systematic error).</p><p><strong>Educational objective:</strong><br>The p-value is the probability of observing a given (or more extreme) result due to chance alone, assuming the None hypothesis is true.&nbsp; A result is generally considered statistically significant when p &lt;0.05.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1012,
            "section": "Shelf Review",
            "subjectId": 240010,
            "subject": "Ambulatory Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": None,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 8373,
            "topic": "P-value and confidence interval",
            "titleId": 8373,
            "title": "P-value and confidence interval",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "2",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "The 95% confidence interval for the relative risk of all-cause mortality includes 1.0",
                    "choiceNumber": 1,
                    "correctTaken": 2629,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "There is a 0.1% probability of observing the given relative risk (or more extreme) by chance alone assuming no differences in mortality",
                    "choiceNumber": 2,
                    "correctTaken": 67670,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "There is a 71% decrease in all-cause mortality in the new aldosterone receptor antagonist compared to the placebo group",
                    "choiceNumber": 3,
                    "correctTaken": 12722,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "There is only a 0.1% chance that the relative risk calculated is biased in favor of the aldosterone receptor antagonist group",
                    "choiceNumber": 4,
                    "correctTaken": 6736,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The results obtained are not statistically significant",
                    "choiceNumber": 5,
                    "correctTaken": 2602,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": None,
            "isCorrect": False,
            "isIncorrect": False,
            "isMarked": False,
            "isOmitted": True,
            "isQuestionDirty": False,
            "isAnswerChoiceDisabled": False,
            "isQuestionDisabled": False,
            "questionMappingReferencesList": None,
            "questionMedia": None,
            "timeSpent": 0,
            "othersAvgTimeSpent": 66,
            "notes": None,
            "peopleTaken": 92359,
            "hotspotImageUrl": None,
            "lastUpdatedDate": "01/01/2022",
            "correctPercentile": 73,
            "isSubmitted": False,
            "isActive": True,
            "activeStatusId": 1,
            "hint": None,
            "allowCalculator": False,
            "difficultyLevelId": None,
            "additionalText": None,
            "mobileExcerpt": None,
            "passageExcerpt": None,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": None,
            "standards": None,
            "totalTimeSpentReview": 11,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": None,
            "examYear": 0,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": None,
            "copyrightId": None,
            "copyrightText": None,
            "frequentHighlights": None,
            "totalWeight": None,
            "weightScored": None,
            "maxAnswerSelection": 0,
            "scoreTypeId": None
        },
        {
            "exhibits": None,
            "sequenceId": 22,
            "questionId": 4452,
            "questionIndex": 4452,
            "questionText": "<p>A 68-year-old woman comes to the office for follow-up after a recent emergency department visit.&nbsp; Two weeks ago, the patient experienced palpitations and mild dizziness; ECG showed atrial fibrillation with rapid ventricular response.&nbsp; The episode resolved spontaneously in 2 hours, and she has had no symptoms since then.&nbsp; The patient has a history of hypertension treated with valsartan and hydrochlorothiazide.&nbsp; She is a lifetime nonsmoker and does not drink alcohol.&nbsp; Her exercise tolerance is good.&nbsp; Blood pressure is 128/72 mm Hg, and pulse is 74/min and regular.&nbsp; Physical examination is unremarkable.&nbsp; TSH is 1.6, creatinine is 1.1 mg/dL, and fasting glucose is 85 mg/dL.&nbsp; Echocardiography shows preserved left ventricular ejection fraction and no significant valvular abnormalities.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t84430\"><table class=\"table-default-style table-header-footer-style table-header-subheader-footer-style\"><tbody><tr><td colspan=\"5\"><p align=\"center\"><strong>CHA<sub>2</sub>DS<sub>2</sub>-VASc score for thromboembolic risk in nonvalvular atrial fibrillation</strong></p></td></tr><tr><td colspan=\"4\" style=\"width: 67%;\"><p align=\"center\"><strong>Risk criteria</strong></p></td><td style=\"width: 33%;\"><p align=\"center\"><strong>Points</strong></p></td></tr><tr><td style=\"width: 10%;\"><p align=\"center\"><strong>C</strong></p></td><td colspan=\"3\" style=\"width: 57%;\"><p>Congestive heart failure</p></td><td style=\"width: 33%;\"><p align=\"center\">1</p></td></tr><tr><td><p align=\"center\"><strong>H</strong></p></td><td colspan=\"3\"><p>Hypertension</p></td><td><p align=\"center\">1</p></td></tr><tr><td><p align=\"center\"><strong>A<sub>2</sub></strong></p></td><td colspan=\"3\"><p>Age &ge;75*</p></td><td><p align=\"center\">2</p></td></tr><tr><td><p align=\"center\"><strong>D</strong></p></td><td colspan=\"3\"><p>Diabetes mellitus</p></td><td><p align=\"center\">1</p></td></tr><tr><td><p align=\"center\"><strong>S<sub>2</sub></strong></p></td><td colspan=\"3\"><p>Stroke or TIA</p></td><td><p align=\"center\">2</p></td></tr><tr><td><p align=\"center\"><strong>V</strong></p></td><td colspan=\"3\"><p>Vascular disease (eg, PAD, prior MI)</p></td><td><p align=\"center\">1</p></td></tr><tr><td><p align=\"center\"><strong>A</strong></p></td><td colspan=\"3\"><p>Age 65-74*</p></td><td><p align=\"center\">1</p></td></tr><tr><td><p align=\"center\"><strong>Sc</strong></p></td><td colspan=\"3\"><p>Sex category female**</p></td><td><p align=\"center\">1</p></td></tr><tr><td></td><td colspan=\"3\"><p>Maximum score</p></td><td><p align=\"center\">9</p></td></tr><tr><td colspan=\"3\" style=\"width: 50%;\"><p align=\"center\"><strong>Total score</strong></p></td><td rowspan=\"2\" style=\"width: 17%;\"><p align=\"center\"><strong>Generalized<br />stroke risk</strong></p></td><td rowspan=\"2\" style=\"width: 33%;\"><p align=\"center\"><strong>Antithrombotic<br />therapy</strong></p></td></tr><tr><td colspan=\"2\" style=\"width: 25%;\"><p align=\"center\"><strong>Male</strong></p></td><td style=\"width: 25%;\"><p align=\"center\"><strong>Female</strong></p></td></tr><tr><td colspan=\"2\" style=\"width: 25%;\"><p align=\"center\">0</p></td><td style=\"width: 25%;\"><p align=\"center\">0</p></td><td style=\"width: 17%;\"><p align=\"center\">Low</p></td><td style=\"width: 33%;\"><p align=\"center\">None</p></td></tr><tr><td colspan=\"2\" style=\"width: 25%;\"><p align=\"center\">1</p></td><td style=\"width: 25%;\"><p align=\"center\">2</p></td><td style=\"width: 17%;\"><p align=\"center\">Moderate</p></td><td style=\"width: 33%;\"><p align=\"center\">None or oral anticoagulant</p></td></tr><tr><td colspan=\"2\" style=\"width: 25%;\"><p align=\"center\">&ge;2</p></td><td style=\"width: 25%;\"><p align=\"center\">&ge;3</p></td><td style=\"width: 17%;\"><p align=\"center\">High</p></td><td style=\"width: 33%;\"><p align=\"center\">Oral anticoagulant</p></td></tr><tr><td colspan=\"5\"><p>*Patients are assigned to 1 of the 2 age categories<strong>.</strong></p><p>**Different cutoffs are used for males &amp; females because female sex is considered a risk modifier that adds to the CHA<sub>2</sub>DS<sub>2</sub>-VASc score only if other (nonsex) risk factors are present.</p><p><strong>MI</strong> = myocardial infarction; <strong>PAD</strong> = peripheral artery disease; <strong>TIA</strong> = transient ischemic attack.</p></td></tr></tbody></table></div><p>This patient had an episode of <strong>atrial fibrillation</strong> that spontaneously resolved within hours.&nbsp; At the time of her clinic follow-up 2 weeks later, she appears to be in normal sinus rhythm (evidenced by a regular pulse rhythm).&nbsp; Given her age and other risk factors (eg, hypertension), this patient will most likely continue to have intermittent episodes of the arrhythmia (ie, <strong>paroxysmal atrial fibrillation</strong>).</p><p>The risk of <strong>systemic thromboembolism</strong> (eg, stroke) is increased in atrial fibrillation, likely to a similar degree in both paroxysmal and persistent/permanent disease.&nbsp; Therefore, an important component in managing new-onset atrial fibrillation is an assessment of the need for <strong>chronic anticoagulation</strong> to lower that risk.&nbsp; In patients with nonvalvular atrial fibrillation, the <strong>CHA</strong><font size=\"2\"><sub><strong>2</strong></sub></font><strong>DS</strong><font size=\"2\"><sub><strong>2</strong></sub></font><strong>-VASc score</strong> is typically used to estimate annual risk, with chronic anticoagulation indicated for <strong>men</strong> with a <strong>total score &#8805;2</strong> and <strong>women</strong> with a <strong>total score &#8805;3</strong> (indicating high thromboembolic risk).&nbsp; Direct <strong>oral anticoagulants</strong> (eg, apixaban, rivaroxaban, dabigatran) are typically used for chronic anticoagulation, although warfarin is sometimes used instead.</p><p>This patient has a CHA<font size=\"2\"><sub>2</sub></font>DS<font size=\"2\"><sub>2</sub></font>-VASc score of 3 (ie, hypertension, age, female sex); therefore, the initiation of apixaban is most appropriate <strong>(Choice F)</strong>.&nbsp; Chronic anticoagulation is not indicated for patients with a CHA<font size=\"2\"><sub>2</sub></font>DS<font size=\"2\"><sub>2</sub></font>-VASc score of 0 and should be considered (but is not necessarily indicated) for patients with a score indicating moderate risk (ie, 1 for men and 2 for women).</p><p><strong>(Choice A)</strong>&nbsp; Ambulatory heart rhythm monitoring (eg, Holter monitor) is used to help diagnose an intermittent arrhythmia that has not been captured on ECG.&nbsp; This patient&#39;s atrial fibrillation has already been recognized on ECG and further diagnostic intervention is not needed.</p><p><strong>(Choice B)</strong>&nbsp; Amiodarone is sometimes used as a rhythm-control agent for atrial fibrillation.&nbsp; However, it has multiple side effects and is not a first-line agent.&nbsp; It is not indicated in this patient whose episode of atrial fibrillation has resolved.</p><p><strong>(Choice D)</strong>&nbsp; Aspirin is not significantly effective in lowering the risk of systemic thromboembolism in atrial fibrillation and should not be used for this purpose, particularly in patients with an elevated CHA<font size=\"2\"><sub>2</sub></font>DS<font size=\"2\"><sub>2</sub></font>-VASc score.</p><p><strong>(Choice E)</strong>&nbsp; Carotid ultrasound is not indicated in the management of new-onset atrial fibrillation.&nbsp; Stroke associated with atrial fibrillation occurs due to embolization of atrial thrombus and is independent of carotid artery atherosclerosis.</p><p><strong>Educational objective:</strong><br>The management of new-onset atrial fibrillation should involve an assessment of systemic thromboembolism risk.&nbsp; Chronic anticoagulation (eg, apixaban) should be initiated for men with a CHA<font size=\"2\"><sub>2</sub></font>DS<font size=\"2\"><sub>2</sub></font>-VASc score &#8805;2 and women with a score &#8805;3 to lower their risk.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1012,
            "section": "Shelf Review",
            "subjectId": 240010,
            "subject": "Ambulatory Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": None,
            "systemId": 203,
            "system": "Cardiovascular System",
            "topicId": 2014,
            "topic": "Atrial fibrillation",
            "titleId": 2014,
            "title": "Atrial fibrillation",
            "topicAttributeId": 331282,
            "topicAttribute": "Cardiac arrhythmias and syncope",
            "correctAnswer": "3",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Ambulatory heart rhythm monitoring",
                    "choiceNumber": 1,
                    "correctTaken": 1183,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Amiodarone",
                    "choiceNumber": 2,
                    "correctTaken": 133,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Apixaban",
                    "choiceNumber": 3,
                    "correctTaken": 1744,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Aspirin",
                    "choiceNumber": 4,
                    "correctTaken": 766,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Carotid ultrasound",
                    "choiceNumber": 5,
                    "correctTaken": 46,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Clinical follow-up only",
                    "choiceNumber": 6,
                    "correctTaken": 1172,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": None,
            "isCorrect": False,
            "isIncorrect": False,
            "isMarked": False,
            "isOmitted": True,
            "isQuestionDirty": False,
            "isAnswerChoiceDisabled": False,
            "isQuestionDisabled": False,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24733535",
                    "mediaDataId": 0,
                    "title": "Anticoagulation in atrial fibrillation.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24733535"
                }
            ],
            "questionMedia": None,
            "timeSpent": 0,
            "othersAvgTimeSpent": 88,
            "notes": None,
            "peopleTaken": 5044,
            "hotspotImageUrl": None,
            "lastUpdatedDate": "01/01/2022",
            "correctPercentile": 34,
            "isSubmitted": False,
            "isActive": True,
            "activeStatusId": 1,
            "hint": None,
            "allowCalculator": False,
            "difficultyLevelId": None,
            "additionalText": None,
            "mobileExcerpt": None,
            "passageExcerpt": None,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": None,
            "standards": None,
            "totalTimeSpentReview": 6,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": None,
            "examYear": 0,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": None,
            "copyrightId": None,
            "copyrightText": None,
            "frequentHighlights": None,
            "totalWeight": None,
            "weightScored": None,
            "maxAnswerSelection": 0,
            "scoreTypeId": None
        },
        {
            "exhibits": None,
            "sequenceId": 23,
            "questionId": 4469,
            "questionIndex": 4469,
            "questionText": "<p>A 44-year-old man comes to the office for follow-up after a recent hospitalization.&nbsp; The patient went to the emergency department with palpitations 2 weeks ago and was found to have atrial fibrillation with rapid ventricular response.&nbsp; He was admitted to the hospital, where he spontaneously converted to normal sinus rhythm overnight and was discharged home the next day.&nbsp; Prior to this episode, the patient had gone on an alcohol drinking binge during a friend&#39;s bachelor party.&nbsp; He otherwise rarely drinks alcohol.&nbsp; Medical history is unremarkable.&nbsp; He is a lifetime nonsmoker.&nbsp; Blood pressure is 124/70 mm Hg and pulse is 78/min and regular.&nbsp; Estimated jugular venous pressure is normal.&nbsp; Examination shows no abnormalities.&nbsp; Review of laboratory results from the hospital admission shows normal creatinine level, liver function tests, thyroid studies, and lipid panel.&nbsp; Echocardiogram shows normal left and right ventricular function and no valvular abnormalities.&nbsp; Which of the following is the best next step in managing this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t84430\"><table class=\"table-default-style table-header-footer-style table-header-subheader-footer-style\"><tbody><tr><td colspan=\"5\"><p align=\"center\"><strong>CHA<sub>2</sub>DS<sub>2</sub>-VASc score for thromboembolic risk in nonvalvular atrial fibrillation</strong></p></td></tr><tr><td colspan=\"4\" style=\"width: 67%;\"><p align=\"center\"><strong>Risk criteria</strong></p></td><td style=\"width: 33%;\"><p align=\"center\"><strong>Points</strong></p></td></tr><tr><td style=\"width: 10%;\"><p align=\"center\"><strong>C</strong></p></td><td colspan=\"3\" style=\"width: 57%;\"><p>Congestive heart failure</p></td><td style=\"width: 33%;\"><p align=\"center\">1</p></td></tr><tr><td><p align=\"center\"><strong>H</strong></p></td><td colspan=\"3\"><p>Hypertension</p></td><td><p align=\"center\">1</p></td></tr><tr><td><p align=\"center\"><strong>A<sub>2</sub></strong></p></td><td colspan=\"3\"><p>Age &ge;75*</p></td><td><p align=\"center\">2</p></td></tr><tr><td><p align=\"center\"><strong>D</strong></p></td><td colspan=\"3\"><p>Diabetes mellitus</p></td><td><p align=\"center\">1</p></td></tr><tr><td><p align=\"center\"><strong>S<sub>2</sub></strong></p></td><td colspan=\"3\"><p>Stroke or TIA</p></td><td><p align=\"center\">2</p></td></tr><tr><td><p align=\"center\"><strong>V</strong></p></td><td colspan=\"3\"><p>Vascular disease (eg, PAD, prior MI)</p></td><td><p align=\"center\">1</p></td></tr><tr><td><p align=\"center\"><strong>A</strong></p></td><td colspan=\"3\"><p>Age 65-74*</p></td><td><p align=\"center\">1</p></td></tr><tr><td><p align=\"center\"><strong>Sc</strong></p></td><td colspan=\"3\"><p>Sex category female**</p></td><td><p align=\"center\">1</p></td></tr><tr><td></td><td colspan=\"3\"><p>Maximum score</p></td><td><p align=\"center\">9</p></td></tr><tr><td colspan=\"3\" style=\"width: 50%;\"><p align=\"center\"><strong>Total score</strong></p></td><td rowspan=\"2\" style=\"width: 17%;\"><p align=\"center\"><strong>Generalized<br />stroke risk</strong></p></td><td rowspan=\"2\" style=\"width: 33%;\"><p align=\"center\"><strong>Antithrombotic<br />therapy</strong></p></td></tr><tr><td colspan=\"2\" style=\"width: 25%;\"><p align=\"center\"><strong>Male</strong></p></td><td style=\"width: 25%;\"><p align=\"center\"><strong>Female</strong></p></td></tr><tr><td colspan=\"2\" style=\"width: 25%;\"><p align=\"center\">0</p></td><td style=\"width: 25%;\"><p align=\"center\">0</p></td><td style=\"width: 17%;\"><p align=\"center\">Low</p></td><td style=\"width: 33%;\"><p align=\"center\">None</p></td></tr><tr><td colspan=\"2\" style=\"width: 25%;\"><p align=\"center\">1</p></td><td style=\"width: 25%;\"><p align=\"center\">2</p></td><td style=\"width: 17%;\"><p align=\"center\">Moderate</p></td><td style=\"width: 33%;\"><p align=\"center\">None or oral anticoagulant</p></td></tr><tr><td colspan=\"2\" style=\"width: 25%;\"><p align=\"center\">&ge;2</p></td><td style=\"width: 25%;\"><p align=\"center\">&ge;3</p></td><td style=\"width: 17%;\"><p align=\"center\">High</p></td><td style=\"width: 33%;\"><p align=\"center\">Oral anticoagulant</p></td></tr><tr><td colspan=\"5\"><p>*Patients are assigned to 1 of the 2 age categories<strong>.</strong></p><p>**Different cutoffs are used for males &amp; females because female sex is considered a risk modifier that adds to the CHA<sub>2</sub>DS<sub>2</sub>-VASc score only if other (nonsex) risk factors are present.</p><p><strong>MI</strong> = myocardial infarction; <strong>PAD</strong> = peripheral artery disease; <strong>TIA</strong> = transient ischemic attack.</p></td></tr></tbody></table></div><p>This patient had an episode of <strong>atrial fibrillation</strong> (AF) that spontaneously resolved within 24 hours.&nbsp; The pathophysiology of AF involves aging and comorbidities (eg, hypertension, heart failure) that cause atrial remodeling and create an <a href=\"46410\">underlying substrate</a> for AF to develop.&nbsp; The substrate creates a lower threshold for <strong>triggers</strong> (eg, binge alcohol intake, hyperthyroidism) to <strong>initiate and sustain</strong> AF; however, sometimes triggers can cause AF in the absence of underlying substrate.&nbsp; After a first episode of AF, patients with risk factors for underlying substrate typically develop recurrent (ie, paroxysmal) or permanent AF.</p><p>In contrast, patients <strong>without risk factors for underlying substrate</strong> (eg, age &lt;50, no significant medical history) are relatively unlikely to experience recurrent AF, especially when the trigger of the episode is removed (eg, cessation of binge alcohol intake, treatment of hyperthyroidism).&nbsp; This is at least part of the reason these patients have <strong>low thromboembolic risk</strong> associated with AF.&nbsp; They often have a <strong>CHA<font size=\"2\"><sub>2</sub></font>DS<font size=\"2\"><sub>2</sub></font>-Vasc score of 0</strong>, as in this patient, for which chronic anticoagulation is not indicated.&nbsp; Men with a CHA<font size=\"2\"><sub>2</sub></font>DS<font size=\"2\"><sub>2</sub></font>-Vasc score of 1 (or women with a score of 2) also have relatively low thromboembolic risk that may not indicate chronic anticoagulation.&nbsp; In men with a CHA<font size=\"2\"><sub>2</sub></font>DS<font size=\"2\"><sub>2</sub></font>-Vasc score &#8805;2 (or women with a score &#8805;3), chronic anticoagulation is indicated and is accomplished via the administration of a direct oral anticoagulant (eg, rivaroxaban, apixaban, dabigatran) or, less commonly, warfarin <strong>(Choices D and E)</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Amiodarone is used occasionally for maintenance of sinus rhythm in patients with recurrent, symptomatic episodes of AF (ie, rhythm-control strategy).&nbsp; This patient has spontaneously converted to sinus rhythm, and amiodarone is not indicated.&nbsp; First-line rate control agents (eg, metoprolol) are commonly used but are not needed in patients with relatively low likelihood of recurrent AF.</p><p><strong>(Choice B)</strong>&nbsp; Dual antiplatelet therapy with aspirin and clopidogrel has shown some benefit in lowering the thromboembolic risk in patients with AF.&nbsp; However, the therapy is rarely used as anticoagulant agents (eg, rivaroxaban, warfarin) provide greater benefit with roughly the same level of increase in bleeding risk.</p><p><strong>Educational objective:</strong><br>Patients without underlying risk factors who develop atrial fibrillation typically have low associated thromboembolic risk.&nbsp; Those with a CHA<font size=\"2\"><sub>2</sub></font>DS<font size=\"2\"><sub>2</sub></font>-Vasc score of 0 have low thromboembolic risk, and chronic anticoagulation (eg, rivaroxaban) is not indicated.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1012,
            "section": "Shelf Review",
            "subjectId": 240010,
            "subject": "Ambulatory Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": None,
            "systemId": 203,
            "system": "Cardiovascular System",
            "topicId": 2014,
            "topic": "Atrial fibrillation",
            "titleId": 2014,
            "title": "Atrial fibrillation",
            "topicAttributeId": 331282,
            "topicAttribute": "Cardiac arrhythmias and syncope",
            "correctAnswer": "3",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Amiodarone",
                    "choiceNumber": 1,
                    "correctTaken": 49,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Aspirin and clopidogrel",
                    "choiceNumber": 2,
                    "correctTaken": 133,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "No additional therapy",
                    "choiceNumber": 3,
                    "correctTaken": 2525,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Rivaroxaban",
                    "choiceNumber": 4,
                    "correctTaken": 223,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Warfarin",
                    "choiceNumber": 5,
                    "correctTaken": 60,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": None,
            "isCorrect": False,
            "isIncorrect": False,
            "isMarked": False,
            "isOmitted": True,
            "isQuestionDirty": False,
            "isAnswerChoiceDisabled": False,
            "isQuestionDisabled": False,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24682347",
                    "mediaDataId": 0,
                    "title": "2014 AHA/ACC/HRS Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24682347"
                }
            ],
            "questionMedia": None,
            "timeSpent": 0,
            "othersAvgTimeSpent": 67,
            "notes": None,
            "peopleTaken": 2989,
            "hotspotImageUrl": None,
            "lastUpdatedDate": "01/01/2022",
            "correctPercentile": 84,
            "isSubmitted": False,
            "isActive": True,
            "activeStatusId": 1,
            "hint": None,
            "allowCalculator": False,
            "difficultyLevelId": None,
            "additionalText": None,
            "mobileExcerpt": None,
            "passageExcerpt": None,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": None,
            "standards": None,
            "totalTimeSpentReview": 10,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": None,
            "examYear": 0,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": None,
            "copyrightId": None,
            "copyrightText": None,
            "frequentHighlights": None,
            "totalWeight": None,
            "weightScored": None,
            "maxAnswerSelection": 0,
            "scoreTypeId": None
        },
        {
            "exhibits": None,
            "sequenceId": 24,
            "questionId": 3915,
            "questionIndex": 3915,
            "questionText": "A study was conducted to assess the relationship between race and end-stage renal disease.&nbsp; Two groups of pathologists independently studied specimens from 1,000 kidney biopsies.&nbsp; The first group of pathologists was aware of the race of the patient from whom the biopsy came, while the second group was blinded from the patient&#39;s race.&nbsp; The first group reported &#x22;hypertensive nephropathy&#x22; much more frequently for Black patients than the second group.&nbsp; This study best demonstrates which of the following types of bias?",
            "questionHeader": "",
            "explanationText": "<p><strong>Observer bias</strong> occurs when the investigator&#39;s decision is adversely affected by knowledge of the exposure status.&nbsp; In this case, some pathologists&#39; decisions were influenced by the fact that hypertensive nephropathy is a common cause of endstage renal disease in the Black population.&nbsp; The pathologists who were blinded to the subjects&#39; race&nbsp;were not under this influence, so their interpretation was more unbiased.</p><p><strong>(Choice A)</strong>&nbsp; Confounding is present when at least part of the exposure-disease relationship can be explained by another variable (confounder).&nbsp; No information on possible confounders is given in this scenario.</p><p><strong>(Choice B)</strong>&nbsp; Respondent bias is present when the outcome is obtained by the patient&#39;s response, and not by objective diagnostic methods (e.g., migraine headache).&nbsp; In this case, the diagnosis was ascertained via kidney biopsy.</p><p><strong>(Choice C)</strong>&nbsp; Recall bias results from inaccurate recall of past exposure by patients.&nbsp; It is not applicable to this case.</p><p><strong>(Choice D)</strong>&nbsp; Selection bias results from the manner in which the subjects are selected for the study, or from the selective losses from the follow-up.</p><p><strong>Educational objective:</strong><br>Observer bias occurs when the investigator&#39;s decision is adversely affected by knowledge of the exposure status.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1012,
            "section": "Shelf Review",
            "subjectId": 240010,
            "subject": "Ambulatory Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": None,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 24175,
            "topic": "Bias",
            "titleId": 24175,
            "title": "Bias",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "5",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Confounding",
                    "choiceNumber": 1,
                    "correctTaken": 7832,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Respondent bias",
                    "choiceNumber": 2,
                    "correctTaken": 10474,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recall bias",
                    "choiceNumber": 3,
                    "correctTaken": 5883,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Selection bias",
                    "choiceNumber": 4,
                    "correctTaken": 12955,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Observer bias",
                    "choiceNumber": 5,
                    "correctTaken": 249144,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": None,
            "isCorrect": False,
            "isIncorrect": False,
            "isMarked": False,
            "isOmitted": True,
            "isQuestionDirty": False,
            "isAnswerChoiceDisabled": False,
            "isQuestionDisabled": False,
            "questionMappingReferencesList": None,
            "questionMedia": None,
            "timeSpent": 0,
            "othersAvgTimeSpent": 30,
            "notes": None,
            "peopleTaken": 286288,
            "hotspotImageUrl": None,
            "lastUpdatedDate": "01/01/2022",
            "correctPercentile": 87,
            "isSubmitted": False,
            "isActive": True,
            "activeStatusId": 1,
            "hint": None,
            "allowCalculator": False,
            "difficultyLevelId": None,
            "additionalText": None,
            "mobileExcerpt": None,
            "passageExcerpt": None,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": None,
            "standards": None,
            "totalTimeSpentReview": 2,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": None,
            "examYear": 0,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": None,
            "copyrightId": None,
            "copyrightText": None,
            "frequentHighlights": None,
            "totalWeight": None,
            "weightScored": None,
            "maxAnswerSelection": 0,
            "scoreTypeId": None
        },
        {
            "exhibits": None,
            "sequenceId": 25,
            "questionId": 4646,
            "questionIndex": 4646,
            "questionText": "<p>A 43-year-old man with a 2-year history of type 2 diabetes mellitus comes to the office for a routine preventive examination.&nbsp; He feels well and has no symptoms.&nbsp; Medications include metformin and aspirin.&nbsp; The patient works as a computer programmer and has a sedentary lifestyle.&nbsp; He drinks 1 or 2 cans of beer on weekends and has a 20-pack-year smoking history.&nbsp; The patient is 183 cm (6 ft) tall and weighs 109 kg (240 lb); BMI is 32.5 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Blood pressure is 153/94 mm Hg and pulse is 82/min.&nbsp; The remainder of the physical examination is unremarkable.&nbsp; Hemoglobin A1c is 7.6%.&nbsp; At a previous visit 3 months ago, blood pressure was 149/92 mm Hg.&nbsp; Which of the following interventions would most likely cause the largest decrease in this patient&#39;s blood pressure?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T37075\"><table class=\"table-default-style table-header-footer-style\" style=\"width:100%\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Lifestyle interventions for hypertension</strong></p></td></tr><tr><td><p align=\"center\"><strong>Modification</strong></p></td><td><p align=\"center\"><strong>Recommended plan</strong></p></td><td><p align=\"center\"><strong>Approximate &#8595;</strong></p><p align=\"center\"><strong>systolic BP (mm Hg)</strong></p></td></tr><tr><td><p align=\"center\"><strong>DASH diet</strong></p></td><td><p align=\"center\">Diet high in fruits &amp; vegetables &amp; low in saturated &amp; total fats</p></td><td><p align=\"center\">11</p></td></tr><tr><td><p align=\"center\"><strong>Weight loss</strong></p></td><td><p align=\"center\">Reduction of BMI to &lt;25 kg/m<sup>2</sup></p></td><td><p align=\"center\">6 per 10-kg loss</p></td></tr><tr><td><p align=\"center\"><strong>Aerobic exercise</strong></p></td><td><p align=\"center\">30 minutes/day for 5+ days/week</p></td><td><p align=\"center\">7</p></td></tr><tr><td><p align=\"center\"><strong>Dietary sodium</strong></p></td><td><p align=\"center\">&lt;1.5-2.3 g/day (response varies)</p></td><td><p align=\"center\">5-8</p></td></tr><tr><td><p align=\"center\"><strong>Alcohol limitation</strong></p></td><td><p align=\"center\">&#8804;2 drinks/day in men, &#8804;1 drink/day in women</p></td><td><p align=\"center\">5</p></td></tr><tr><td colspan=\"3\"><p><strong>DASH</strong> = <strong>D</strong>ietary <strong>A</strong>pproaches to <strong>S</strong>top <strong>H</strong>ypertension.</p></td></tr></tbody></table></div><p>This patient has <strong>hypertension</strong>, defined as systolic blood pressure &#8805;130 mm Hg and/or diastolic blood pressure &#8805;80 mm Hg.&nbsp; Current guidelines recommend that all patients with hypertension be advised to get regular aerobic <strong>exercise</strong>, avoid excessive <strong>alcohol intake</strong>, and follow a <strong>dietary program</strong> proven to lower blood pressure (eg, Dietary Approaches to Stop Hypertension [DASH] diet).</p><p>In addition, patients who are overweight (BMI 25-29.9 kg/m<font size=\"2\"><sup>2</sup></font>) or obese (BMI &#8805;30 kg/m<font size=\"2\"><sup>2</sup></font>) should be advised to <strong>lose weight</strong> to achieve and maintain a healthy weight.&nbsp; Obesity, particularly central/visceral obesity, is the single greatest lifestyle risk factor for hypertension, with an attributable risk of approximately 60%-70%.&nbsp; In patients with obesity, each 10 kg (22 lb) of weight loss can lower blood pressure by ~6 mm Hg; therefore, weight loss is one of the most effective nonpharmacologic interventions for lowering blood pressure.&nbsp; However, additional lifestyle modifications, including dietary changes and exercise, are typically implemented concurrently.</p><p><strong>(Choice B)</strong>&nbsp; Moderate-intensity aerobic exercise can lower blood pressure in both hypertensive and normotensive individuals and facilitates weight loss.&nbsp; However, weight loss has a greater impact on blood pressure than exercise alone.</p><p><strong>(Choice C)</strong>&nbsp; Daily heavy alcohol consumption (&#8805;3 drinks per day in men, &#8805;2 in women) or binge drinking can raise blood pressure and is a common cause of refractory hypertension (hypertension that remains uncontrolled despite multiple medications).&nbsp; However, moderate alcohol intake, as in this patient, does not significantly affect blood pressure.</p><p><strong>(Choice D)</strong>&nbsp; Sodium restriction can lower blood pressure when implemented as part of the DASH diet (low in sodium and saturated fat; high in potassium, calcium, and dietary fiber).&nbsp; Sodium restriction alone is somewhat less effective and inconsistent, with the greatest effect in individuals age &gt;65, the African American population, and patients with chronic kidney disease.</p><p><strong>(Choice E)</strong>&nbsp; Smoking cessation is an important component of lifestyle modification that reduces the risk of future cardiovascular events and all-cause mortality.&nbsp; However, many studies indicate that chronic smoking is not clearly related to an increased incidence of hypertension.&nbsp; Weight loss would be more effective in controlling this patient&#39;s blood pressure.</p><p><strong>Educational objective:</strong><br>Obesity is the single greatest contributing lifestyle risk factor for hypertension; weight loss and the Dietary Approaches to Stop Hypertension (DASH) diet are the most effective nonpharmacologic interventions for lowering blood pressure.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1012,
            "section": "Shelf Review",
            "subjectId": 240010,
            "subject": "Ambulatory Medicine",
            "secondarySubjectId": 250008,
            "secondarySubject": "Family Medicine",
            "systemId": 203,
            "system": "Cardiovascular System",
            "topicId": 6690,
            "topic": "Primary hypertension",
            "titleId": 6690,
            "title": "Primary hypertension",
            "topicAttributeId": 330611,
            "topicAttribute": "Hypertension",
            "correctAnswer": "1",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "15-kg (33-lb) weight loss",
                    "choiceNumber": 1,
                    "correctTaken": 3309,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Aerobic exercise",
                    "choiceNumber": 2,
                    "correctTaken": 161,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cessation of alcohol intake",
                    "choiceNumber": 3,
                    "correctTaken": 54,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Dietary salt restriction",
                    "choiceNumber": 4,
                    "correctTaken": 468,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Smoking cessation",
                    "choiceNumber": 5,
                    "correctTaken": 1061,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": None,
            "isCorrect": False,
            "isIncorrect": False,
            "isMarked": False,
            "isOmitted": True,
            "isQuestionDirty": False,
            "isAnswerChoiceDisabled": False,
            "isQuestionDisabled": False,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21389976",
                    "mediaDataId": 0,
                    "title": "Non-pharmacological aspects of blood pressure management: what are the data?",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21389976"
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26934541",
                    "mediaDataId": 0,
                    "title": "Long-term effects of weight-reducing diets in people with hypertension.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26934541"
                }
            ],
            "questionMedia": None,
            "timeSpent": 0,
            "othersAvgTimeSpent": 53,
            "notes": None,
            "peopleTaken": 5052,
            "hotspotImageUrl": None,
            "lastUpdatedDate": "01/01/2022",
            "correctPercentile": 65,
            "isSubmitted": False,
            "isActive": True,
            "activeStatusId": 1,
            "hint": None,
            "allowCalculator": False,
            "difficultyLevelId": None,
            "additionalText": None,
            "mobileExcerpt": None,
            "passageExcerpt": None,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": None,
            "standards": None,
            "totalTimeSpentReview": 6,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": None,
            "examYear": 0,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": None,
            "copyrightId": None,
            "copyrightText": None,
            "frequentHighlights": None,
            "totalWeight": None,
            "weightScored": None,
            "maxAnswerSelection": 0,
            "scoreTypeId": None
        },
        {
            "exhibits": None,
            "sequenceId": 26,
            "questionId": 19670,
            "questionIndex": 21157,
            "questionText": "<p>A 27-year-old man comes to the office due to syncope.&nbsp; Two days ago, the patient was sitting at his computer at work and then suddenly awakened lying on the ground.&nbsp; His coworkers saw him collapse to the floor, jerk a few times, and become still.&nbsp; The patient was unconscious for 1-2 minutes.&nbsp; He was not lethargic or confused after the episode and did not experience chest pain or shortness of breath.&nbsp; The patient has had two similar episodes in the last year but did not seek medical attention.&nbsp; He has become concerned following this third episode.&nbsp; He has no medical history and takes no medications.&nbsp; Temperature is 36.7 C (98.1 F), blood pressure is 120/60 mm Hg, pulse is 72/min, and respirations are 16/min.&nbsp; Pulse oximetry is 100% on room air.&nbsp; The patient is awake, alert, and oriented, with normal speech.&nbsp; He has a small occipital hematoma.&nbsp; Oropharyngeal examination is normal.&nbsp; The pupils are equal and reactive to light.&nbsp; Heart and lung examinations are normal.&nbsp; Strength is 5/5 in the upper and lower extremities, and gait is normal.&nbsp; ECG is normal.&nbsp; What is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T57146\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Clues to etiology of syncope</strong></p></td></tr><tr><td rowspan=\"3\"><p align=\"center\"><strong>Reflex<br>syncope</strong></p></td><td><p align=\"center\"><strong>Vasovagal</strong></p></td><td><ul><li>Trigger (eg, emotional stress, prolonged standing)</li><li>Prodrome (eg, nausea, sweating, warmth)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Situational</strong></p></td><td><ul><li>Occurs with micturition, defecation, swallow, or cough</li></ul></td></tr><tr><td><p align=\"center\"><strong>Carotid</strong><br><strong>hypersensitivity</strong></p></td><td><ul><li>Tactile stimulation of carotid sinus while standing</li><li>Advanced age, carotid atherosclerosis</li></ul></td></tr><tr><td rowspan=\"3\"><p align=\"center\"><strong>Orthostatic</strong><br><strong>syncope</strong></p></td><td><p align=\"center\"><strong>Medications</strong></p></td><td><ul><li>Vasodilators (eg, alpha-1 blockers, antihypertensives)</li><li>Inotropic/chronotropic blockade (eg, beta blockers)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Hypovolemia</strong></p></td><td><ul><li>History consistent with volume loss</li></ul></td></tr><tr><td><p align=\"center\"><strong>Autonomic<br>dysfunction</strong></p></td><td><ul><li>Advanced age</li><li>Predisposing disease (eg, DM, Parkinson)</li></ul></td></tr><tr><td rowspan=\"3\"><p align=\"center\"><strong>Cardiac<br>syncope</strong></p></td><td><p align=\"center\"><strong>LV outflow</strong><br><strong>obstruction</strong></p></td><td><ul><li>Syncope with exertion</li><li>Systolic ejection murmur</li></ul></td></tr><tr><td><p align=\"center\"><strong>Ventricular</strong><br><strong>tachycardia</strong></p></td><td><ul><li>No warning symptoms</li><li>Cardiomyopathy or ischemic HD (monomorphic)</li><li>QT-interval prolongation (polymorphic)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Conduction</strong><br><strong>impairment*</strong></p></td><td><ul><li>Preceding fatigue or light-headedness</li><li>ECG abnormalities (eg, sinus pauses, dropped QRS)</li></ul></td></tr><tr><td colspan=\"3\"><p>*Sick sinus syndrome or advanced atrioventricular block.</p><p><strong>DM</strong> = diabetes mellitus; <strong>HD</strong> = heart disease; <strong>LV</strong> = left ventricular.</p></td></tr></tbody></table></div><p>This patient&#39;s <strong>sudden, brief</strong> (eg, 1-2 min) episode of <strong>loss of consciousness</strong> (LOC) and postural tone, followed by <strong>rapid recovery</strong>, is consistent with <strong>syncope</strong>.&nbsp; Syncope occurs due to global hypoperfusion of the brain and can have many causes.&nbsp; In most cases, syncope is benign and self-limiting; however, it can be the initial manifestation of a life-threatening disease process (eg, cardiac syncope).</p><p>A detailed initial evaluation can provide several clues to the underlying etiology.&nbsp; This patient&#39;s syncopal episode had <strong>no obvious trigger or prodrome</strong> to implicate reflex syncope; it also did not occur with position change (ie, standing from a seated position) to suggest orthostatic syncope.&nbsp; Instead, the syncopal episode occurred with the patient <strong>at rest</strong> and <strong>without warning symptoms</strong>.&nbsp; This presentation raises concern for a <strong>cardiac etiology</strong>, specifically an <strong>arrhythmic</strong> etiology, and should prompt further cardiac evaluation <strong>(Choice D)</strong>.</p><p><strong>Continuous ECG monitoring</strong> can evaluate for transient arrhythmia (eg, <strong>ventricular tachycardia</strong>) that may not be detected on initial ECG.&nbsp; In relatively young patients (eg, age &lt;40) without structural heart disease, ambulatory ECG monitoring (eg, Holter monitor, insertable cardiac monitor) is usually appropriate.&nbsp; In contrast, patients likely need hospital admission for closer monitoring and expedited cardiac evaluation when they are older, have underlying structural heart disease (eg, prior myocardial infarction), or have an abnormal ECG.</p><p><strong>(Choice B)</strong>&nbsp; CT angiography of the chest can evaluate for pulmonary embolism (PE), which sometimes presents with syncope.&nbsp; However, other symptoms (eg, chest pain, dyspnea) or signs (eg, hypoxemia, tachycardia) are usually present, and PE is unlikely to account for recurrent episodes of syncope.</p><p><strong>(Choice C)</strong>&nbsp; Seizure activity (diagnosed on electroencephalography) can cause LOC with jerking movements; however, other suggestive features (eg, prodromal aura, postictal period) are typically present.&nbsp; Muscle jerks can occur in all types of syncope because sudden cerebral hypoperfusion often causes brief myoclonus.</p><p><strong>(Choice E)</strong>&nbsp; Noncontrast CT scan of the head helps rule out trauma-induced intracranial injury (eg, hemorrhage).&nbsp; It is not indicated in this patient who experienced a relatively low-impact mechanism of injury and has no abnormal neurologic symptoms or findings 2 days after the incident.</p><p><strong>Educational objective:</strong><br>Patients with syncope not clearly attributable to a benign etiology (eg, reflex or orthostatic syncope) should undergo further cardiac workup (eg, ambulatory ECG) to determine whether a cardiac etiology is present.&nbsp; Syncope that occurs while supine or sitting, at rest, and without warning symptoms suggests an arrhythmic etiology.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1012,
            "section": "Shelf Review",
            "subjectId": 240010,
            "subject": "Ambulatory Medicine",
            "secondarySubjectId": 250002,
            "secondarySubject": "Medicine",
            "systemId": 203,
            "system": "Cardiovascular System",
            "topicId": 19621,
            "topic": "Syncope",
            "titleId": 19621,
            "title": "Syncope",
            "topicAttributeId": 331282,
            "topicAttribute": "Cardiac arrhythmias and syncope",
            "correctAnswer": "1",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Ambulatory ECG monitoring",
                    "choiceNumber": 1,
                    "correctTaken": 2196,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "CT angiography of the chest",
                    "choiceNumber": 2,
                    "correctTaken": 38,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Electroencephalography",
                    "choiceNumber": 3,
                    "correctTaken": 927,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "No additional workup",
                    "choiceNumber": 4,
                    "correctTaken": 322,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Noncontrast CT scan of the head",
                    "choiceNumber": 5,
                    "correctTaken": 1654,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": None,
            "isCorrect": False,
            "isIncorrect": False,
            "isMarked": False,
            "isOmitted": True,
            "isQuestionDirty": False,
            "isAnswerChoiceDisabled": False,
            "isQuestionDisabled": False,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "19713422",
                    "mediaDataId": 0,
                    "title": "Guidelines for the diagnosis and management of syncope (version 2009).",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/19713422"
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27752576",
                    "mediaDataId": 0,
                    "title": "Syncope: a review of emergency department management and disposition.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27752576"
                }
            ],
            "questionMedia": None,
            "timeSpent": 0,
            "othersAvgTimeSpent": 88,
            "notes": None,
            "peopleTaken": 5137,
            "hotspotImageUrl": None,
            "lastUpdatedDate": "01/01/2022",
            "correctPercentile": 42,
            "isSubmitted": False,
            "isActive": True,
            "activeStatusId": 1,
            "hint": None,
            "allowCalculator": False,
            "difficultyLevelId": None,
            "additionalText": None,
            "mobileExcerpt": None,
            "passageExcerpt": None,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": None,
            "standards": None,
            "totalTimeSpentReview": 11,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": None,
            "examYear": 0,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": None,
            "copyrightId": None,
            "copyrightText": None,
            "frequentHighlights": None,
            "totalWeight": None,
            "weightScored": None,
            "maxAnswerSelection": 0,
            "scoreTypeId": None
        },
        {
            "exhibits": None,
            "sequenceId": 27,
            "questionId": 4107,
            "questionIndex": 4107,
            "questionText": "Two cross-sectional studies were conducted using different questionnaires to determine the prevalence of over-the-counter analgesics use in a population.&nbsp; The first study showed a prevalence of 7.5% (95% confidence interval 6.0 - 9.0), and the second study demonstrated a prevalence of 7.3% (95% confidence interval 6.9 - 7.6).&nbsp; If the true prevalence of over-the-counter analgesics use in the population is 7.4%, which of the following statements about the results of the study is the most accurate?",
            "questionHeader": "",
            "explanationText": "<P>Precision is the measure of random error in the study.&nbsp; The study is precise if the results are not scattered widely; this is reflected by a tight confidence interval.&nbsp; The first study has a wider confidence interval compared to the second study; therefore, the second study is more precise.</P><P><STRONG>(Choices A and B)</STRONG> Specificity and sensitivity are measures of validity.&nbsp; The sensitivity and specificity of the questionnaires used in these studies cannot be determined from the given information.</P><P><STRONG>(Choices C and D)</STRONG> Validity and accuracy are measures of systematic error (bias).&nbsp; Accuracy is reduced if the result does not reflect the true value of the parameter measured.&nbsp; Increasing the sample size increases the precision of the study, but does not affect accuracy.&nbsp; In our case, the results of both studies are pretty close to the true value, and are thus seemingly accurate.</P><P><STRONG>Educational Objective:</STRONG><BR>Precision is the measure of random error.&nbsp; The tighter the confidence interval, the more precise the result. Increasing the sample size increases precision.</P>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1012,
            "section": "Shelf Review",
            "subjectId": 240010,
            "subject": "Ambulatory Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": None,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 24442,
            "topic": "Accuracy and precision",
            "titleId": 24442,
            "title": "Accuracy and precision",
            "topicAttributeId": 330622,
            "topicAttribute": "Measures and distribution of data",
            "correctAnswer": "5",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "The first study results are more specific",
                    "choiceNumber": 1,
                    "correctTaken": 8034,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The second study results are more sensitive",
                    "choiceNumber": 2,
                    "correctTaken": 22038,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The first study results are more valid",
                    "choiceNumber": 3,
                    "correctTaken": 12097,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The first study results are more accurate",
                    "choiceNumber": 4,
                    "correctTaken": 12486,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The second study results are more precise",
                    "choiceNumber": 5,
                    "correctTaken": 232496,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": None,
            "isCorrect": False,
            "isIncorrect": False,
            "isMarked": False,
            "isOmitted": True,
            "isQuestionDirty": False,
            "isAnswerChoiceDisabled": False,
            "isQuestionDisabled": False,
            "questionMappingReferencesList": None,
            "questionMedia": None,
            "timeSpent": 0,
            "othersAvgTimeSpent": 60,
            "notes": None,
            "peopleTaken": 287151,
            "hotspotImageUrl": None,
            "lastUpdatedDate": "01/01/2022",
            "correctPercentile": 80,
            "isSubmitted": False,
            "isActive": True,
            "activeStatusId": 1,
            "hint": None,
            "allowCalculator": False,
            "difficultyLevelId": None,
            "additionalText": None,
            "mobileExcerpt": None,
            "passageExcerpt": None,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": None,
            "standards": None,
            "totalTimeSpentReview": 9,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": None,
            "examYear": 0,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": None,
            "copyrightId": None,
            "copyrightText": None,
            "frequentHighlights": None,
            "totalWeight": None,
            "weightScored": None,
            "maxAnswerSelection": 0,
            "scoreTypeId": None
        },
        {
            "exhibits": None,
            "sequenceId": 28,
            "questionId": 3094,
            "questionIndex": 3094,
            "questionText": "<p>A 56-year-old man comes to the office for follow-up of high blood pressure.&nbsp; At his 3 previous visits, systolic blood pressure has been 140-145 mm Hg, and diastolic blood pressure has been 90-96 mm Hg.&nbsp; The patient has no other medical problems and takes no medications.&nbsp; He has smoked 2 or 3 cigarettes daily for 30 years and drinks 1 or 2 glasses of wine nightly.&nbsp; The patient&#39;s diet mainly consists of fried foods and meat, with limited intake of fruits and vegetables.&nbsp; There is no family history of diabetes mellitus, coronary artery disease, hyperlipidemia, or hypertension.&nbsp; Blood pressure is 146/97 mm Hg and pulse is 80/min.&nbsp; BMI is 27 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Physical examination is normal.&nbsp; Which of the following nonpharmacologic interventions is likely to have the greatest impact on this patient&#39;s blood pressure?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T37075\"><table class=\"table-default-style table-header-footer-style\" style=\"width:100%\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Lifestyle interventions for hypertension</strong></p></td></tr><tr><td><p align=\"center\"><strong>Modification</strong></p></td><td><p align=\"center\"><strong>Recommended plan</strong></p></td><td><p align=\"center\"><strong>Approximate &#8595;</strong></p><p align=\"center\"><strong>systolic BP (mm Hg)</strong></p></td></tr><tr><td><p align=\"center\"><strong>DASH diet</strong></p></td><td><p align=\"center\">Diet high in fruits &amp; vegetables &amp; low in saturated &amp; total fats</p></td><td><p align=\"center\">11</p></td></tr><tr><td><p align=\"center\"><strong>Weight loss</strong></p></td><td><p align=\"center\">Reduction of BMI to &lt;25 kg/m<sup>2</sup></p></td><td><p align=\"center\">6 per 10-kg loss</p></td></tr><tr><td><p align=\"center\"><strong>Aerobic exercise</strong></p></td><td><p align=\"center\">30 minutes/day for 5+ days/week</p></td><td><p align=\"center\">7</p></td></tr><tr><td><p align=\"center\"><strong>Dietary sodium</strong></p></td><td><p align=\"center\">&lt;1.5-2.3 g/day (response varies)</p></td><td><p align=\"center\">5-8</p></td></tr><tr><td><p align=\"center\"><strong>Alcohol limitation</strong></p></td><td><p align=\"center\">&#8804;2 drinks/day in men, &#8804;1 drink/day in women</p></td><td><p align=\"center\">5</p></td></tr><tr><td colspan=\"3\"><p><strong>DASH</strong> = <strong>D</strong>ietary <strong>A</strong>pproaches to <strong>S</strong>top <strong>H</strong>ypertension.</p></td></tr></tbody></table></div><p>Guidelines define <strong>hypertension</strong> as systolic blood pressure &#8805;130 mm Hg and/or diastolic blood pressure &#8805;80 mm Hg, as confirmed by multiple blood pressure readings.&nbsp; Although most patients with hypertension require pharmacologic therapy, all patients with hypertension should also institute <strong>lifestyle interventions</strong> to reduce blood pressure.&nbsp; Major interventions include dietary modification, weight loss (for overweight and obese patients), regular aerobic exercise, and limitation of alcohol intake.</p><p>One of the most effective interventions to treat hypertension is the <strong>DASH (Dietary Approaches to Stop Hypertension) diet</strong>, which is a combination diet rich in fruits, vegetables, legumes, low-fat dairy products, and low in saturated and total fat.&nbsp; In patients with hypertension, the DASH diet can produce a reduction in systolic blood pressure of approximately 11 mm Hg, with a corresponding reduction in diastolic pressure.&nbsp; Overweight and obese patients should also be counseled on additional dietary and exercise interventions for weight loss, which can further reduce blood pressure.</p><p><strong>(Choice B)</strong>&nbsp; Although regular aerobic exercise consistently reduces blood pressure in hypertensive patients, isometric resistance training has not demonstrated this effect.</p><p><strong>(Choice C)</strong>&nbsp; The base DASH diet generally provides less sodium than many patients with hypertension typically consume; a specific low-sodium version of the DASH diet can further reduce blood pressure.&nbsp; However, blood pressure reduction from sodium restriction alone is variable and generally less than either version of the DASH diet.</p><p><strong>(Choice D)</strong>&nbsp; Smoking cessation should be recommended to all patients to reduce the overall risk of cardiovascular complications.&nbsp; However, the effect of smoking on blood pressure is small and generally inconsistent; discontinuation of this patient&#39;s light smoking habit is unlikely to have a significant effect in reducing his blood pressure.</p><p><strong>Educational objective:</strong><br>In patients with hypertension, the DASH (Dietary Approaches to Stop Hypertension) diet, which is a combination diet rich in fruits, vegetables, legumes, low-fat dairy products, and low in saturated and total fat, can produce a reduction in systolic blood pressure of approximately 11 mm Hg, with a corresponding reduction in diastolic pressure.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1012,
            "section": "Shelf Review",
            "subjectId": 240008,
            "subject": "Family Medicine",
            "secondarySubjectId": 250010,
            "secondarySubject": "Ambulatory Medicine",
            "systemId": 203,
            "system": "Cardiovascular System",
            "topicId": 6690,
            "topic": "Primary hypertension",
            "titleId": 6690,
            "title": "Primary hypertension",
            "topicAttributeId": 330611,
            "topicAttribute": "Hypertension",
            "correctAnswer": "1",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "DASH (Dietary Approaches to Stop Hypertension) diet",
                    "choiceNumber": 1,
                    "correctTaken": 3149,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Isometric resistance training",
                    "choiceNumber": 2,
                    "correctTaken": 110,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reduced sodium intake",
                    "choiceNumber": 3,
                    "correctTaken": 293,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Smoking cessation",
                    "choiceNumber": 4,
                    "correctTaken": 1541,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": None,
            "isCorrect": False,
            "isIncorrect": False,
            "isMarked": False,
            "isOmitted": True,
            "isQuestionDirty": False,
            "isAnswerChoiceDisabled": False,
            "isQuestionDisabled": False,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21389976",
                    "mediaDataId": 0,
                    "title": "Non-pharmacological aspects of blood pressure management: what are the data?",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21389976"
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "17059793",
                    "mediaDataId": 0,
                    "title": "Nonpharmacologic therapy for hypertension: does it really work?",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/17059793"
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "9099655",
                    "mediaDataId": 0,
                    "title": "A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/9099655"
                }
            ],
            "questionMedia": None,
            "timeSpent": 0,
            "othersAvgTimeSpent": 47,
            "notes": None,
            "peopleTaken": 5093,
            "hotspotImageUrl": None,
            "lastUpdatedDate": "01/01/2022",
            "correctPercentile": 61,
            "isSubmitted": False,
            "isActive": True,
            "activeStatusId": 1,
            "hint": None,
            "allowCalculator": False,
            "difficultyLevelId": None,
            "additionalText": None,
            "mobileExcerpt": None,
            "passageExcerpt": None,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": None,
            "standards": None,
            "totalTimeSpentReview": 4,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": None,
            "examYear": 0,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": None,
            "copyrightId": None,
            "copyrightText": None,
            "frequentHighlights": None,
            "totalWeight": None,
            "weightScored": None,
            "maxAnswerSelection": 0,
            "scoreTypeId": None
        },
        {
            "exhibits": None,
            "sequenceId": 29,
            "questionId": 3945,
            "questionIndex": 3945,
            "questionText": "<p>A 60-year-old man comes to the office for evaluation of a 6-month history of intermittent chest pain.&nbsp; He describes substernal tightness and pain that occur when he walks quickly or climbs stairs.&nbsp; The symptoms last about 10 minutes and slowly fade away with rest.&nbsp; These episodes do not happen at rest.&nbsp; The patient has a known history of coronary artery disease with coronary artery bypass grafting surgery 7 years ago.&nbsp; Other medical problems include hypertension and hyperlipidemia.&nbsp; Blood pressure is 140/78 mm Hg and pulse is 78/min and regular.&nbsp; There are no murmurs on cardiac auscultation.&nbsp; Lungs are clear bilaterally.&nbsp; Treadmill stress test is performed.&nbsp; Seven minutes into the test, the patient develops chest pain and the treadmill is stopped.&nbsp; Sublingual nitroglycerin is administered, which almost immediately relieves the patient&#39;s pain.&nbsp; What is the predominant mechanism responsible for the rapid pain relief in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient with coronary artery disease has a classic presentation of <strong>chronic stable angina</strong> (exertional chest pain relieved by rest), with rapid relief of his symptoms following the administration of sublingual nitroglycerin.&nbsp; <strong>Nitrates</strong> exert their effect by direct vascular smooth muscle relaxation causing systemic venodilation and an increase in peripheral venous capacitance.&nbsp; Their primary <strong>anti-ischemic</strong> effect is mediated by <strong>systemic vasodilation</strong> and <strong>decrease in cardiac preload</strong> resulting in a decrease in left ventricular end-diastolic and end-systolic volume.&nbsp; This, in turn, leads to a <strong>reduction in left ventricular systolic wall stress</strong> - which reflects <strong>afterload</strong> and is proportional to (pressure * radius / thickness) - and a decrease in myocardial <strong>oxygen demand</strong>, resulting in relief of anginal symptoms.</p><p>Although nitrates act as coronary vasodilators (via direct relaxation of coronary vascular smooth muscle cells), the beneficial effect of this mechanism is uncertain <strong>(Choice A)</strong>.&nbsp; The coronary arterioles in the area of flow-limiting coronary stenosis are already dilated by innate mechanisms, allowing maintenance of resting blood flow across the stenotic lesion.&nbsp; Nitrate-induced coronary vasodilation paradoxically decreases coronary perfusion pressure across the stenotic lesion by diverting blood flow to arterioles supplying the normal myocardium.</p><p><strong>(Choices B and E)</strong>&nbsp; Beta blockers and calcium channel blockers exert an antianginal effect partially via a decrease in the heart rate (negative chronotropic effect) or contractility (negative inotropic effect).&nbsp; Nitrates do not have a direct effect on cardiac chronotropy; they may cause decreased inotropy due to decreased preload, but their antianginal effect is thought to be due primarily to a reduction in wall stress.</p><p><strong>(Choice D)</strong>&nbsp; At low doses (such as those used in sublingual nitroglycerin preparations), nitrates have only a modest effect on arterial and arteriolar dilation and cause minimal or no change in systemic vascular resistance.&nbsp; Higher doses can lead to a drop in systemic blood pressure.</p><p><strong>Educational objective:</strong><br>Sublingual nitroglycerin is used as a first-line agent for rapid relief of symptoms in patients with angina pectoris.&nbsp; The antiischemic effect of nitrates is mediated by systemic vasodilation with a decrease in left ventricular end-diastolic volume and wall stress resulting in decreased myocardial oxygen demand.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1012,
            "section": "Shelf Review",
            "subjectId": 240010,
            "subject": "Ambulatory Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": None,
            "systemId": 203,
            "system": "Cardiovascular System",
            "topicId": 2149,
            "topic": "Coronary artery disease",
            "titleId": 2149,
            "title": "Coronary artery disease",
            "topicAttributeId": 330578,
            "topicAttribute": "Coronary heart disease",
            "correctAnswer": "3",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Coronary vasodilation",
                    "choiceNumber": 1,
                    "correctTaken": 8462,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Decreased left ventricular contractility",
                    "choiceNumber": 2,
                    "correctTaken": 733,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Decreased left ventricular wall stress",
                    "choiceNumber": 3,
                    "correctTaken": 8929,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Dilation of small arteries",
                    "choiceNumber": 4,
                    "correctTaken": 1194,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Negative chronotropic effect",
                    "choiceNumber": 5,
                    "correctTaken": 207,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": None,
            "isCorrect": False,
            "isIncorrect": False,
            "isMarked": False,
            "isOmitted": True,
            "isQuestionDirty": False,
            "isAnswerChoiceDisabled": False,
            "isQuestionDisabled": False,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "7873467",
                    "mediaDataId": 0,
                    "title": "Mechanisms of action of nitrates.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/7873467"
                }
            ],
            "questionMedia": None,
            "timeSpent": 0,
            "othersAvgTimeSpent": 61,
            "notes": None,
            "peopleTaken": 19525,
            "hotspotImageUrl": None,
            "lastUpdatedDate": "01/01/2022",
            "correctPercentile": 45,
            "isSubmitted": False,
            "isActive": True,
            "activeStatusId": 1,
            "hint": None,
            "allowCalculator": False,
            "difficultyLevelId": None,
            "additionalText": None,
            "mobileExcerpt": None,
            "passageExcerpt": None,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": None,
            "standards": None,
            "totalTimeSpentReview": 6,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": None,
            "examYear": 0,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": None,
            "copyrightId": None,
            "copyrightText": None,
            "frequentHighlights": None,
            "totalWeight": None,
            "weightScored": None,
            "maxAnswerSelection": 0,
            "scoreTypeId": None
        },
        {
            "exhibits": None,
            "sequenceId": 30,
            "questionId": 4680,
            "questionIndex": 4680,
            "questionText": "<p>A 32-year-old man comes to the office for a routine preemployment physical.&nbsp; He has been feeling well.&nbsp; Ten years ago, his father died suddenly at age 54.&nbsp; Blood pressure is 175/103 mm Hg in the right arm and 180/105 mm Hg in the left, and pulse is 82/min.&nbsp; BMI is 22.1 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; The lungs are clear bilaterally and heart sounds are normal.&nbsp; Bilateral, nontender, upper abdominal masses are palpated on examination.&nbsp; Hemoglobin level is 15.2 g/dL and creatinine concentration is 0.8 mg/dL.&nbsp; Which of the following is the most appropriate next step in evaluating this patient&#39;s condition?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t35852\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Autosomal dominant polycystic kidney disease</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical<br>presentation</strong></p></td><td><ul><li>Most patients asymptomatic until age 30-40</li><li>Flank pain, hematuria</li><li>Hypertension</li><li>Palpable abdominal masses (usually bilateral)</li><li>Chronic kidney disease (CKD)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Extrarenal<br>features</strong></p></td><td><ul><li>Cerebral aneurysms</li><li>Hepatic &amp; pancreatic cysts</li><li>Mitral valve prolapse, aortic regurgitation</li><li>Colonic diverticulosis</li><li>Ventral &amp; inguinal hernias</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><ul><li>Ultrasonography showing multiple renal cysts</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Aggressive control of risk factors for CV&nbsp;&amp; CKD</li><li>ACE inhibitors preferred for hypertension</li><li>Hemodialysis, renal transplant for ESRD</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>CV</strong> = cardiovascular; <strong>ESRD</strong> = end-stage renal disease.</p></td></tr></tbody></table></div><p>This patient with early-onset hypertension and bilateral upper abdominal masses likely has <strong>autosomal dominant polycystic kidney disease (ADPKD)</strong>, which is the most common genetic cause of <strong>chronic kidney disease</strong>.&nbsp; Mutation of the <em>PKD1</em> or <em>PKD2</em> gene disrupts the function of polycystin proteins and leads to cystic degeneration of the renal parenchyma that begins early in life.</p><p>Most patients are <strong>asymptomatic</strong> until age 30-40, when cysts have become large and numerous.&nbsp; <strong>Hypertension</strong> is a common early disease manifestation and is typically present before any significant decline in renal function.&nbsp; Other early disease findings can include hematuria, nephrolithiasis, flank pain, and urinary tract infections.&nbsp; Some patients have an elevated hemoglobin concentration due to increased erythropoietin production (possibly from local ischemia around the renal cysts).&nbsp; As cystic degeneration progresses with age, patients experience <strong>progressive renal dysfunction</strong> that eventually leads to end-stage renal disease.</p><p>Extrarenal complications of ADPKD include cerebral aneurysms, hepatic or pancreatic cysts, cardiac valvular abnormalities (ie, mitral valve prolapse, aortic regurgitation), colonic diverticula, and ventral or inguinal hernias.&nbsp; The sudden death of this patient&#39;s father suggests rupture of a cerebral aneurysm in the setting of ADPKD.&nbsp; The <strong>diagnosis</strong> of ADPKD is based mainly on <strong>abdominal ultrasound</strong> or CT showing enlarged kidneys with numerous cysts.</p><p><strong>(Choice A)</strong>&nbsp; Elevated 24-hour urine cortisol excretion is seen in Cushing syndrome.&nbsp; Although Cushing syndrome can cause secondary hypertension, it is unlikely in this patient who is not overweight and is feeling well, without suggestive symptoms (eg, fatigue, irritability).&nbsp; Cushing syndrome may be due to adrenal tumors but is unlikely to cause palpable abdominal masses.</p><p><strong>(Choice C)</strong>&nbsp; Captopril-enhanced radionuclide renal scan is used occasionally to diagnose suspected renovascular disease or renal artery stenosis as a cause of refractory hypertension.&nbsp; However, these conditions are not associated with palpable renal enlargement.</p><p><strong>(Choice D)</strong>&nbsp; A high plasma aldosterone/renin ratio is seen in patients with primary aldosteronism (Conn syndrome), which is a common cause of secondary hypertension.&nbsp; However, it usually involves a unilateral adrenal adenoma that is not easily palpable; bilateral palpable adenomas would be highly unusual.</p><p><strong>(Choice E)</strong>&nbsp; Urinary excretion of metanephrines is increased in patients with pheochromocytoma.&nbsp; These patients usually have a paroxysmal elevation in blood pressure accompanied by headaches, palpitations, and/or diaphoresis.</p><p><strong>Educational objective:</strong><br>Most patients with autosomal dominant polycystic kidney disease are asymptomatic until age 30-40, when renal cysts become large and numerous.&nbsp; Bilateral upper abdominal masses are typically palpable on physical examination, and hypertension is an early disease manifestation that typically precedes a progressive decline in renal function.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1012,
            "section": "Shelf Review",
            "subjectId": 240010,
            "subject": "Ambulatory Medicine",
            "secondarySubjectId": 250002,
            "secondarySubject": "Medicine",
            "systemId": 203,
            "system": "Cardiovascular System",
            "topicId": 1168,
            "topic": "Polycystic kidney disease",
            "titleId": 1168,
            "title": "Polycystic kidney disease",
            "topicAttributeId": 330611,
            "topicAttribute": "Hypertension",
            "correctAnswer": "2",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "24-hour urine cortisol",
                    "choiceNumber": 1,
                    "correctTaken": 85,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Abdominal ultrasound",
                    "choiceNumber": 2,
                    "correctTaken": 3523,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Captopril-enhanced radionuclide renal scan",
                    "choiceNumber": 3,
                    "correctTaken": 58,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Plasma aldosterone/renin ratio",
                    "choiceNumber": 4,
                    "correctTaken": 1007,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Urine metanephrines",
                    "choiceNumber": 5,
                    "correctTaken": 493,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": None,
            "isCorrect": False,
            "isIncorrect": False,
            "isMarked": False,
            "isOmitted": True,
            "isQuestionDirty": False,
            "isAnswerChoiceDisabled": False,
            "isQuestionDisabled": False,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "17434405",
                    "mediaDataId": 0,
                    "title": "Autosomal dominant polycystic kidney disease.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/17434405"
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20219618",
                    "mediaDataId": 0,
                    "title": "Hypertension in autosomal dominant polycystic kidney disease.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20219618"
                }
            ],
            "questionMedia": None,
            "timeSpent": 0,
            "othersAvgTimeSpent": 71,
            "notes": None,
            "peopleTaken": 5166,
            "hotspotImageUrl": None,
            "lastUpdatedDate": "01/01/2022",
            "correctPercentile": 68,
            "isSubmitted": False,
            "isActive": True,
            "activeStatusId": 1,
            "hint": None,
            "allowCalculator": False,
            "difficultyLevelId": None,
            "additionalText": None,
            "mobileExcerpt": None,
            "passageExcerpt": None,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": None,
            "standards": None,
            "totalTimeSpentReview": 12,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": None,
            "examYear": 0,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": None,
            "copyrightId": None,
            "copyrightText": None,
            "frequentHighlights": None,
            "totalWeight": None,
            "weightScored": None,
            "maxAnswerSelection": 0,
            "scoreTypeId": None
        },
        {
            "exhibits": None,
            "sequenceId": 31,
            "questionId": 19479,
            "questionIndex": 20965,
            "questionText": "<p>A 61-year-old woman comes to the office due to elevated blood pressure.&nbsp; Blood pressure was 152/92 mm Hg a month ago; she has been monitoring it at home since then, with an average of 148/88 mm Hg.&nbsp; The patient&#39;s only other medical condition is osteoporosis, diagnosed 6 months ago and treated with vitamin D, calcium, and alendronate.&nbsp; Today in the office, blood pressure is 156/90 mm Hg on the left arm and 152/92 mm Hg on the right and pulse is 70/min.&nbsp; Physical examination is normal.&nbsp; Complete blood count, serum creatinine, serum electrolytes, TSH, and urinalysis are normal.&nbsp; ECG is normal.&nbsp; Which of the following is the best next step in management of this patient&#39;s blood pressure?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T69278\"><table class=\"table-default-style table-header-footer-style\" style=\"width:504px\"><tbody><tr><td colspan=\"2\" style=\"width:70.0%;\"><p align=\"center\"><strong>Choice of antihypertensive drug<br>for comorbid conditions</strong></p></td></tr><tr><td style=\"width:30.0%;\"><p align=\"center\"><strong>Coronary<br>atherosclerosis</strong></p></td><td style=\"width:70.0%;\"><ul><li>Angina pectoris: &#946;-blocker, CCB</li><li>Post&ndash;myocardial infarction: ACE inhibitor or ARB, &#946;-blocker</li></ul></td></tr><tr><td style=\"width:30.0%;\"><p align=\"center\"><strong>Heart failure<br>with reduced<br>ejection fraction</strong></p></td><td style=\"width:70.0%;\"><ul><li>ACE inhibitor or ARB, &#946;-blocker, diuretic, aldosterone antagonist</li></ul></td></tr><tr><td style=\"width:30.0%;\"><p align=\"center\"><strong>Atrial fibrillation<br>or flutter</strong></p></td><td style=\"width:70.0%;\"><ul><li>&#946;-Blocker, nondihydropyridine CCB</li></ul></td></tr><tr><td style=\"width:30.0%;\"><p align=\"center\"><strong>Chronic kidney<br>disease</strong></p></td><td style=\"width:70.0%;\"><ul><li>ACE inhibitor or ARB</li></ul></td></tr><tr><td style=\"width:30.0%;\"><p align=\"center\"><strong>Gout</strong></p></td><td style=\"width:70.0%;\"><ul><li>Losartan, other ARB, CCB (avoid diuretics)</li></ul></td></tr><tr><td style=\"width:30.0%;\"><p align=\"center\"><strong>Osteoporosis</strong></p></td><td style=\"width:70.0%;\"><ul><li>Thiazide diuretic</li></ul></td></tr><tr><td style=\"width:30.0%;\"><p align=\"center\"><strong>Migraine</strong></p></td><td style=\"width:70.0%;\"><ul><li>&#946;-Blocker, CCB</li></ul></td></tr><tr><td colspan=\"2\" style=\"width:70.0%\"><p><strong>ARB</strong> = angiotensin II receptor blocker; <strong>CCB</strong> = calcium channel blocker.</p></td></tr></tbody></table></div><p>This patient has <strong>hypertension</strong>, confirmed on multiple occasions in both a health care setting and at home.&nbsp; A short-term trial of lifestyle modification only (eg, dietary modification, weight loss) may be considered for low-risk patients with minimal blood pressure elevation (ie, 130-140 mm Hg systolic, 80-90 mm Hg diastolic).&nbsp; In patients who have confirmed significant out-of-office blood pressure elevation (as in this patient), <a href=\"43399\">starting antihypertensives</a> without delay is recommended (possibly with a more liberal goal in those with advanced age) <strong>(Choice A)</strong>.</p><p>First-line antihypertensive agents include ACE inhibitors, angiotensin II receptor blockers, calcium channel blockers, and thiazide diuretics (eg, chlorthalidone).&nbsp; The choice of drug is determined largely by patient factors (eg, comorbidities, concurrent medications, adverse effects profile).</p><p>For patients with <strong>osteoporosis</strong>, <strong>thiazide diuretics</strong> are generally preferred; thiazides <a href=\"1710\">increase calcium reabsorption</a> in the distal tubule, reducing renal calcium wasting and <strong>slowing the rate of bone loss</strong>.&nbsp; Although thiazides can cause hypercalcemia, especially in patients taking supplemental calcium, it is rarely significant (unless hyperparathyroidism is present), and the calcium supplements may be continued; regular electrolyte monitoring is necessary with all diuretics.</p><p><strong>(Choices B and C)</strong>&nbsp; Common medications that raise blood pressure include decongestants (eg, pseudoephedrine), stimulants (eg, methylphenidate), some antidepressants (eg, bupropion), erythropoietin, and nonsteroidal anti-inflammatory drugs; alendronate and calcium do not generally affect blood pressure.</p><p><strong>(Choice D)</strong>&nbsp; Beta blockers (eg, atenolol) are commonly used for hypertension in patients with comorbid coronary heart disease (with angina or a history of myocardial infarction), heart failure with reduced ejection fraction, and atrial fibrillation.&nbsp; Although the benefit of hypertensive treatment is determined primarily by the degree of blood pressure lowering rather than the choice of drug, beta blockers appear to not confer the same benefits as other classes, especially in patients age &gt;60.</p><p><strong>Educational objective:</strong><br>First-line antihypertensive medications include ACE inhibitors, angiotensin II receptor blockers, calcium channel blockers, and thiazide diuretics; the choice of drug is determined largely by comorbid conditions, concurrent medications, and adverse effects profile.&nbsp; Thiazide diuretics reduce renal calcium wasting and slow the rate of bone loss and are therefore preferred in patients with osteoporosis.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1012,
            "section": "Shelf Review",
            "subjectId": 240008,
            "subject": "Family Medicine",
            "secondarySubjectId": 250010,
            "secondarySubject": "Ambulatory Medicine",
            "systemId": 203,
            "system": "Cardiovascular System",
            "topicId": 6690,
            "topic": "Primary hypertension",
            "titleId": 6690,
            "title": "Primary hypertension",
            "topicAttributeId": 330611,
            "topicAttribute": "Hypertension",
            "correctAnswer": "5",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Advise lifestyle modifications only",
                    "choiceNumber": 1,
                    "correctTaken": 764,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Change alendronate to denosumab",
                    "choiceNumber": 2,
                    "correctTaken": 318,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Discontinue calcium supplements",
                    "choiceNumber": 3,
                    "correctTaken": 111,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Start atenolol",
                    "choiceNumber": 4,
                    "correctTaken": 801,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Start chlorthalidone",
                    "choiceNumber": 5,
                    "correctTaken": 2970,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": None,
            "isCorrect": False,
            "isIncorrect": False,
            "isMarked": False,
            "isOmitted": True,
            "isQuestionDirty": False,
            "isAnswerChoiceDisabled": False,
            "isQuestionDisabled": False,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29146533",
                    "mediaDataId": 0,
                    "title": "2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29146533"
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "32149161",
                    "mediaDataId": 0,
                    "title": "Association between hypertension, antihypertensive drugs, and osteoporosis in postmenopausal Syrian women: a cross-sectional study.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/32149161"
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30993395",
                    "mediaDataId": 0,
                    "title": "Long-term thiazide use and risk of low-energy fractures among persons with Alzheimer&#39;s diseasenested case-control study",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30993395"
                }
            ],
            "questionMedia": None,
            "timeSpent": 0,
            "othersAvgTimeSpent": 74,
            "notes": None,
            "peopleTaken": 4964,
            "hotspotImageUrl": None,
            "lastUpdatedDate": "01/01/2022",
            "correctPercentile": 59,
            "isSubmitted": False,
            "isActive": True,
            "activeStatusId": 1,
            "hint": None,
            "allowCalculator": False,
            "difficultyLevelId": None,
            "additionalText": None,
            "mobileExcerpt": None,
            "passageExcerpt": None,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": None,
            "standards": None,
            "totalTimeSpentReview": 11,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": None,
            "examYear": 0,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": None,
            "copyrightId": None,
            "copyrightText": None,
            "frequentHighlights": None,
            "totalWeight": None,
            "weightScored": None,
            "maxAnswerSelection": 0,
            "scoreTypeId": None
        },
        {
            "exhibits": None,
            "sequenceId": 32,
            "questionId": 8810,
            "questionIndex": 8819,
            "questionText": "<p>A 29-year-old man comes to clinic 2 weeks after an emergency department visit for epistaxis requiring anterior nasal packing.&nbsp; In the emergency department, his blood pressure was 170/110 mm Hg.&nbsp; He has occasional headaches and fatigue but no chest pain, palpitations, or syncope.&nbsp; His past medical history is unremarkable and he does not use tobacco, alcohol, or illicit drugs.&nbsp; The patient&#39;s current blood pressure is 180/112 mm Hg and pulse is 78/min and regular.&nbsp; Cardiac auscultation in the supine position reveals no murmurs or additional sounds.&nbsp; Abdominal examination shows no periumbilical bruits.&nbsp; ECG shows normal sinus rhythm, high-voltage QRS complexes, downsloping ST-segment depression, and T wave inversion in leads V5 and V6.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td>Hemoglobin</td><td>14.2 g/dL</td></tr><tr><td>Platelets</td><td>230,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>Creatinine</td><td>1.0 mg/dL</td></tr></tbody></table><p>Which of the following is the best next step in evaluation of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t31286\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Coarctation of the aorta </strong></p></td></tr><tr><td><p align=\"center\"><strong>Etiology </strong></p></td><td><ul><li>Congenital</li><li>Acquired (rare) (eg, Takayasu arteritis)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features </strong></p></td><td><ul><li>Upper body<ul style=\"list-style-type:circle;\"><li>Well developed</li><li>Hypertension (headaches, epistaxis)</li></ul></li><li>Lower extremities<ul style=\"list-style-type:circle;\"><li>Underdeveloped</li><li>Claudication</li></ul></li><li>Brachial-femoral pulse delay</li><li>Upper &amp; lower extremity blood pressure differential</li><li>Left interscapular systolic or continuous murmur</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnostic studies </strong></p></td><td><ul><li>ECG: Left ventricular hypertrophy</li><li>Chest x-ray<ul style=\"list-style-type:circle;\"><li>Inferior notching of the 3rd to 8th ribs</li><li>&quot;3&quot; sign due to aortic indentation</li></ul></li></ul><ul><li>Echocardiography: diagnostic confirmation</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment </strong></p></td><td><ul><li>Balloon angioplasty &plusmn; stent placement</li><li>Surgery</li></ul></td></tr></tbody></table></div><p>This patient&#39;s elevated blood pressure and ECG findings consistent with left ventricular hypertrophy (LVH) (eg, high-voltage QRS complexes, lateral ST segment depression, lateral T wave inversion) are suggestive of <strong>long-standing systemic hypertension</strong>.&nbsp; Essential hypertension rarely leads to end-organ damage (eg, LVH) in young patients (eg, age &lt;40), and therefore a cause of <strong>secondary hypertension</strong> should be sought.</p><p><strong>Coarctation of the aorta</strong>&nbsp;is a <a href=\"209\">narrowing of the descending aorta</a> (typically located just distal to the origin of the left subclavian artery) that results in a proximal increase in arterial pressure and decreased blood flow to the lower body.&nbsp; Patients usually present with asymptomatic hypertension; however, <strong>epistaxis</strong>, headaches, and lower extremity claudication can occur.&nbsp; A continuous murmur is characteristically present but may be difficult to auscultate in the supine position.&nbsp; Patients should be initially evaluated for coarctation of the aorta with:</p><ol><li>Simultaneous palpation of the brachial and femoral pulses to assess for <strong>brachial-femoral delay</strong></li><li>Bilateral upper extremity (supine position) and lower extremity (prone position) blood pressure measurement to evaluate for <strong>upper and lower extremity blood pressure differential</strong></li></ol><p>Patients with abnormal findings should undergo diagnostic confirmation with echocardiogram.</p><p><strong>(Choice A)</strong>&nbsp; Ambulatory blood pressure monitoring is sometimes used for patients in whom the diagnosis of hypertension is uncertain.&nbsp; It is not indicated in this patient with significantly elevated blood pressure and evidence of LVH.</p><p><strong>(Choice C)</strong>&nbsp; Squatting increases the volume of blood in the left ventricle and allows for differentiating the systolic murmur of aortic stenosis (intensifies with squatting, lessens with standing) from that of hypertrophic cardiomyopathy (lessens with squatting, intensifies with standing).&nbsp; This patient&#39;s epistaxis, headaches, and systemic hypertension are more suggestive of aortic coarctation.</p><p><strong>(Choice D)</strong>&nbsp; Carotid sinus massage slows atrioventricular node conduction and can sometimes terminate paroxysmal supraventricular tachycardia (eg, atrioventricular nodal reentrant tachycardia).&nbsp; However, it is not useful in the evaluation or treatment of hypertension.</p><p><strong>(Choice E)</strong>&nbsp; Exercise stress testing is often used to evaluate for coronary artery disease; however, this patient&#39;s ECG changes are more suggestive of LVH.&nbsp; In addition, coronary artery disease is very unlikely in this young patient, especially in the absence of chest pain.</p><p><strong>Educational objective:</strong><br>Coarctation of the aorta is a potential cause of secondary hypertension in young adults.&nbsp; Patients should be initially evaluated with simultaneous palpation of the brachial and femoral pulses to assess for brachial-femoral delay, and bilateral upper and lower extremity blood pressure measurement to assess for blood pressure differential.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1012,
            "section": "Shelf Review",
            "subjectId": 240010,
            "subject": "Ambulatory Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": None,
            "systemId": 203,
            "system": "Cardiovascular System",
            "topicId": 1967,
            "topic": "Aortic coarctation",
            "titleId": 1967,
            "title": "Aortic coarctation",
            "topicAttributeId": 330577,
            "topicAttribute": "Congenital heart disease",
            "correctAnswer": "2",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Ambulatory blood pressure monitoring",
                    "choiceNumber": 1,
                    "correctTaken": 491,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bilateral arm and leg blood pressure measurements",
                    "choiceNumber": 2,
                    "correctTaken": 2658,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cardiac auscultation in squatting and standing positions",
                    "choiceNumber": 3,
                    "correctTaken": 826,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Carotid sinus massage",
                    "choiceNumber": 4,
                    "correctTaken": 406,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Exercise stress testing",
                    "choiceNumber": 5,
                    "correctTaken": 669,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": None,
            "isCorrect": False,
            "isIncorrect": False,
            "isMarked": False,
            "isOmitted": True,
            "isQuestionDirty": False,
            "isAnswerChoiceDisabled": False,
            "isQuestionDisabled": False,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "16256011",
                    "mediaDataId": 0,
                    "title": "Coarctation of the aorta.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/16256011"
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "19038677",
                    "mediaDataId": 0,
                    "title": "ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/19038677"
                }
            ],
            "questionMedia": None,
            "timeSpent": 0,
            "othersAvgTimeSpent": 110,
            "notes": None,
            "peopleTaken": 5050,
            "hotspotImageUrl": None,
            "lastUpdatedDate": "01/01/2022",
            "correctPercentile": 52,
            "isSubmitted": False,
            "isActive": True,
            "activeStatusId": 1,
            "hint": None,
            "allowCalculator": False,
            "difficultyLevelId": None,
            "additionalText": None,
            "mobileExcerpt": None,
            "passageExcerpt": None,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": None,
            "standards": None,
            "totalTimeSpentReview": 4,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": None,
            "examYear": 0,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": None,
            "copyrightId": None,
            "copyrightText": None,
            "frequentHighlights": None,
            "totalWeight": None,
            "weightScored": None,
            "maxAnswerSelection": 0,
            "scoreTypeId": None
        },
        {
            "exhibits": None,
            "sequenceId": 33,
            "questionId": 3627,
            "questionIndex": 3627,
            "questionText": "<p>A study is undertaken to evaluate a new serological screening test for the diagnosis of tuberculosis infection.&nbsp; In the study, 1000 people were randomly selected from the population and given the new diagnostic test, and positive and negative results were recorded.&nbsp; Each study participant also was given the gold standard diagnostic procedure to determine the true infection state of the individual.&nbsp; The findings are as follows:</p><blockquote><table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" width=\"400\"><tbody><tr><td width=\"29%\"></td><td colspan=\"3\" width=\"71%\"><b>True Tuberculosis infection state</b></td></tr><tr><td width=\"29%\"><b>Test results</b></td><td width=\"19%\"><b>Yes</b></td><td width=\"30%\"><b>No</b></td><td width=\"23%\"><b>Total</b></td></tr><tr><td width=\"29%\"><b>Positive</b></td><td width=\"19%\">130</td><td width=\"30%\">60</td><td width=\"23%\">190</td></tr><tr><td width=\"29%\"><b>Negative</b></td><td width=\"19%\">50</td><td width=\"30%\">760</td><td width=\"23%\">810</td></tr><tr><td width=\"29%\"><b>Total</b></td><td width=\"19%\">180</td><td width=\"30%\">820</td><td width=\"23%\">1000</td></tr></tbody></table></blockquote><p>Which of the following is the positive predictive value of the screening test under study?</p>",
            "questionHeader": "",
            "explanationText": "<p>Although predictive values are not true indices of the validity of a test, these are still of prime importance to physicians.&nbsp; In clinical practice, patients will more often present with a positive or negative test result, rather than a disease or disease-free state; therefore, one should have sufficient knowledge about the predictive values of a test.</p><p>Positive predictive value is defined as the proportion of subjects with a positive test result who actually have the disease.&nbsp; Negative predictive value is defined as the proportion of subjects with a negative test result who are free of disease.&nbsp; Consider the following 2 x 2 table:</p><blockquote><table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" width=\"600\"><tbody><tr><td width=\"25%\"></td><td align=\"center\" colspan=\"3\" width=\"75%\"><b>Disease</b></td></tr><tr><td width=\"25%\"><b>Test results</b></td><td width=\"25%\"><b>Present</b></td><td width=\"25%\"><b>Absent</b></td><td width=\"25%\"><b>Total</b></td></tr><tr><td width=\"25%\"><b>Positive</b></td><td width=\"25%\">A<br>True positive (TP)</td><td width=\"25%\">B<br>False positive (FP)</td><td width=\"25%\">A+B</td></tr><tr><td width=\"25%\"><b>Negative</b></td><td width=\"25%\">C<br>False Negative (FN)</td><td width=\"25%\">D<br>True Negative (TN)</td><td width=\"25%\">C+D</td></tr><tr><td width=\"25%\"><b>Total</b></td><td width=\"25%\">A+C</td><td width=\"25%\">B+D</td><td width=\"25%\">A+B+C+D</td></tr></tbody></table></blockquote><blockquote>Positive predictive value = TP/(TP+FP) or A/(A+B)<br>Negative predictive value = TN/(TN+FN) or D/(C+D)<br>In this case, the PPV is 130 / 190.</blockquote><p><strong>(Choice A)</strong>&nbsp; Sensitivity and specificity are useful for assessing the validity of a test.&nbsp; 130/180 is the sensitivity of the test.</p><p><strong>(Choice D)</strong>&nbsp; 760/810 is the negative predictive value of the test.</p><p><strong>Educational objective:</strong><br>Know how to calculate the predictive values of a test.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1012,
            "section": "Shelf Review",
            "subjectId": 240010,
            "subject": "Ambulatory Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": None,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 10211,
            "topic": "Sensitivity, specificity, NPV, PPV",
            "titleId": 10211,
            "title": "Sensitivity, specificity, NPV, PPV",
            "topicAttributeId": 330659,
            "topicAttribute": "Probability and principles of testing",
            "correctAnswer": "2",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "130/180",
                    "choiceNumber": 1,
                    "correctTaken": 42331,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "130/190",
                    "choiceNumber": 2,
                    "correctTaken": 236224,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "50/810",
                    "choiceNumber": 3,
                    "correctTaken": 3199,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "760/810",
                    "choiceNumber": 4,
                    "correctTaken": 2815,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "60/190",
                    "choiceNumber": 5,
                    "correctTaken": 2500,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": None,
            "isCorrect": False,
            "isIncorrect": False,
            "isMarked": False,
            "isOmitted": True,
            "isQuestionDirty": False,
            "isAnswerChoiceDisabled": False,
            "isQuestionDisabled": False,
            "questionMappingReferencesList": None,
            "questionMedia": None,
            "timeSpent": 0,
            "othersAvgTimeSpent": 38,
            "notes": None,
            "peopleTaken": 287069,
            "hotspotImageUrl": None,
            "lastUpdatedDate": "01/01/2022",
            "correctPercentile": 82,
            "isSubmitted": False,
            "isActive": True,
            "activeStatusId": 1,
            "hint": None,
            "allowCalculator": False,
            "difficultyLevelId": None,
            "additionalText": None,
            "mobileExcerpt": None,
            "passageExcerpt": None,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": None,
            "standards": None,
            "totalTimeSpentReview": 6,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": None,
            "examYear": 0,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": None,
            "copyrightId": None,
            "copyrightText": None,
            "frequentHighlights": None,
            "totalWeight": None,
            "weightScored": None,
            "maxAnswerSelection": 0,
            "scoreTypeId": None
        },
        {
            "exhibits": None,
            "sequenceId": 34,
            "questionId": 19478,
            "questionIndex": 20964,
            "questionText": "<p>A 70-year-old man comes to the office for a follow-up for gout.&nbsp; It has been well controlled, with no joint pain since he started taking allopurinol 6 months ago.&nbsp; The patient has had no chest pain, trouble breathing, headaches, or lightheadedness.&nbsp; He does not use tobacco, alcohol, or illicit drugs.&nbsp; The patient&#39;s blood pressure was 145/90 mm Hg and 150/95 mm Hg at his 2 previous visits.&nbsp; Today, his blood pressure is 148/92 mm Hg on the left arm and 144/90 mm Hg on the right arm.&nbsp; Physical examination is normal.&nbsp; Complete blood cell count, serum creatinine, serum electrolytes, TSH, uric acid, and urinalysis results are normal.&nbsp; ECG indicates left ventricular hypertrophy.&nbsp; Which of the following is the best next step in managing this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t69278\"><table class=\"table-default-style table-header-footer-style\" style=\"width:504px\"><tbody><tr><td colspan=\"2\" style=\"width:70.0%;\"><p align=\"center\"><strong>Choice of antihypertensive drug<br />for comorbid conditions</strong></p></td></tr><tr><td style=\"width:30.0%;\"><p align=\"center\"><strong>Coronary<br />atherosclerosis</strong></p></td><td style=\"width:70.0%;\"><ul><li>Angina pectoris: &beta;-blocker, CCB</li><li>Post&ndash;myocardial infarction: ACE inhibitor or ARB, &beta;-blocker</li></ul></td></tr><tr><td style=\"width:30.0%;\"><p align=\"center\"><strong>Heart failure<br />with reduced<br />ejection fraction</strong></p></td><td style=\"width:70.0%;\"><ul><li>ACE inhibitor or ARB, &beta;-blocker, diuretic, aldosterone antagonist</li></ul></td></tr><tr><td style=\"width:30.0%;\"><p align=\"center\"><strong>Atrial fibrillation<br />or flutter</strong></p></td><td style=\"width:70.0%;\"><ul><li>&beta;-Blocker, nondihydropyridine CCB</li></ul></td></tr><tr><td style=\"width:30.0%;\"><p align=\"center\"><strong>Chronic kidney<br />disease</strong></p></td><td style=\"width:70.0%;\"><ul><li>ACE inhibitor or ARB</li></ul></td></tr><tr><td style=\"width:30.0%;\"><p align=\"center\"><strong>Gout</strong></p></td><td style=\"width:70.0%;\"><ul><li>Losartan, other ARB, CCB (avoid diuretics)</li></ul></td></tr><tr><td style=\"width:30.0%;\"><p align=\"center\"><strong>Osteoporosis</strong></p></td><td style=\"width:70.0%;\"><ul><li>Thiazide diuretic</li></ul></td></tr><tr><td style=\"width:30.0%;\"><p align=\"center\"><strong>Migraine</strong></p></td><td style=\"width:70.0%;\"><ul><li>&beta;-Blocker, CCB</li></ul></td></tr><tr><td colspan=\"2\" style=\"width:70.0%\"><p><strong>ARB</strong> = angiotensin II receptor blocker; <strong>CCB</strong> = calcium channel blocker.</p></td></tr></tbody></table></div><p>This patient has newly diagnosed <strong>hypertension</strong>, confirmed by measurements on 3 different office visits.&nbsp; His initial workup shows evidence of end-organ injury (ie, <strong>left ventricular hypertrophy</strong> [LVH]), so <strong>antihypertensive treatment</strong> must be started without delay <strong>(Choice C)</strong>.</p><p>First-line antihypertensive agents that can lower blood pressure and minimize LVH include angiotensin II receptor blockers (ARBs), ACE inhibitors, calcium channel blockers, and thiazide diuretics.&nbsp; However, comorbid <strong>gout</strong> in this patient makes thiazide diuretics <strong>(Choice D)</strong> a poor choice because they can raise uric acid levels and increase the risk of gout attack.&nbsp; In contrast, the ARB <strong>losartan</strong> has a mild <strong>uricosuric</strong> effect, which decreases the risk of gout attack.&nbsp; In addition, ARBs provide the <a href=\"44722\">greatest reduction in LVH</a> of all first-line antihypertensive agents.&nbsp; Other antihypertensive options for patients with gout include other ARBs, ACE inhibitors, and calcium channel blockers.</p><p><strong>(Choice A)</strong>&nbsp; Discontinuing allopurinol would not decrease the patient&#39;s blood pressure or address LVH, putting him at increased risk for stroke, myocardial infarction, and additional hypertensive damage.&nbsp; Without allopurinol, the patient&#39;s uric acid level would increase, causing more frequent gout attacks.</p><p><strong>(Choice B)</strong>&nbsp; Exercise stress testing is used to evaluate cardiac ischemia; this patient has no evidence of ischemia (eg, chest pain, dyspnea, ST-segment depression).&nbsp; Echocardiography should be considered to further assess LVH, but obtaining this test should not delay initiation of blood pressure medication.</p><p><strong>Educational objective:</strong><br>Losartan is an angiotensin II receptor blocker (ARB) that has a mild uricosuric effect and is the preferred first-line antihypertensive drug for patients with gout.&nbsp; Other options include other ARBs, ACE inhibitors, and calcium channel blockers.&nbsp; Thiazide diuretics can raise circulating uric acid levels and should be avoided.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1012,
            "section": "Shelf Review",
            "subjectId": 240008,
            "subject": "Family Medicine",
            "secondarySubjectId": 250010,
            "secondarySubject": "Ambulatory Medicine",
            "systemId": 203,
            "system": "Cardiovascular System",
            "topicId": 6690,
            "topic": "Primary hypertension",
            "titleId": 6690,
            "title": "Primary hypertension",
            "topicAttributeId": 330611,
            "topicAttribute": "Hypertension",
            "correctAnswer": "5",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Discontinue allopurinol and recheck blood pressure in 4 weeks",
                    "choiceNumber": 1,
                    "correctTaken": 170,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Order exercise stress testing",
                    "choiceNumber": 2,
                    "correctTaken": 131,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reassure patient and follow up in 3 months to recheck blood pressure",
                    "choiceNumber": 3,
                    "correctTaken": 195,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Start hydrochlorothiazide",
                    "choiceNumber": 4,
                    "correctTaken": 727,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Start losartan",
                    "choiceNumber": 5,
                    "correctTaken": 3821,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": None,
            "isCorrect": False,
            "isIncorrect": False,
            "isMarked": False,
            "isOmitted": True,
            "isQuestionDirty": False,
            "isAnswerChoiceDisabled": False,
            "isQuestionDisabled": False,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22240117",
                    "mediaDataId": 0,
                    "title": "Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22240117"
                }
            ],
            "questionMedia": None,
            "timeSpent": 0,
            "othersAvgTimeSpent": 79,
            "notes": None,
            "peopleTaken": 5044,
            "hotspotImageUrl": None,
            "lastUpdatedDate": "01/01/2022",
            "correctPercentile": 75,
            "isSubmitted": False,
            "isActive": True,
            "activeStatusId": 1,
            "hint": None,
            "allowCalculator": False,
            "difficultyLevelId": None,
            "additionalText": None,
            "mobileExcerpt": None,
            "passageExcerpt": None,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": None,
            "standards": None,
            "totalTimeSpentReview": 9,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": None,
            "examYear": 0,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": None,
            "copyrightId": None,
            "copyrightText": None,
            "frequentHighlights": None,
            "totalWeight": None,
            "weightScored": None,
            "maxAnswerSelection": 0,
            "scoreTypeId": None
        },
        {
            "exhibits": None,
            "sequenceId": 35,
            "questionId": 3914,
            "questionIndex": 3914,
            "questionText": "<p>A 34-year-old woman comes to the office for a follow-up blood pressure check.&nbsp; Over the last 12 months, the patient&#39;s blood pressure readings have ranged from 145/90 to 150/95 mm Hg.&nbsp; Her blood pressure was measured during a health fair 2 weeks ago and it was 145/90 mm Hg.&nbsp; The patient feels well, has no other medical conditions, and has never been pregnant.&nbsp; Medications include a combination oral contraceptive for the past 5 years and, occasionally, acetaminophen for relief of tension headaches.&nbsp; She does not use tobacco, alcohol, or illicit drugs.&nbsp; There is no family history of hypertension, stroke, deep venous thrombosis, or heart attack.&nbsp; Blood pressure is 150/90 mm Hg and pulse is 80/min.&nbsp; BMI is 22 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Physical examination and ECG are normal.&nbsp; Six months ago, the patient&#39;s total cholesterol level was 170 mg/dL.&nbsp; Complete blood count, urinalysis, and basic metabolic panel are unremarkable.&nbsp; Which of the following is the most appropriate next step in management of this patient&#39;s hypertension?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient has stage 2 <strong>hypertension</strong>, defined as systolic blood pressure &#8805;140 mm Hg and/or diastolic blood pressure &#8805;90 mm Hg.&nbsp; <strong>Oral contraceptives</strong> (OCs) commonly cause a mild elevation in blood pressure and sometimes (in up to 5% of chronic users) can lead to overt hypertension.&nbsp; The mechanism is unclear but is possibly due to an estrogen-mediated increase in hepatic angiotensinogen synthesis or other effects on the renin-angiotensin system.&nbsp; The risk of hypertension increases with the <strong>duration of OC use</strong> and is elevated in those who have a family history of hypertension or who developed hypertension during a previous pregnancy.</p><p>The Centers for Disease Control and Prevention recommends against the use of combination estrogen-progestin OCs in women with hypertension.&nbsp; In patients whose hypertension is caused by OC use, discontinuation can reduce blood pressure and often corrects the condition.&nbsp; The physician should have a discussion with the patient about the benefit of stopping the OC, the risks of drug continuation, and alternate contraceptive methods.</p><p><strong>(Choices A and E)</strong>&nbsp; If elevated blood pressure persists after OC discontinuation, lifestyle modification and/or medication (eg, low-dose thiazide diuretic) may be required.</p><p><strong>(Choice B)</strong>&nbsp; Renovascular hypertension and fibromuscular dysplasia are uncommon causes of hypertension; therefore, routine CT angiogram of the abdomen is not recommended.&nbsp; Investigation for secondary causes of hypertension is considered for patients with more severe or refractory hypertension or with other signs of renovascular disease (eg, acute kidney injury after initiation of an ACE inhibitor, recurrent flash pulmonary edema).</p><p><strong>(Choice D)</strong>&nbsp; Reassurance without intervention is inappropriate because hypertension is an important cardiovascular risk factor that should be treated properly to reduce the risk of cardiovascular events.</p><p><strong>Educational objective:</strong><br>Oral contraceptives (OCs) commonly cause a mild elevation in blood pressure and can sometimes lead to overt hypertension.&nbsp; OCs should not be used in patients with hypertension, and those who develop hypertension while taking OCs should discontinue the medication.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1012,
            "section": "Shelf Review",
            "subjectId": 240010,
            "subject": "Ambulatory Medicine",
            "secondarySubjectId": 250008,
            "secondarySubject": "Family Medicine",
            "systemId": 203,
            "system": "Cardiovascular System",
            "topicId": 15573,
            "topic": "Secondary hypertension",
            "titleId": 15573,
            "title": "Secondary hypertension",
            "topicAttributeId": 330611,
            "topicAttribute": "Hypertension",
            "correctAnswer": "3",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Initiate a low-dose thiazide diuretic",
                    "choiceNumber": 1,
                    "correctTaken": 765,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Perform a CT angiogram of the abdomen",
                    "choiceNumber": 2,
                    "correctTaken": 437,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prescribe an alternate form of contraception",
                    "choiceNumber": 3,
                    "correctTaken": 2978,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reassure the patient; no intervention is required",
                    "choiceNumber": 4,
                    "correctTaken": 42,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recommend a diet and exercise regimen",
                    "choiceNumber": 5,
                    "correctTaken": 840,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": None,
            "isCorrect": False,
            "isIncorrect": False,
            "isMarked": False,
            "isOmitted": True,
            "isQuestionDirty": False,
            "isAnswerChoiceDisabled": False,
            "isQuestionDisabled": False,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22129517",
                    "mediaDataId": 0,
                    "title": "Hypertension in women.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22129517"
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22195528",
                    "mediaDataId": 0,
                    "title": "Drug-induced hypertension: an unappreciated cause of secondary hypertension.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22195528"
                }
            ],
            "questionMedia": None,
            "timeSpent": 0,
            "othersAvgTimeSpent": 81,
            "notes": None,
            "peopleTaken": 5062,
            "hotspotImageUrl": None,
            "lastUpdatedDate": "01/01/2022",
            "correctPercentile": 58,
            "isSubmitted": False,
            "isActive": True,
            "activeStatusId": 1,
            "hint": None,
            "allowCalculator": False,
            "difficultyLevelId": None,
            "additionalText": None,
            "mobileExcerpt": None,
            "passageExcerpt": None,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": None,
            "standards": None,
            "totalTimeSpentReview": 16,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": None,
            "examYear": 0,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": None,
            "copyrightId": None,
            "copyrightText": None,
            "frequentHighlights": None,
            "totalWeight": None,
            "weightScored": None,
            "maxAnswerSelection": 0,
            "scoreTypeId": None
        },
        {
            "exhibits": None,
            "sequenceId": 36,
            "questionId": 3885,
            "questionIndex": 3885,
            "questionText": "A prospective cohort study revealed a strong positive association between smoking and liver cirrhosis (relative risk&nbsp; = 2.8).&nbsp; The researchers then divided the cohort into two groups: alcohol consumers and non-consumers.&nbsp; Subsequent statistical analysis did not reveal any association between smoking and liver cirrhosis with either group.&nbsp; The scenario described above is an example of which of the following?",
            "questionHeader": "",
            "explanationText": "<P>Confounding refers to the bias that results when the exposure-disease relationship is mixed with the effect of extraneous factors (i.e., confounders).&nbsp; Confounders influence both the exposure and outcome.&nbsp; In the given study, crude analysis of the data initially revealed an association between smoking and liver cirrhosis.&nbsp; The most likely potential confounder is concomitant alcohol consumption in people who smoke.&nbsp; It is a well-known fact that alcohol consumption is strongly associated with liver cirrhosis.&nbsp; Furthermore, alcohol consumption can explain at least part of the association observed between smoking and liver cirrhosis.</P><P>Methods to deal with confounding include matching of cases and controls based on the confounding factor, or stratification of the study population based on the confounding factor.&nbsp; In this case, running separate analyses for alcohol consumers and non-consumers (this technique is called stratified analysis) can unmask confounding and disclose the true unconfounded value of the RR.</P><P><STRONG>(Choice A)</STRONG> Selection bias results from the manner in which people are selected for the study, or from the selective losses from follow-up.&nbsp; The scenario does not mention any of these problems.</P><P><STRONG>(Choices B and C)</STRONG> Observer's bias and measurement bias distort the measure of association by misclassifying exposed/unexposed and/or diseased/non-diseased subjects.&nbsp; The scenario does not describe this classification process.</P><P><STRONG>(Choice D)</STRONG> Recall bias results from the inaccurate recall of past exposure by people in the study.&nbsp; It applies mostly to case-control studies, not cohort studies.</P><P><STRONG>Educational Ojective:</STRONG><BR>Know the concept of confounding.&nbsp; Distinguish between crude and adjusted measures of association.&nbsp; Confounding&nbsp; refers to the bias that can result when the exposure-disease relationship is mixed with the effect of extraneous factors (i.e., confounders).</P>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1012,
            "section": "Shelf Review",
            "subjectId": 240010,
            "subject": "Ambulatory Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": None,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 6409,
            "topic": "Confounding, effect modification, bias, errors",
            "titleId": 6409,
            "title": "Confounding, effect modification, bias, errors",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "5",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Selection bias",
                    "choiceNumber": 1,
                    "correctTaken": 28456,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Observer's bias",
                    "choiceNumber": 2,
                    "correctTaken": 8173,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Measurement bias",
                    "choiceNumber": 3,
                    "correctTaken": 14174,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recall bias",
                    "choiceNumber": 4,
                    "correctTaken": 5092,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Confounding",
                    "choiceNumber": 5,
                    "correctTaken": 232119,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": None,
            "isCorrect": False,
            "isIncorrect": False,
            "isMarked": False,
            "isOmitted": True,
            "isQuestionDirty": False,
            "isAnswerChoiceDisabled": False,
            "isQuestionDisabled": False,
            "questionMappingReferencesList": None,
            "questionMedia": None,
            "timeSpent": 0,
            "othersAvgTimeSpent": 33,
            "notes": None,
            "peopleTaken": 288014,
            "hotspotImageUrl": None,
            "lastUpdatedDate": "01/01/2022",
            "correctPercentile": 80,
            "isSubmitted": False,
            "isActive": True,
            "activeStatusId": 1,
            "hint": None,
            "allowCalculator": False,
            "difficultyLevelId": None,
            "additionalText": None,
            "mobileExcerpt": None,
            "passageExcerpt": None,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": None,
            "standards": None,
            "totalTimeSpentReview": 8,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": None,
            "examYear": 0,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": None,
            "copyrightId": None,
            "copyrightText": None,
            "frequentHighlights": None,
            "totalWeight": None,
            "weightScored": None,
            "maxAnswerSelection": 0,
            "scoreTypeId": None
        },
        {
            "exhibits": None,
            "sequenceId": 37,
            "questionId": 4157,
            "questionIndex": 4157,
            "questionText": "<p>A cohort study was conducted to assess the relationship between high saturated fat consumption and the occurrence of colorectal carcinoma among women.&nbsp; A group of women aged 40-65 was selected.&nbsp; The baseline saturated fat consumption was calculated using a food questionnaire, and the cohort was followed for seven years for the development of colon cancer.&nbsp; The study showed that women with high baseline saturated fat consumption have four times the risk of colorectal cancer in a 7-year period, compared to women with low fat consumption (RR = 4.0, 95% CI = 1.5 - 6.5).&nbsp; According to the study results, what percent of colorectal carcinoma in women with high fat consumption could be attributed to their diet?</p>",
            "questionHeader": "",
            "explanationText": "<p>Attributable risk percent (ARP) or etiologic fraction is an important measure of the impact of a risk factor being studied.&nbsp; ARP represents the excess risk in a population that can be explained by exposure to a particular risk factor.&nbsp; It is calculated by subtracting the risk in the unexposed population (<em>baseline risk</em>) from the risk in the exposed population, and dividing the result by the risk in the exposed population:</p><blockquote><p>ARP = (risk in exposed - risk in unexposed)/risk in exposed.</p></blockquote><p>An easier way to calculate the ARP is to derive it from the relative risk (RR):</p><blockquote><p>ARP = (RR - 1)/RR.</p></blockquote><p>In this case, ARP = (4.0 - 1)/4.0 = 0.75 (75%).&nbsp; According to the study results, 75% of colorectal carcinoma in the high consumption group was attributable to high saturated fat intake.</p><p><strong>Educational Objective:</strong><br>ARP represents the excess risk in the exposed population that can be attributed to the risk factor.&nbsp; It can be easily derived from the relative risk using the following formula: ARP = (RR - 1)/RR.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1012,
            "section": "Shelf Review",
            "subjectId": 240010,
            "subject": "Ambulatory Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": None,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 20684,
            "topic": "Risk",
            "titleId": 20684,
            "title": "Risk",
            "topicAttributeId": 330595,
            "topicAttribute": "Epidemiology and population health",
            "correctAnswer": "3",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "25%",
                    "choiceNumber": 1,
                    "correctTaken": 99895,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "50%",
                    "choiceNumber": 2,
                    "correctTaken": 19950,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "75%",
                    "choiceNumber": 3,
                    "correctTaken": 126610,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "90%",
                    "choiceNumber": 4,
                    "correctTaken": 20620,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "100%",
                    "choiceNumber": 5,
                    "correctTaken": 20179,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": None,
            "isCorrect": False,
            "isIncorrect": False,
            "isMarked": False,
            "isOmitted": True,
            "isQuestionDirty": False,
            "isAnswerChoiceDisabled": False,
            "isQuestionDisabled": False,
            "questionMappingReferencesList": None,
            "questionMedia": None,
            "timeSpent": 0,
            "othersAvgTimeSpent": 86,
            "notes": None,
            "peopleTaken": 287254,
            "hotspotImageUrl": None,
            "lastUpdatedDate": "01/01/2022",
            "correctPercentile": 44,
            "isSubmitted": False,
            "isActive": True,
            "activeStatusId": 1,
            "hint": None,
            "allowCalculator": False,
            "difficultyLevelId": None,
            "additionalText": None,
            "mobileExcerpt": None,
            "passageExcerpt": None,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": None,
            "standards": None,
            "totalTimeSpentReview": 5,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": None,
            "examYear": 0,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": None,
            "copyrightId": None,
            "copyrightText": None,
            "frequentHighlights": None,
            "totalWeight": None,
            "weightScored": None,
            "maxAnswerSelection": 0,
            "scoreTypeId": None
        },
        {
            "exhibits": None,
            "sequenceId": 38,
            "questionId": 4445,
            "questionIndex": 4445,
            "questionText": "<p>A 43-year-old woman complains of fatigue and shortness of breath over the last 2 weeks.&nbsp; She has no chest pain, nausea, vomiting, or weight loss.&nbsp; She reports a recent upper respiratory tract infection.&nbsp; The patient does not use tobacco, alcohol, or illicit drugs.&nbsp; Her blood pressure is 98/55 mm Hg and pulse is 105/min.&nbsp; Jugular veins are distended with the patient in the seated position.&nbsp; Lungs are clear to auscultation.&nbsp; Chest x-ray is shown below.</p><p><img draggable=\"false\" id=\"5260\" src=\"https://www.uworld.com/media/U18550.png\" ></p><p>Which of the following is the most likely additional finding in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient&#39;s clinical presentation - recent upper respiratory tract infection, dyspnea, elevated jugular venous pressure (JVP), clear lung fields, and increased cardiac silhouette on chest x-ray - is suggestive of <strong>early cardiac tamponade due to a large pericardial effusion</strong>.&nbsp; Pericardial effusion is most commonly idiopathic (thought to be likely from a viral illness) but can also occur due to bacterial or fungal infections, neoplasms (metastatic or primary), post myocardial infarction, trauma, uremia, autoimmune diseases, and hypothyroidism.</p><p>Large pericardial effusions typically appear on chest x-ray as an <strong>enlarged and globular</strong> <a href=\"43819\">cardiac silhouette</a> with <strong>clear lung fields</strong>.&nbsp; Physical examination findings in pericardial effusion are nonspecific and vary depending on size of the effusion.&nbsp; However, the <strong>inability to palpate</strong> the <strong>point of maximal apical impulse</strong> is consistent with large pericardial effusion.&nbsp; Patients with cardiac tamponade may also have Beck&#39;s triad of hypotension, elevated JVP, and muffled heart sounds.</p><p><strong>(Choice A)</strong>&nbsp; Patients with viral myocarditis may present similarly with a history of recent upper respiratory infection, fatigue, dyspnea, elevated JVP, and cardiomegaly on imaging.&nbsp; However, patients typically have an audible S3 and bibasilar rales on physical examination, along with pulmonary vascular congestion on imaging studies.&nbsp; An abnormal S4 may be heard in patients with decreased left ventricular compliance, including those with hypertensive heart disease, aortic stenosis, or hypertrophic cardiomyopathy, and during the acute phase of myocardial infarction.</p><p><strong>(Choice B)</strong>&nbsp; Fixed splitting of the second heart sound is heard in patients with atrial septal defect.&nbsp; Chest x-ray may show an enlarged right atrium and ventricle along with prominent hilar or proximal pulmonary arterial vasculature.</p><p><strong>(Choice C)</strong>&nbsp; Intermittent ptosis can be seen in patients with myasthenia gravis, which can occur as an autoimmune disorder or as a paraneoplastic disorder in association with thymoma.&nbsp; These tumors present as anterior mediastinal (or retrosternal) masses on lateral chest x-ray projection.&nbsp; Cardiac size and silhouette are typically normal.</p><p><strong>(Choice E)</strong>&nbsp; An opening snap is heard in patients with mitral stenosis.&nbsp; Significant mitral stenosis leads to left atrial enlargement, which presents on chest x-ray as straightening of the left heart border, elevated left main bronchus, and pulmonary vascular congestion with cephalization of the blood flow to upper lobes.&nbsp; Lateral chest x-ray projection can reveal posterior displacement and impingement of the esophagus.</p><p><strong>(Choice F)</strong>&nbsp; Pulsus bisferiens (or biphasic pulse) refers to 2 strong systolic peaks of the aortic pulse from left ventricular ejection separated by a midsystolic dip.&nbsp; It can be palpated in patients with significant <strong>aortic regurgitation</strong> (with or without aortic stenosis), hypertrophic obstructive cardiomyopathy, and, occasionally, large patent ductus arteriosus.</p><p><strong>Educational objective:</strong><br>A pericardial effusion appears as an enlarged, globular cardiac silhouette on chest x-ray.&nbsp; Physical examination findings of effusion without cardiac tamponade include diminished heart sounds on auscultation and a maximal apical impulse that is difficult to palpate.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1012,
            "section": "Shelf Review",
            "subjectId": 240010,
            "subject": "Ambulatory Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": None,
            "systemId": 203,
            "system": "Cardiovascular System",
            "topicId": 5853,
            "topic": "Cardiac tamponade",
            "titleId": 5853,
            "title": "Cardiac tamponade",
            "topicAttributeId": 330628,
            "topicAttribute": "Myopericardial diseases",
            "correctAnswer": "4",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Audible fourth heart sound",
                    "choiceNumber": 1,
                    "correctTaken": 1297,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fixed splitting of the second heart sound",
                    "choiceNumber": 2,
                    "correctTaken": 316,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intermittent ptosis",
                    "choiceNumber": 3,
                    "correctTaken": 32,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Nonpalpable point of maximal impulse",
                    "choiceNumber": 4,
                    "correctTaken": 2353,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Opening snap",
                    "choiceNumber": 5,
                    "correctTaken": 202,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pulsus bisferiens",
                    "choiceNumber": 6,
                    "correctTaken": 802,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": None,
            "isCorrect": False,
            "isIncorrect": False,
            "isMarked": False,
            "isOmitted": True,
            "isQuestionDirty": False,
            "isAnswerChoiceDisabled": False,
            "isQuestionDisabled": False,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "10967149",
                    "mediaDataId": 0,
                    "title": "Clinical clues to the causes of large pericardial effusions.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/10967149"
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21808166",
                    "mediaDataId": 0,
                    "title": "A systematic approach to evaluation of pericardial effusion and cardiac tamponade.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21808166"
                }
            ],
            "questionMedia": None,
            "timeSpent": 0,
            "othersAvgTimeSpent": 83,
            "notes": None,
            "peopleTaken": 5002,
            "hotspotImageUrl": None,
            "lastUpdatedDate": "01/01/2022",
            "correctPercentile": 47,
            "isSubmitted": False,
            "isActive": True,
            "activeStatusId": 1,
            "hint": None,
            "allowCalculator": False,
            "difficultyLevelId": None,
            "additionalText": None,
            "mobileExcerpt": None,
            "passageExcerpt": None,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": None,
            "standards": None,
            "totalTimeSpentReview": 14,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": None,
            "examYear": 0,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": None,
            "copyrightId": None,
            "copyrightText": None,
            "frequentHighlights": None,
            "totalWeight": None,
            "weightScored": None,
            "maxAnswerSelection": 0,
            "scoreTypeId": None
        },
        {
            "exhibits": None,
            "sequenceId": 39,
            "questionId": 2151,
            "questionIndex": 2151,
            "questionText": "<p>A study evaluated the relationship between the common cold and the number of cigarettes smoked per day.&nbsp; The research was conducted among fourth-year medical students and sponsored by the public health department of the medical school.&nbsp; Medical students with symptoms of common cold were interviewed about their smoking status, number of packs smoked per day, and duration of smoking.&nbsp; All participants completed the interview and their data analyzed.&nbsp; Based on this information, which of the following is of most concern regarding the study?</p>",
            "questionHeader": "",
            "explanationText": "<p><strong>Response bias</strong> occurs when participants in cross-sectional studies (eg, surveys, polls, questionnaires, interviews) purposely give desirable responses to questions about topics perceived to be sensitive (eg, health behaviors).&nbsp; Biased <strong>responses</strong> become less useful as they are <strong>inaccurate</strong> and may lead to <strong>incorrect conclusions</strong> (eg, lower than expected prevalence of disease or frequency of risk factors).</p><p>In this example, medical students likely know the risk of smoking and may purposely report smoking a lesser number of cigarettes than they truly smoke, especially to interviewers from the public health department of their institution.&nbsp; This underreporting may significantly affect the results of the study.</p><p><strong>(Choice A)</strong>&nbsp; Admission rate bias occurs when a distortion in risk ratio exists due to hospitals&#39; differing admission rates for certain cases.&nbsp; For instance, patients with cardiac diseases may be admitted to hospitals with more specialized cardiology services.</p><p><strong>(Choice B)</strong>&nbsp; Lead-time bias occurs when a screening test diagnoses a disease earlier than it would have appeared by natural history alone, so that the time from diagnosis until death appears prolonged even though there might actually be no improvement in survival.</p><p><strong>(Choice C)</strong>&nbsp; Nonresponse bias occurs when respondents differ from nonrespondents in such meaningful ways that threaten the generalizability of study results.&nbsp; All participants in this study completed the interview, so there were no nonrespondents.</p><p><strong>(Choice D)</strong>&nbsp; Regression to the mean refers to a set of data where the first assessment of a variable reveals an extreme value but repeat assessment reveals values closer to the center of the distribution of that variable.</p><p><strong>Educational objective:</strong><br>Response bias occurs when participants purposely give desirable responses to questions about topics perceived to be sensitive (eg, health behaviors).&nbsp; This practice results in responses that are inaccurate and may lead to incorrect conclusions (eg, lower than expected prevalence of disease or frequency of risk factors).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1012,
            "section": "Shelf Review",
            "subjectId": 240010,
            "subject": "Ambulatory Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": None,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 24175,
            "topic": "Bias",
            "titleId": 24175,
            "title": "Bias",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "5",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Admission rate bias",
                    "choiceNumber": 1,
                    "correctTaken": 887,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lead-time bias",
                    "choiceNumber": 2,
                    "correctTaken": 142,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Nonresponse bias",
                    "choiceNumber": 3,
                    "correctTaken": 607,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Regression to the mean",
                    "choiceNumber": 4,
                    "correctTaken": 149,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Response bias",
                    "choiceNumber": 5,
                    "correctTaken": 3243,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": None,
            "isCorrect": False,
            "isIncorrect": False,
            "isMarked": False,
            "isOmitted": True,
            "isQuestionDirty": False,
            "isAnswerChoiceDisabled": False,
            "isQuestionDisabled": False,
            "questionMappingReferencesList": None,
            "questionMedia": None,
            "timeSpent": 0,
            "othersAvgTimeSpent": 49,
            "notes": None,
            "peopleTaken": 5028,
            "hotspotImageUrl": None,
            "lastUpdatedDate": "01/01/2022",
            "correctPercentile": 64,
            "isSubmitted": False,
            "isActive": True,
            "activeStatusId": 1,
            "hint": None,
            "allowCalculator": False,
            "difficultyLevelId": None,
            "additionalText": None,
            "mobileExcerpt": None,
            "passageExcerpt": None,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": None,
            "standards": None,
            "totalTimeSpentReview": 7,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": None,
            "examYear": 0,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": None,
            "copyrightId": None,
            "copyrightText": None,
            "frequentHighlights": None,
            "totalWeight": None,
            "weightScored": None,
            "maxAnswerSelection": 0,
            "scoreTypeId": None
        },
        {
            "exhibits": None,
            "sequenceId": 40,
            "questionId": 18522,
            "questionIndex": 19993,
            "questionText": "<p>A 35-year-old man comes to the office due to 3 months of persistent cough and shortness of breath with exertion.&nbsp; The patient was treated for sinusitis 3 times and pneumonia twice in the past 2 years; symptoms improved after antibiotic therapy but recurred quickly thereafter.&nbsp; He has never smoked cigarettes and takes no medications.&nbsp; Temperature is 37 C (98.6 F), blood pressure is 110/78 mm Hg, pulse is 86/min, and respirations are 15/min.&nbsp; BMI is 23 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; The oropharynx is clear.&nbsp; There is no lymphadenopathy or hepatosplenomegaly.&nbsp; Complete blood count, serum electrolytes, and renal function tests are normal.&nbsp; HIV testing is negative.&nbsp; CT scans reveal mucosal thickening of the paranasal sinuses and fibrosis at bilateral lung bases.&nbsp; What is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T33026\"><table class=\"table-default-style\" style=\"width:576px\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Common variable immunodeficiency</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathophysiology</strong></p></td><td><ul><li>Abnormal differentiation of B cells into plasma cells &#8594; decreased immunoglobulin production</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical manifestations</strong></p></td><td><ul><li>Symptom onset classically age 20-40, as early as puberty</li><li>Recurrent respiratory infections (eg, pneumonia, sinusitis, otitis)</li><li>Recurrent GI infections (eg, <em>Salmonella, Campylobacter, Giardia</em>)</li><li>Chronic disease:<ul style=\"list-style-type:circle;\"><li>Autoimmune (eg, RA, thyroid disease)</li><li>Pulmonary (eg, bronchiectasis, fibrosis)</li><li>GI (eg, chronic diarrhea, IBD-like conditions)</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><ul><li>&#8595;&#8595; IgG, &#8595; IgA/IgM</li><li>No response to vaccination</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Immunoglobulin replacement therapy</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>GI</strong> = gastrointestinal; <strong>IBD</strong> = inflammatory bowel disease; <strong>RA</strong> = rheumatoid arthritis.</p></td></tr></tbody></table></div><p>This patient has <strong>recurrent sinopulmonary infections</strong> and <strong>chronic lung disease</strong>, findings suggestive of an <strong>immunoglobulin deficiency</strong> disorder.&nbsp; Symptom onset in <strong>young adulthood</strong> (age 20-40) is characteristic of <strong>common variable immunodeficiency</strong> (CVID), a primary humoral immunodeficiency in which antibody production is decreased because B cells cannot differentiate into plasma cells.</p><p>The most common initial manifestations of CVID include acute and chronic rhinosinusitis, as seen on this patient&#39;s imaging.&nbsp; Patients may subsequently develop progressive cough and dyspnea due to restrictive or obstructive lung disease.&nbsp; Mechanisms for chronic lung disease include the following:</p><ul><li><p>Immune-mediated <strong>interstitial lung disease</strong> resulting in <strong>pulmonary fibrosis</strong> and <strong>scarring</strong></p></li><li><p><strong>Bronchiectasis</strong> (ie, dilated, thickened airways) due to frequent infection and inflammation</p></li></ul><p>Other manifestations can include chronic gastrointestinal illness, autoimmune disorders, and atopic disease.</p><p>The next step in evaluation of a humoral immunodeficiency is a <strong>quantitative immunoglobulin panel</strong>.&nbsp; Patients with CVID have <strong>low IgG</strong> in combination with <strong>low IgM and/or IgA</strong>.&nbsp; Antibody response to vaccines is also low in CVID, but leukocyte count is generally normal.&nbsp; Treatment is immunoglobulin replacement therapy and management of chronic lung disease.</p><p><strong>(Choice A)</strong>&nbsp; Bronchoalveolar lavage can be used to diagnose a primary lung disease (eg, pneumonia, malignancy).&nbsp; The presence of concomitant, chronic sinus disease in this patient makes an underlying immunodeficiency more likely.</p><p><strong>(Choice B)</strong>&nbsp; Flow cytometry may be considered in an infant or toddler with low immunoglobulin levels concerning for X-linked agammaglobulinemia, which is characterized by markedly low B cells.&nbsp; This patient&#39;s age makes this diagnosis unlikely.&nbsp; Flow cytometry is not required for the diagnosis of CVID but typically reveals normal B and T lymphocytes.</p><p><strong>(Choice C)</strong>&nbsp; Alpha-1 antitrypsin deficiency is characterized by tissue damage in the lungs and liver.&nbsp; The sinuses are not involved, and CT scan would reveal emphysematous changes (eg, large air spaces) rather than fibrosis in the lower lungs.</p><p><strong>(Choice E)</strong>&nbsp; Sputum culture for acid-fast bacilli is diagnostic for <em>Mycobacterium tuberculosis</em>, which can cause chronic pulmonary infection but very rarely affects the sinuses.&nbsp; Classic x-ray findings of pulmonary tuberculosis include consolidation, cavitation, hilar adenopathy, and pleural effusions.</p><p><strong>Educational objective:</strong><br>Recurrent sinopulmonary infections and evidence of chronic lung disease (eg, bronchiectasis, fibrosis/scarring) in a young adult are suspicious for an underlying immunoglobulin deficiency such as common variable immunodeficiency.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1012,
            "section": "Shelf Review",
            "subjectId": 240002,
            "subject": "Medicine",
            "secondarySubjectId": 250010,
            "secondarySubject": "Ambulatory Medicine",
            "systemId": 201,
            "system": "Allergy & Immunology",
            "topicId": 6351,
            "topic": "Common variable immunodeficiency",
            "titleId": 6351,
            "title": "Common variable immunodeficiency",
            "topicAttributeId": 330613,
            "topicAttribute": "Immune deficiencies",
            "correctAnswer": "4",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bronchoalveolar lavage",
                    "choiceNumber": 1,
                    "correctTaken": 551,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Flow cytometry of peripheral blood",
                    "choiceNumber": 2,
                    "correctTaken": 312,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Measurement of serum alpha-1 antitrypsin level",
                    "choiceNumber": 3,
                    "correctTaken": 1420,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Quantitative immunoglobulin assay",
                    "choiceNumber": 4,
                    "correctTaken": 2718,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Sputum culture for acid-fast bacilli",
                    "choiceNumber": 5,
                    "correctTaken": 64,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": None,
            "isCorrect": False,
            "isIncorrect": False,
            "isMarked": False,
            "isOmitted": True,
            "isQuestionDirty": False,
            "isAnswerChoiceDisabled": False,
            "isQuestionDisabled": False,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24952009",
                    "mediaDataId": 0,
                    "title": "CT screening for pulmonary pathology in common variable immunodeficiency disorders and the correlation with clinical and immunological parameters.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24952009"
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23880700",
                    "mediaDataId": 0,
                    "title": "Common variable immunodeficiencyassociated granulomatous and interstitial lung disease.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23880700"
                }
            ],
            "questionMedia": None,
            "timeSpent": 0,
            "othersAvgTimeSpent": 101,
            "notes": None,
            "peopleTaken": 5065,
            "hotspotImageUrl": None,
            "lastUpdatedDate": "01/01/2022",
            "correctPercentile": 53,
            "isSubmitted": False,
            "isActive": True,
            "activeStatusId": 1,
            "hint": None,
            "allowCalculator": False,
            "difficultyLevelId": None,
            "additionalText": None,
            "mobileExcerpt": None,
            "passageExcerpt": None,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": None,
            "standards": None,
            "totalTimeSpentReview": 7,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": None,
            "examYear": 0,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": None,
            "copyrightId": None,
            "copyrightText": None,
            "frequentHighlights": None,
            "totalWeight": None,
            "weightScored": None,
            "maxAnswerSelection": 0,
            "scoreTypeId": None
        }
    ]
    course = Course.objects.get(id=1)

    for x in data:
  
        # question = Question.objects.get(questionText=x["questionText"])
        # section = Section.objects.get(section=x["section"])
        # system = System.objects.get(system=x["system"])
        
        topic = Topic.objects.get(topic=x["topic"])
        
        subject = Subject.objects.get(subject=x["subject"])
        section = Section.objects.get(section=x["section"])
        system = System.objects.get(system=x["system"])
        # question  = Question.objects.get(questionText=x["questionText"])

        # print(section, system, topic, subject)
        # subject = Subject.objects.update_or_create(subject=x["subject"])
        # topic = Topic.objects.update_or_create(topic=x["topic"], topicAttribute=x["topicAttribute"])
        # system = System.objects.update_or_create(system=x["system"])
        # subject.system.add(system)
        # Question.objects.update_or_create(questionText=x["questionText"], explanationText=x["explanationText"], questionHeader=x["questionHeader"], course=course, section=section, topic=topic, subject=subject, system=system, correctAnswer=int(x["correctAnswer"]))
        # for z in x["answerChoiceList"]:
        #     ans = Answer.objects.create(choice=z["choice"], choiceNumber=int(z["choiceNumber"]))
        #     question.answerChoiceList.add(ans)

            # Answer.objects.update_or_create(choice=)

    return HttpResponse("Hello, world. You're at the polls index.")

@api_view(["GET", "POST"])
def course(request):
    q = Question.objects.filter(section=Section.objects.get(id=1))
    
    if request.method == "GET":
        courses = Course.objects.all().distinct()
        serializer = CourseSerializer(courses, many=True)

        return Response(serializer.data)

    if request.method == "POST":
        data = request.data

        h = Question.objects.filter(system__system__in=request.data["system"], topic__topicAttribute__in=request.data["topics"])
        serializer = QuestionSerializer(h, many=True)

        for x in data:
            print(x)
        return Response(serializer.data)

@api_view(["GET"])
def questions_list(request):
    
    if request.method == "GET":
        questions = Question.objects.all()
        serializer = QuestionSerializer(questions, many=True)
        return Response(serializer.data)